<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.2 20190208//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD Journal Publishing DTD v2.3 20070202//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName journalpublishing.dtd?><?SourceDTD.Version 2.3?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Front Neural Circuits</journal-id><journal-id journal-id-type="iso-abbrev">Front Neural Circuits</journal-id><journal-id journal-id-type="publisher-id">Front. Neural Circuits</journal-id><journal-title-group><journal-title>Frontiers in Neural Circuits</journal-title></journal-title-group><issn pub-type="epub">1662-5110</issn><publisher><publisher-name>Frontiers Media S.A.</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">6473068</article-id><article-id pub-id-type="doi">10.3389/fncir.2019.00024</article-id><article-categories><subj-group subj-group-type="heading"><subject>Neuroscience</subject><subj-group><subject>Review</subject></subj-group></subj-group></article-categories><title-group><article-title>Cellular, Synaptic and Network Effects of Acetylcholine in the Neocortex</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Colangelo</surname><given-names>Cristina</given-names></name><xref ref-type="corresp" rid="c001"><sup>*</sup></xref><uri xlink:type="simple" xlink:href="https://loop.frontiersin.org/people/454964/overview"/></contrib><contrib contrib-type="author"><name><surname>Shichkova</surname><given-names>Polina</given-names></name><uri xlink:type="simple" xlink:href="https://loop.frontiersin.org/people/686621/overview"/></contrib><contrib contrib-type="author"><name><surname>Keller</surname><given-names>Daniel</given-names></name><uri xlink:type="simple" xlink:href="https://loop.frontiersin.org/people/42205/overview"/></contrib><contrib contrib-type="author"><name><surname>Markram</surname><given-names>Henry</given-names></name><uri xlink:type="simple" xlink:href="https://loop.frontiersin.org/people/74/overview"/></contrib><contrib contrib-type="author"><name><surname>Ramaswamy</surname><given-names>Srikanth</given-names></name><xref ref-type="corresp" rid="c001"><sup>*</sup></xref><uri xlink:type="simple" xlink:href="https://loop.frontiersin.org/people/32852/overview"/></contrib></contrib-group><aff id="aff1"><institution>Blue Brain Project, Ecole Polytechnique F&#x000e9;d&#x000e9;rale de Lausanne (EPFL)</institution>, <addr-line>Geneva</addr-line>, <country>Switzerland</country></aff><author-notes><fn fn-type="edited-by"><p>Edited by: Robert C. Froemke, New York University, United States</p></fn><fn fn-type="edited-by"><p>Reviewed by: Heiko J. Luhmann, Johannes Gutenberg University Mainz, Germany; Gilad Silberberg, Karolinska Institute (KI), Sweden</p></fn><corresp id="c001">*Correspondence: Cristina Colangelo <email>cristina.colangelo@epfl.ch</email> Srikanth Ramaswamy <email>srikanth.ramaswamy@epfl.ch</email></corresp></author-notes><pub-date pub-type="epub"><day>12</day><month>4</month><year>2019</year></pub-date><pub-date pub-type="collection"><year>2019</year></pub-date><volume>13</volume><elocation-id>24</elocation-id><history><date date-type="received"><day>28</day><month>1</month><year>2019</year></date><date date-type="accepted"><day>22</day><month>3</month><year>2019</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2019 Colangelo, Shichkova, Keller, Markram and Ramaswamy.</copyright-statement><copyright-year>2019</copyright-year><copyright-holder>Colangelo, Shichkova, Keller, Markram and Ramaswamy</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p></license></permissions><abstract><p>The neocortex is densely innervated by basal forebrain (BF) cholinergic neurons. Long-range axons of cholinergic neurons regulate higher-order cognitive function and dysfunction in the neocortex by releasing acetylcholine (ACh). ACh release dynamically reconfigures neocortical microcircuitry through differential spatiotemporal actions on cell-types and their synaptic connections. At the cellular level, ACh release controls neuronal excitability and firing rate, by hyperpolarizing or depolarizing target neurons. At the synaptic level, ACh impacts transmission dynamics not only by altering the presynaptic probability of release, but also the magnitude of the postsynaptic response. Despite the crucial role of ACh release in physiology and pathophysiology, a comprehensive understanding of the way it regulates the activity of diverse neocortical cell-types and synaptic connections has remained elusive. This review aims to summarize the state-of-the-art anatomical and physiological data to develop a functional map of the cellular, synaptic and microcircuit effects of ACh in the neocortex of rodents and non-human primates, and to serve as a quantitative reference for those intending to build data-driven computational models on the role of ACh in governing brain states.</p></abstract><kwd-group><kwd>neuromodulation</kwd><kwd>acetylcholine</kwd><kwd>Ach receptors</kwd><kwd>neocortex</kwd><kwd>cellular excitability</kwd><kwd>synaptic transmission</kwd><kwd>network activity</kwd></kwd-group><counts><fig-count count="5"/><table-count count="4"/><equation-count count="0"/><ref-count count="167"/><page-count count="27"/><word-count count="23064"/></counts></article-meta></front><body><sec sec-type="introduction" id="s1"><title>Introduction</title><p>The cholinergic system is one of the most well-studied neuromodulatory systems, and perhaps phylogenetically the oldest. Acetylcholine (ACh) is found in both vertebrates and invertebrates and together with adrenaline and noradrenaline (NA), it acts as one of the main effectors of the autonomic nervous system. In the central nervous system (CNS), ACh impacts cellular and synaptic physiology and may switch network dynamics resulting in behavioral transitions such as from sleep to wakefulness, distraction to attention, and learning and recall (Hasselmo and Sarter, <xref rid="B54" ref-type="bibr">2011</xref>; Lee and Dan, <xref rid="B79" ref-type="bibr">2012</xref>).</p><p>Cholinergic effects have been studied for more than a century. In 1869, Schmiedeberg and Koppe (<xref rid="B214" ref-type="bibr">1869</xref>) demonstrated how extracts of a common mushroom, <italic>Amanita muscaria</italic>, could slow, and at a higher concentration arrest the beat of the frog heart. They purified the extract and named it muscarine. This substance, when applied to the brain and spinal cord was able to produce flaccidity and weaken the peripheral reflexes. However, the pharmacology of the nitrite ester of choline was different in that it had considerable nicotinic activity (nicotine is the major alkaloid of tobacco, first isolated by Posselt and Reiman from <italic>Nicotiniana tabacum</italic> leaves in 1828; Koukouli et al., <xref rid="B76" ref-type="bibr">2017</xref>). In 1921 experimental proof was obtained for ACh&#x02019;s role as a chemical transmitter at the cardiac vagal endings. The active substance was initially named &#x0201c;vagusstoff&#x0201d; by Otto Loewi in 1921 (Loewi, <xref rid="B85" ref-type="bibr">1924</xref>). Sir Henry Dale further described that muscarinic responses were antagonized by atropine, whereas the nicotine actions were antagonized by curare (Dale, <xref rid="B30" ref-type="bibr">1914</xref>).</p><p>It has long been known that ACh is also present at the level of the CNS, however, it was not until 1953 that evidence of the release of ACh in the brain was provided (Eccles et al., <xref rid="B39" ref-type="bibr">1953</xref>). Prior to this discovery, it was known that anti-cholinergic drugs could influence learning and memory&#x02014;pharmacological activation of muscarinic ACh receptors (mAChRs) was known to produce delirium symptoms, while receptor blockade generates severe anterograde amnesia. Moreover, the dementia of Alzheimer&#x02019;s and Parkinson&#x02019;s diseases has been associated with the loss of cortical cholinergic innervation (Little et al., <xref rid="B84" ref-type="bibr">1998</xref>; Giacobini, <xref rid="B45" ref-type="bibr">2003</xref>; Sabri et al., <xref rid="B114" ref-type="bibr">2008</xref>; Hasselmo and Sarter, <xref rid="B54" ref-type="bibr">2011</xref>), and chronic administration of nicotine reverses hypofrontality in animal models of addiction and schizophrenia (Koukouli et al., <xref rid="B76" ref-type="bibr">2017</xref>).</p><p>Classical notions sustain the view that the central cholinergic system works by a diffuse release of ACh across the cortex, activating its receptors globally and producing slow responses. While this view might be applicable to long-lasting behavioral phenomena, such as cortical arousal, it does not explain the modulation of processes that happen on a much faster scale, such as sensory gating, or plasticity (Mu&#x000f1;oz and Rudy, <xref rid="B98" ref-type="bibr">2014</xref>). ACh release in the neocortex originates from neurons distributed within the basal forebrain (BF) nuclei, including the medial septum, the vertical and horizontal diagonal band of Broca, the substantia innominata, and the nucleus basalis of Meynert (NBM). Release occurs through topographical projections, and all the projections arise from six groups of choline acetyl-transferase (ChAT)-positive neurons in the BF (Ch1&#x02013;Ch4) and brainstem (Ch5&#x02013;Ch6; Wevers, <xref rid="B142" ref-type="bibr">2011</xref>). The innervation sparsely reaches all cortical layers, but layer 5 is more heavily innervated, particularly in the motor and sensory areas; cholinergic pathways often provide <italic>en passant</italic> innervation (Dani and Bertrand, <xref rid="B31" ref-type="bibr">2007</xref>) to the neocortex. Additionally, ACh-releasing cells are found in cortical layer 2/3. These cells exhibit a bipolar morphology, stain positive for calretinin (CR) and vasoactive intestinal peptide (VIP), and are GABAergic (von Engelhardt et al., <xref rid="B140" ref-type="bibr">2007</xref>; Granger et al., <xref rid="B49" ref-type="bibr">2018</xref>).</p><p>The function of a neuromodulatory system is largely defined by the anatomy of its projections. Projections from the BF selectively control cortical activity and target neocortical regions more specifically than previously assumed (Hasselmo and Sarter, <xref rid="B54" ref-type="bibr">2011</xref>; Mu&#x000f1;oz and Rudy, <xref rid="B98" ref-type="bibr">2014</xref>; Obermayer et al., <xref rid="B104" ref-type="bibr">2017</xref>). Recent evidence suggests that a roughly topographical organizational scheme exists in the rostro-caudal sequence of neurons of the BF (Zaborszky et al., <xref rid="B146" ref-type="bibr">2015</xref>) and that specific BF nuclei innervate specific cortical areas, as opposed to what happens with noradrenergic fibers originating from the locus coeruleus (Chaves-Coira et al., <xref rid="B24" ref-type="bibr">2016</xref>; Kim et al., <xref rid="B72" ref-type="bibr">2016</xref>). Cholinergic fibers can take one of four different routes to cortical structures: the septal pathway (which projects mainly to the hippocampal cortex) the medial pathway, the lateral pathway, or the internal capsule projection (which preferentially project to the neocortex; Poorthuis et al., <xref rid="B107" ref-type="bibr">2014</xref>). Cholinergic terminals that reach the neocortex, mainly <italic>via</italic> layer 1 or layer 6 (Obermayer et al., <xref rid="B104" ref-type="bibr">2017</xref>), can either exert a spread out control of cortical activity and regulate processes such as the transition from sleep to wakefulness and arousal, or contact a restricted number of cortical elements and have cell-type specific effects; here contextual cholinergic signals act in concert with local processing of sensory inputs in order to guide behavior.</p><p>The aim of this review is to bring together current knowledge of cholinergic modulation in the neocortex and to identify the gaps to propose future directions to advance the field of neuromodulation. Here, we summarize existing literature on ACh release in the neocortex of rodents and non-human primates, specifically focusing on how ACh-induced effects on the diversity of cell-types and synapses shape the emergence of network states and review theories that bridge the modulation of local circuit properties and the consequent reconfiguration of cortical states. Data-driven computational models allow predictions on the potential role of ACh in reconfiguring neocortical states (Ramaswamy et al., <xref rid="B110" ref-type="bibr">2018</xref>). Therefore, this review reconciles the minimal, although sparse, datasets required to build a multi-scale computational model of the neocortical cholinergic system.</p></sec><sec id="s2"><title>Volume vs. Synaptic Transmission</title><p>A major factor that determines the spatiotemporal precision of ACh action is the transmission mode at cholinergic terminals. Cholinergic cortical signaling has historically been considered a slow and diffuse process, which was established upon examination of the functional organization of cholinergic projections and was mainly based on reports indicating a nearly complete absence of classical synapses at the level of cholinergic terminals (Mu&#x000f1;oz and Rudy, <xref rid="B98" ref-type="bibr">2014</xref>). Before optogenetic techniques were available, cholinergic pathways could not be activated in a selective manner, and thus evidence of the existence of fast cholinergic synaptic transmission was lacking, although some proof of fast nicotinic responses was already available from hippocampal recordings (Kalmbach et al., <xref rid="B65" ref-type="bibr">2012</xref>; Obermayer et al., <xref rid="B104" ref-type="bibr">2017</xref>).</p><p>In the cerebral cortex, cholinergic fibers are distributed in an intricate network with a characteristic laminar pattern. They have a higher density in the deeper layers. Cholinergic innervation reflects the classic organizational scheme of information processing systems (Kennedy and Bullier, <xref rid="B71" ref-type="bibr">1985</xref>), with a higher number of projections being present in higher-order areas. Presumed cholinergic release sites have been ultra-structurally inspected and the subtle presence of synapse-like contacts has indeed been revealed; however, a relatively large number of these small varicosities, which are often associated with accumulated synaptic vesicles, do not seem to effectively establish synaptic contact with neighboring neurons, or exhibit only a few morphologically identifiable synapses Furthermore, the scarceness of astrocytic processes in the immediate vicinity of ChAT-immuno-reactive axons (when compared to glutamatergic terminals) may also allow greater diffusion of ACh within the extracellular space (Aoki and Kabak, <xref rid="B7" ref-type="bibr">1992</xref>). Thus, relatively low concentrations of ACh will reach locations that are distant from the release site. This produces volume transmission or bulk release: neuromodulators slowly diffuse in a wide cortical area and bind to a large pool of extra-synaptic receptors (Dani and Bertrand, <xref rid="B31" ref-type="bibr">2007</xref>).</p><p>Many studies (Umbriaco et al., <xref rid="B134" ref-type="bibr">1994</xref>; Descarries and Mechawar, <xref rid="B35" ref-type="bibr">2000</xref>; Sarter et al., <xref rid="B117" ref-type="bibr">2009</xref>; Yamasaki et al., <xref rid="B144" ref-type="bibr">2010</xref>) conducted in the neocortex have suggested that ACh acts preferentially non-synaptically; however, central cholinergic synapses had already been observed in the early &#x02018;90s. Actual synapses were found on cholinergic varicosities in the cingulate cortex of the rat (Umbriaco et al., <xref rid="B134" ref-type="bibr">1994</xref>), and in macaque more than 40 percent of cholinergic varicosities contained synaptic specializations (Mrzijak et al., <xref rid="B96" ref-type="bibr">1995</xref>). Later, Turrini et al. (<xref rid="B133" ref-type="bibr">2001</xref>) provide definitive evidence that suggests that synaptic mechanisms of cholinergic transmission not only exist but prevail in the rat neocortex. Ultrastructural observations that most (66%) cholinergic boutons&#x02014;as revealed by IR assays for the specific cholinergic marker, vesicular ACh transporter (vAChT)&#x02014;establish classical synapses in layer 5 of the rat parietal cortex. By applying an improved fixation protocol and by using an antibody for vAChT, Turrini et al. (<xref rid="B133" ref-type="bibr">2001</xref>) demonstrated that cholinergic boutons predominantly established symmetric synapses on layer 5 dendritic shafts. The authors also found that immuno-stained varicosities occasionally established asymmetric contacts, but always on dendritic spines.</p><p>Another study probed the molecular-anatomical relationship between detectable cholinergic varicosities and the most abundant receptor subtype in the cortex&#x02014;the muscarinic receptor subtype M1 (Yamasaki et al., <xref rid="B144" ref-type="bibr">2010</xref>). This study established that in the mouse neocortex M1 can be found almost exclusively on the extra-synaptic membrane of pyramidal cells (PCs). Here, they observed that M1 distribution is far denser than the putative cholinergic release sites and that it does not show any apposition pattern to the varicosities, nor to the cytomatrix active zone proteins that are normally found at glutamatergic terminals. Hence, M1&#x02019;s function in cortical PCs may be to sense ambient ACh released from cholinergic terminals at variable distances, and the main modality through which it is recruited is likely to be volume transmission. These approaches not only contribute to building a more refined knowledge of the subcellular localization of receptor subtypes but also provide a method to qualitatively discriminate between two major modes of transmission. Because of a substantial difference in the distribution pattern of cholinergic receptors across species, it is very likely that experiments performed in different species will yield conflicting results. For instance, even though a low incidence of classical synapses was reported for the rodent brain, a much higher proportion of cholinergic synapses was found in primates (Smiley et al., <xref rid="B124" ref-type="bibr">1997</xref>). In the human cerebral cortex, the same authors found that up to 67% of all cholinergic varicosities established synaptic contacts, suggesting that ACh signaling in humans is mostly mediated by point-to-point synaptic transmission; this mechanism appears to prevail in the primate brain, but whether the same can be said for rodents is still a matter of open debate.</p><p>Cholinergic innervation from the BF is more specific than previously considered; ACh can control cortical activity on a fine spatial scale as well. Indeed, these findings agree with the evidence of ACh signaling occurring through direct fast point-to-point synaptic transmission brought about by the application of optogenetic tools (Kalmbach et al., <xref rid="B65" ref-type="bibr">2012</xref>). Overall, it is not completely clear yet whether one mode of cholinergic transmission prevails over the other. Instead, a growing body of evidence suggests that volume and synaptic transmission may be complementary mechanisms by which ACh modulates cortical function (Sarter et al., <xref rid="B117" ref-type="bibr">2009</xref>). While bulk release is thought to cause a more tonic change in extracellular ACh concentration, in the scale of seconds and minutes, and is mainly mediated by activation of extra-synaptic receptors, ACh release occurring at junctional sites would have a more circumscribed influence, with the modulation of circuit activity being restricted to the contacted cortical elements and to a much more delimited spatiotemporal scale (Mu&#x000f1;oz and Rudy, <xref rid="B98" ref-type="bibr">2014</xref>). Taken together, evidence shows that ACh modulates microcircuit activity with different modalities, ranging from synaptic release to volume transmission, and exerts its effects by modifying membrane excitability or synaptic activity.</p><p>Instead of trying to proclaim one modality over the other, future research should address the issue of whether they can occur simultaneously and have a differential impact on the temporal aspects of the response. Traditional bath application of agonists results in broad spatial and temporal activation that might not reflect the accuracy of endogenous ACh release (Urban-Ciecko et al., <xref rid="B136" ref-type="bibr">2018</xref>). It is thus of crucial importance to determine whether the different ways in which cholinergic agonists are experimentally applied reflect different transmission modalities, and how faithfully stimulation protocols replicate physiological conditions. In the future, ACh application should be standardized according to precisely obtained dose-response and sensitization kinetics curves, and ascending concentrations should be used in order to detect eventual dose-dependent responses. Furthermore, it would be of outstanding interest to better understand how ACh release obtained by optogenetic stimulation of cholinergic afferents compares against bath application of cholinergic agonists. In a recent study, optogenetic recruitment of cholinergic fibers was performed in parallel with 1 mM ACh bath-application to detect changes in Martinotti cells (MCs) activity: the two techniques yielded very similar results (Obermayer et al., <xref rid="B103" ref-type="bibr">2018</xref>). Perhaps the high concentration of ACh used in this case is comparable with a more physiological activation of the cholinergic system. Further clarification is required on the matter, and future studies should, therefore, consider this issue and design their experiments accordingly.</p><p>Cholinergic projections are likely to be arranged according to a modular pattern, with isolated bands of neighboring ChAT<sup>+</sup> cells in the BF having defined cortical targets that are, in turn, functionally associated. When retrograde dyes are injected in distant cortical areas, labeled regions of cholinergic cells in the BF still largely overlap, even though the innervated cortical space is quite restricted (Mu&#x000f1;oz and Rudy, <xref rid="B98" ref-type="bibr">2014</xref>). Furthermore, Zaborszky et al. (<xref rid="B146" ref-type="bibr">2015</xref>) assert that the degree of overlap of labeled neuronal locations within the BF is positively correlated to the connection strength between the different injected cortical regions. Such an organization could induce widespread modulation even when the system is only focally activated (Mu&#x000f1;oz and Rudy, <xref rid="B98" ref-type="bibr">2014</xref>). Nevertheless, the response to neuromodulatory inputs is determined by the interplay of multiple factors, such as post-synaptic target, receptor type and subunit composition, subcellular localization of the receptors and their sensitivity. This way, a diffusely-organized projection system can fine-tune microcircuit activity. The cholinergic projection system should be viewed as a highly dynamic structure, able to propagate inputs either selectively or diffusely, switching from one modality to another, depending on the needs.</p><p>The next section aims to unravel the contribution of each subtype of cholinergic receptor to microcircuit modulation and attempts to determine the physiological relevance of their compartmentalized distribution and differential activation.</p></sec><sec id="s3"><title>Cholinergic Receptors</title><p>Even though the differential pharmacological effects had already been characterized, it was not until the early 1950s that the idea of &#x0201c;receptors&#x0201d; as the binding site for ACh was firmly established by Eccles et al. (<xref rid="B39" ref-type="bibr">1953</xref>). Cholinergic receptors are composed of two classes of transmembrane macromolecular complexes, the muscarinic and the nicotinic receptor families, each of which is further divided into subclasses. The occurrence of many ACh receptor subtypes and their differential dendritic, somatic, axonal, and synaptic localization contribute to the varied roles that these receptors play in the CNS. Cholinergic receptors have been found on axons originating from thalamic, cortical or basalo-cortical fibers as well as on cortical pyramidal excitatory neurons and inhibitory GABAergic interneurons (Groleau et al., <xref rid="B50" ref-type="bibr">2015</xref>). The precise layer-wise distribution of cholinergic terminals, the identification of cell-types that actually express cholinergic receptors, and the subcellular localization of these receptors are described in the following sections.</p></sec><sec id="s4"><title>Muscarinic Receptors</title><p>Cholinergic synapses throughout the CNS are composed of muscarinic receptors (mAChRs), which can be further differentiated into subtypes that are encoded by a single gene (Venter et al., <xref rid="B139" ref-type="bibr">1988</xref>; Van der Zee and Luiten, <xref rid="B137" ref-type="bibr">1999</xref>). Five genetically defined and pharmacologically characterized (M1 to M5) mAChR subtypes have been identified in the CNS with high levels of expression in subcortical structures and the cerebral cortex (Wevers, <xref rid="B142" ref-type="bibr">2011</xref>). Immunocytochemical approaches have identified different levels of expression of mAChRs throughout the cerebral cortex. These studies have detected moderate levels of mAChRs in the frontal cortex, parietal cortex, temporal cortex, entorhinal cortex, occipital cortex, insular and cingulate cortex, with the highest values for the temporal and occipital cortex. M1 receptors are the most abundantly expressed among all subtypes of mAChRs (Wevers, <xref rid="B142" ref-type="bibr">2011</xref>). The density of cholinergic terminals in the rat neocortex differs between the six layers and depends on the cortical region studied (Eckenstein et al., <xref rid="B40" ref-type="bibr">1988</xref>; Lysakowski et al., <xref rid="B86" ref-type="bibr">1989</xref>). The pattern of cellular staining for mAChRs in the neocortex is characterized by a clear laminar distribution: in most of the cortical mantle, especially in neocortical areas, predominantly layer 5 PCs (L5PCs) show strong immunoreactivity across mammals such as the mouse, golden hamster, rat, cat, and human (Van der Zee and Luiten, <xref rid="B137" ref-type="bibr">1999</xref>).</p><p>The density of each mAChR subtype differs throughout the brain with M1 being the most abundantly expressed and M5 the least (Alger et al., <xref rid="B2" ref-type="bibr">2014</xref>). In the hippocampus and neocortex, M1 is present at high levels, M3 is moderately represented (though generally low elsewhere) and M4 is present in high density, as almost anywhere else in the brain, even though its concentration is considerably lower than M1. M2 instead, is found at very low densities, and this class of receptors seems to be distributed according to a precise pattern. M2 receptors frequently reside on presynaptic axonal terminals, whereas M1 receptors are often located on somato-dendritic regions of neurons. The M5 subtype is believed to play an important role in cortical perfusion, and it is mainly expressed on endothelial cells of the cerebral vascular system (Elhusseiny and Hamel, <xref rid="B42" ref-type="bibr">2000</xref>; Gericke et al., <xref rid="B44" ref-type="bibr">2011</xref>) even though recent evidence suggests that the M3 subtype is also involved in this kind of process (Zuccolo et al., <xref rid="B151" ref-type="bibr">2017</xref>). In the rodent visual cortex, the subtypes M1 and M2 predominate, while in primates the subtypes M1, M2 and M4 prevail. Besides a few regional variations, highest labeling densities have been observed in the superficial layers of most cortical areas for both M1 and M2 (Wevers, <xref rid="B142" ref-type="bibr">2011</xref>).</p><p>Most cholinergic receptors are metabotropic and mediate slow responses, which are typically associated with volume transmission. In the neonatal and adult cortices of rodents and primates, M1&#x02013;M5 subtypes of mAChRs occur in both pre-synaptic and post-synaptic positions (Mrzljak et al., <xref rid="B97" ref-type="bibr">1993</xref>; Groleau et al., <xref rid="B50" ref-type="bibr">2015</xref>). All mAChRs are transmembrane macromolecular complexes that are coupled to membrane-embedded G-proteins of different kinds; g-proteins act as intracellular effectors and initiate signaling cascades that ultimately have an effect on intracellular processes, leading to the opening or closing of some ion channel, or to the production of long-term modifications of genetic activity and protein expression. Different mAChRs are coupled to specific G-proteins. The pre-synaptic mAChRs M2 and M4 preferentially couple to G<sub>i</sub> and G<sub>o</sub> proteins that generally have inhibitory effects on voltage-activated calcium channels or extend the opening of potassium channels. The resulting decrease in c-AMP signaling suppresses neurotransmitter release (Groleau et al., <xref rid="B50" ref-type="bibr">2015</xref>). M1, M3 and M5 subtypes are preferentially coupled to G<sub>q</sub> and G<sub>11</sub> proteins and are mainly located post-synaptically. Their activation seems to trigger membrane depolarization and increases the input-resistance of the cell membrane. M1-like (M1-M3-M5) receptors are known to potentiate NMDA currents and also influence and modulate voltage-dependent calcium currents, mostly by upregulating phospholipase C (PLC) signaling and inositol triphosphate (IP<sub>3</sub>) turnover. One major effect that can be attributed to M1-type receptors is the inhibition of potassium currents, including the I<sub>m</sub> and the I<sub>AHP</sub> (both medium and slow rate). However, M1-type receptors can also potentiate cationic currents like the I<sub>h</sub> and the TRP currents, and the I<sub>cat</sub> (Teles-Grilo Ruivo and Mellor, <xref rid="B130" ref-type="bibr">2013</xref>). For a more detailed description of the effects of ACh on various currents and their associated intracellular signaling pathways, we direct the reader to the section &#x0201c;Subcellular Nicotinic and Muscarinic Pathways&#x0201d; of this review.</p></sec><sec id="s5"><title>Pre-synaptic Localization</title><p>What anatomical and functional evidence exists on the distribution of mAChRs in the neocortex? Muscarinic cholinergic activity influences sensory processing by facilitating or depressing neuronal responses to specific stimuli, and by modulating connections strength and neural synchronization: this results in the fine-tuning of cellular and network properties during developmental processes, the execution of attention tasks and perceptual learning (Groleau et al., <xref rid="B50" ref-type="bibr">2015</xref>). These effects can largely be attributed to M1 and M2 subtypes, which appear to be highly prevalent in the neocortex. The presence of M1 and M2 mAChRs on PC somata and apical dendrites in non-human primates is well established, but M2 receptors are also found on excitatory and inhibitory axons in the primate neocortex (Mrzljak et al., <xref rid="B97" ref-type="bibr">1993</xref>). Disney et al. (<xref rid="B37" ref-type="bibr">2006</xref>) report that M1 and M2 receptor labeling can be observed, but is quite weak in axons and terminals in the macaque visual cortex, whereas mAChRs are mostly expressed at the level of the soma of GABAergic neurons and in the dendritic compartments of glutamatergic cells.</p><p>Among the presynaptic receptors in the rodent and human visual cortex, M2 is very abundant while M4 is less prevalent (Groleau et al., <xref rid="B50" ref-type="bibr">2015</xref>). M2 and M4 are mostly found at the presynaptic terminals; activation of these receptor subtypes causes membrane hyperpolarization and conveys a self-inhibitory signal. Thus, extracellular levels of ACh are regulated by means of negative feedback. In the rat&#x02019;s primary visual cortex (V1) M2 is mainly found at the level of cholinergic terminals in layer 4 and layer 5. Being the main inhibitory auto-receptor, it contributes to the suppression of presynaptic ACh release (Mrzljak et al., <xref rid="B97" ref-type="bibr">1993</xref>).</p><p>It is not yet clear whether the presence of M2-like subtypes at the level of the presynaptic terminal is a distinctive feature of cholinergic axons innervating the neocortex. Conflicting results emerge when looking at rodent studies, while experiments done on non-human primates and cats corroborate M2 receptors as the main auto-receptors localized on BF cholinergic axons. Subsequent research should, therefore, address this issue and determine the extent to which presynaptic M2-like receptors account for negative feedback <italic>via</italic> auto-inhibition, since this type of self-regulatory process is crucial for the fine-tuning of the response. Moreover, given that BF fibers originating from distinct neuron clusters differentially innervate separate cortical areas (Zaborszky et al., <xref rid="B146" ref-type="bibr">2015</xref>; Chaves-Coira et al., <xref rid="B24" ref-type="bibr">2016</xref>; Kim et al., <xref rid="B72" ref-type="bibr">2016</xref>), discrepancies should be expected when assessing receptor subtype distributions across neocortical regions. Estimation of the physiological presynaptic distribution profile of inhibitory auto-receptors in the rodent sensory cortex is of key importance to understanding the system&#x02019;s self-calibrating features. A systematic anatomical profiling of receptor expression should be performed in the rodent models, and quantitative comparisons should be made across sensory areas.</p></sec><sec id="s6"><title>Post-synaptic Localization</title><p>Neocortical PCs and inhibitory interneurons are strongly innervated by cholinergic axons, with L5PCs being the most densely innervated cells; however, numerous immuno-reactive interneurons can be found in all layers, but most frequently in layer 2/3 and layer 5. Here, the mAChR positive interneurons are intermingled with labeled PCs, but in general, the immunostaining of interneurons is less dense than that of the PCs (Van der Zee and Luiten, <xref rid="B137" ref-type="bibr">1999</xref>). While mAChRs are more easily found in the dendritic compartments of PCs, their expression profile throughout the diversity of inhibitory interneurons is quite homogeneous, as these receptors are detected in proximity of the somatic compartment (Disney et al., <xref rid="B37" ref-type="bibr">2006</xref>). mAChRs are expressed by different types of interneurons. In macaque, M2 receptors are found in 31% of PV neurons, 23% of CB neurons, and 25% of CR neurons. 87% of PV<sup>+</sup> neurons, 60% of CB<sup>+</sup> neurons and 40% of CR<sup>+</sup> neurons however, express M1-type mAChRs. The M1 subtype is found across the cortical mantle on the cell bodies and dendrites of post-synaptic PCs, and it appears to be present mainly in layers 2/3 and 6, but it can be found across all cortical layers. In macaque V1, M1 is mostly expressed on GABAergic interneurons, but it is also found on cortico-cortical fibers (Mrzljak et al., <xref rid="B97" ref-type="bibr">1993</xref>; Groleau et al., <xref rid="B50" ref-type="bibr">2015</xref>). M1 immuno-reactivity is also observable in interneurons of the rat neocortex (Levey et al., <xref rid="B81" ref-type="bibr">1991</xref>), although other studies have pointed to a low expression of M1 in primary sensory cortices of rats, such as S1 and V1. Some found M1 expression on PV<sup>+</sup> neurons to be low or even undetectable in mice neocortex (Yamasaki et al., <xref rid="B144" ref-type="bibr">2010</xref>). The significant difference in expression between rodents and primates could be explained by the fact that M1 receptors are much more associated to the extra-synaptic membrane compartments and are usually activated by volume transmission. Given that the BF cholinergic projection system is scaled-up in primates relative to rodents, there could be a more widespread distribution of M1 receptors throughout cortical interneurons. M1 immuno-reactivity is also detected at the synaptic level, in both inhibitory and excitatory synapses across cortical layers, but more frequently on asymmetric synapses, and here, preferentially on dendritic spines, as opposed to symmetric synapses where M1 is found mostly on dendritic shafts (Mrzljak et al., <xref rid="B97" ref-type="bibr">1993</xref>). This preferential distribution perspective is challenged though, by experimental evidence that cholinergic boutons form synapses mainly with dendritic shafts, much fewer with dendritic spines and only occasionally on neuronal somata (Beaulieu and Somogyi, <xref rid="B14" ref-type="bibr">1991</xref>; Mrzljak et al., <xref rid="B97" ref-type="bibr">1993</xref>; Umbriaco et al., <xref rid="B134" ref-type="bibr">1994</xref>). However, in mice, the highest density of M1 immuno-particles is observed in small-caliber oblique dendrites (smaller than 0.66 &#x003bc;m in diameter) of PCs (Yamasaki et al., <xref rid="B144" ref-type="bibr">2010</xref>).</p><p>In L5PCs, M2 mAChRs are mainly localized postsynaptically, where they bring about a decrease in excitatory conductances, but M2 and M4 receptors are also present on the cell bodies of GABAergic interneurons in layers 2/3 and 4; here, M2 activation inhibits GABA release. The M3 subtype is localized postsynaptically in rodent inhibitory neurons and dendrites, where it enhances inhibitory transmission (Mrzljak et al., <xref rid="B97" ref-type="bibr">1993</xref>; Groleau et al., <xref rid="B50" ref-type="bibr">2015</xref>). Finally, M4 mAChRs are expressed in cortical excitatory neurons, in particular, in layer 4 spiny stellate neurons (L4SS) across different neocortical regions&#x02014;S1, V1, and prefrontal cortex (PFC)&#x02014;where they generate a persistent hyperpolarizing response (Radnikow and Feldmeyer, <xref rid="B109" ref-type="bibr">2018</xref>). Perhaps the presence of M4 mAChRs is a marker to tell apart layer 4 from other layers.</p><p>Cholinergic inputs to the cortex generate different responses depending on which receptor is recruited: while M1-like (M1-M3-M5) receptors activation generally leads to an increase in postsynaptic conductance, M2-like receptors (M2-M4) have the opposite tendency to decrease synaptic transmission, by regulating presynaptic ACh release or by directly hyperpolarizing the post-synaptic membrane. mAChRs thus seem to be distributed both at the presynaptic and the postsynaptic level, and the resulting effect depends mostly on which subtype is activated. A detailed understanding of the cellular localization of each receptor subtype for every cell-type is still lacking; some generalizations can be made (as can be seen in <xref ref-type="fig" rid="F3">Figure 3</xref>), but in order to precisely understand how neuromodulatory signals affect neural computation, a detailed knowledge of the amount and distribution of receptor subtypes at the level of each compartment is essential. Furthermore, it is of vital importance to gather this information for each neocortical cell-type. Neuromodulatory inputs very likely affect each cell-type differently, unlocking the possibility of fine-tuning the response and allowing delicate recalibration based on contextual information processing. This is most likely achieved by differentially distributing receptors along cellular compartments, thus creating modulatory micro-domains.</p><fig id="F1" position="float"><label>Figure 1</label><caption><p>Effect of nicotinic acetylcholine receptors (nAChRs) and muscarinic ACh receptors (mAChRs) activation on the membrane potential of various neocortical cell types. The central schema represents the main cell types in the neocortex. Excitatory neurons are shown in red and inhibitory GABAergic neurons are shown in blue. The electrophysiological responses to the optogenetic activation of cholinergic fibers (in light blue) or the application of a cholinergic agonist (shown in green) or antagonist (shown in red) of each cell type are depicted in the inserts. Timing of cholinergic manipulation is shown as a vertical or horizontal bar. Muscarinic and nicotinic cholinergic receptors associated with the observed response, when known, are shown as four main subtypes: M1-M3-M5 like receptors (yellow and red), M2-M4 like receptors (violet and red), &#x003b1;4&#x003b2;2 heteromeric nAChRs (violet and blue) and &#x003b1;7 homomeric nAChRs (yellow and blue). All shown experimental traces reflect studies listed in <xref rid="T1" ref-type="table">Tables s 1</xref>, <xref rid="T2" ref-type="table">2</xref>. Selected traces were recorded in sensory areas of the rodent neocortex. Inclusion criteria for the experimental traces comprise knowledge of the cell-types and the receptor subtype (nicotinic or muscarinic) involved in the electrophysiological response. Abbreviations: PC, pyramidal cell; SS, spiny-stellate cell; IN, interneuron; MC, Martinotti cell; BC, basket cell; DBC, double-bouquet cell; NGFC, neurogliaform cell; BPC, bipolar cell. Reproduced and adapted from: (left, top to bottom): <bold>(A)</bold>. Brombas et al., <xref rid="B18" ref-type="bibr">2014</xref>; <bold>(B)</bold> Arroyo et al., <xref rid="B8" ref-type="bibr">2012</xref>; <bold>(C)</bold> Dasgupta et al., <xref rid="B33" ref-type="bibr">2018</xref>; <bold>(D)</bold> Hedrick and Waters, <xref rid="B56" ref-type="bibr">2015</xref>; <bold>(E)</bold> Kawaguchi, <xref rid="B69" ref-type="bibr">1997</xref> (Right, top to bottom): <bold>(F)</bold> Gulledge et al., <xref rid="B52" ref-type="bibr">2007</xref>; <bold>(G)</bold> Kawaguchi, <xref rid="B69" ref-type="bibr">1997</xref>; <bold>(H)</bold> Shalinsky et al., <xref rid="B215" ref-type="bibr">2002</xref>; <bold>(I)</bold> Dasgupta et al., <xref rid="B33" ref-type="bibr">2018</xref>; <bold>(J)</bold> Hedrick and Waters, <xref rid="B56" ref-type="bibr">2015</xref>. For more exhaustive information on agonist concentration, species and cortical area examined, see <xref rid="T1" ref-type="table">Tables s 1</xref>, <xref rid="T2" ref-type="table">2</xref>.</p></caption><graphic xlink:href="fncir-13-00024-g0001"/></fig><fig id="F2" position="float"><label>Figure 2</label><caption><p>Effect of nAChRs and mAChRs activation on neocortical synaptic dynamics. The central schema represents the main neocortical cell types and their synaptic connections. A fiber of subcortical provenance associated with cholinergic boutons is also shown. Excitatory neurons are shown in red and inhibitory GABAergic neurons are shown in blue. The electrophysiological responses to the application of a cholinergic agonist or antagonist or to basal forebrain (BF) optical stimulation are depicted in the inserts. Panels show the modulation of synaptic dynamics in terms of increase or decrease in PSP/PSC size. Muscarinic and nicotinic cholinergic receptors associated with the observed response, when known, are shown as four main subtypes: M1-M3-M5 like receptors (yellow and red), M2-M4 like receptors (violet and red), &#x003b1;4&#x003b2;2 heteromeric nAChRs (violet and blue) and &#x003b1;7 homomeric nAChRs (yellow and blue). All shown experimental traces reflect studies listed in <xref rid="T3" ref-type="table">Table 3</xref>. Selected traces were recorded in sensory areas of the rodent neocortex. Inclusion criteria for the experimental traces comprise knowledge of the pre and postsynaptic cell-types and the receptor subtype (nicotinic or muscarinic) involved in the response. Abbreviations: PC, pyramidal cell; TTPC, thick tufted pyramidal cell; STPC, slender tufted pyramidal cell; SS, spiny-stellate cell; MC, Martinotti cell; BC, basket cell; NGFC, neurogliaform cell; BPC, bipolar pyramidal cell; IPC, inverted pyramidal cell. Reproduced and adapted from: (left, top to bottom): <bold>(A)</bold> Brombas et al., <xref rid="B18" ref-type="bibr">2014</xref>; <bold>(B)</bold> Urban-Ciecko et al., <xref rid="B136" ref-type="bibr">2018</xref>; <bold>(C)</bold> Kruglikov and Rudy, <xref rid="B78" ref-type="bibr">2008</xref>; <bold>(D)</bold> Dasgupta et al., <xref rid="B33" ref-type="bibr">2018</xref>; <bold>(E)</bold> Yamamoto et al., <xref rid="B219" ref-type="bibr">2010</xref>; <bold>(F)</bold> Salgado et al., <xref rid="B213" ref-type="bibr">2007</xref>; <bold>(G,H)</bold> Eggermann and Feldmeyer, <xref rid="B41" ref-type="bibr">2009</xref>; <bold>(I)</bold> Kruglikov and Rudy, <xref rid="B78" ref-type="bibr">2008</xref>; <bold>(J)</bold> Markram et al., <xref rid="B209" ref-type="bibr">1997</xref>. For more exhaustive information on technique, species and cortical area examined, see <xref rid="T3" ref-type="table">Table 3</xref>.</p></caption><graphic xlink:href="fncir-13-00024-g0002"/></fig><fig id="F3" position="float"><label>Figure 3</label><caption><p>Differential expression of cholinergic receptors in various neuronal compartments across cell-types. Heatmap matrices show the occurrence of cholinergic receptor subtypes at the level of different cell-types. The presence of a given subtype in a cellular compartment is classified as consistently expressed (consistent findings across experimental studies), sometimes expressed (evidence of its presence is only partial) and never expressed (presence of a given subtype is undetectable). Abbreviations: PC, pyramidal cell; M1, M2, M3, M4, muscarinic cholinergic receptors 1&#x02013;4; nAChR, nicotinic acetylcholine (ACh) receptor.</p></caption><graphic xlink:href="fncir-13-00024-g0003"/></fig></sec><sec id="s7"><title>Regulation of Neuronal and Synaptic Physiology</title><p>ACh can either increase or decrease neurotransmitter release probability, consistent with its role as a neuromodulator rather than a transmitter, and the effect on synaptic release probability depends on the identity of the pre and postsynaptic partners. Cell-types in the neocortex are differentially regulated by ACh, and the effects of cholinergic release include modulation of membrane properties (<xref ref-type="fig" rid="F1">Figure 1</xref>) and synaptic dynamics (<xref ref-type="fig" rid="F2">Figure 2</xref>).</p><p>The effects of ACh on neocortical PCs have been thoroughly investigated, and many studies (Gil et al., <xref rid="B46" ref-type="bibr">1997</xref>; Disney et al., <xref rid="B36" ref-type="bibr">2007</xref>) have come to the conclusion that besides generating direct PC depolarization, cholinergic modulation has an overall effect of increasing the signal to noise ratio (SNR) of incoming thalamic inputs. ACh seems to plays a role in enhancing circuit responses to relevant stimuli, providing a mechanism to regulate sensory processing during learning and attention.</p><p>The involvement of mAChRs in the depolarizing response of PCs to BF cholinergic inputs has been established by numerous studies (McCormick and Prince, <xref rid="B90" ref-type="bibr">1985</xref>; Delmas and Brown, <xref rid="B34" ref-type="bibr">2005</xref>; Gulledge and Stuart, <xref rid="B51" ref-type="bibr">2005</xref>; Carr and Surmeier, <xref rid="B21" ref-type="bibr">2007</xref>; Zhang and S&#x000e9;gu&#x000e9;la, <xref rid="B148" ref-type="bibr">2010</xref>), which report that muscarinic activation in PCs leads to an initial SK-mediated hyperpolarization, followed by a more sustained and slow depolarization (<xref rid="T1" ref-type="table">Table 1</xref>, <xref ref-type="fig" rid="F1">Figure 1</xref>). Interestingly, the same biphasic response can be induced by bath perfusion of muscarinic agonists in hippocampal interneurons (Heys and Hasselmo, <xref rid="B58" ref-type="bibr">2012</xref>; Heys et al., <xref rid="B59" ref-type="bibr">2012</xref>). The mechanism by which this depolarization emerges has not been fully clarified yet, but some authors suggest the suppression of muscarinic-sensitive and voltage-dependent K<sup>+</sup> conductance termed the M current (I<sub>m</sub>) or the activation of a non-specific cationic current both support the observed depolarization (McCormick and Prince, <xref rid="B90" ref-type="bibr">1985</xref>; Krnjevi&#x00107;, <xref rid="B77" ref-type="bibr">2004</xref>).</p><table-wrap id="T1" position="float"><label>Table 1</label><caption><p>Effect of muscarinic acetylcholine receptors (mAChRs) activation on membrane potential in various neocortical cell types.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1">Cell type</th><th align="left" rowspan="1" colspan="1">Receptor</th><th align="left" rowspan="1" colspan="1">Effect</th><th align="left" rowspan="1" colspan="1">Area</th><th align="left" rowspan="1" colspan="1">Technique&#x02014;Reference</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">L5 PC</td><td align="left" rowspan="1" colspan="1">M1 (soma)</td><td align="left" rowspan="1" colspan="1">Transient hyperpolarization</td><td align="left" rowspan="1" colspan="1">Rat PMC/V1/PFC</td><td align="left" rowspan="1" colspan="1">Optogenetics (Hedrick and Waters, <xref rid="B56" ref-type="bibr">2015</xref>)</td></tr><tr><td rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">M1 (soma)</td><td align="left" rowspan="1" colspan="1">Slow depolarization</td><td align="left" rowspan="1" colspan="1">Rat PMC/V1/PFC</td><td align="left" rowspan="1" colspan="1">1. Optogenetics (Hedrick and Waters, <xref rid="B56" ref-type="bibr">2015</xref>)<break/> 2. Somatic puff 100 &#x003bc;M ACh/CCh (Gulledge and Stuart, <xref rid="B51" ref-type="bibr">2005</xref>)<break/> 3. 100 &#x003bc;M ACh focally applied (Gulledge et al., <xref rid="B52" ref-type="bibr">2007</xref>)</td></tr><tr><td rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">M1 (soma)</td><td align="left" rowspan="1" colspan="1">Hyperpolarization</td><td align="left" rowspan="1" colspan="1">Rat SSC</td><td align="left" rowspan="1" colspan="1">100 &#x003bc;M ACh focally applied (Gulledge et al., <xref rid="B52" ref-type="bibr">2007</xref>)</td></tr><tr><td rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">M1 (soma)</td><td align="left" rowspan="1" colspan="1">Depolarization</td><td align="left" rowspan="1" colspan="1">Rat mPFC</td><td align="left" rowspan="1" colspan="1">30 &#x003bc;m muscarine or oxotremorine bath application (Haj-Dahmane and Andrade, <xref rid="B204" ref-type="bibr">1996</xref>)</td></tr><tr><td align="left" rowspan="1" colspan="1">L23 PC</td><td align="left" rowspan="1" colspan="1">Muscarinic</td><td align="left" rowspan="1" colspan="1">Depolarization</td><td align="left" rowspan="1" colspan="1">Mouse V1</td><td align="left" rowspan="1" colspan="1"><italic>In vivo</italic> 2-photon imaging (Alitto and Dan, <xref rid="B3" ref-type="bibr">2013</xref>)</td></tr><tr><td rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Muscarinic</td><td align="left" rowspan="1" colspan="1">Prolonged depolarization</td><td align="left" rowspan="1" colspan="1">Rat EC layer II</td><td align="left" rowspan="1" colspan="1">100 mM CCh bath application (Shalinsky et al., <xref rid="B215" ref-type="bibr">2002</xref>)</td></tr><tr><td rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">M2&#x02013;M4</td><td align="left" rowspan="1" colspan="1">Hyperpolarization</td><td align="left" rowspan="1" colspan="1">Mouse SSC (p12&#x02013;p16)</td><td align="left" rowspan="1" colspan="1">Optogenetics (Dasgupta et al., <xref rid="B33" ref-type="bibr">2018</xref>)</td></tr><tr><td align="left" rowspan="1" colspan="1">L4 PC</td><td align="left" rowspan="1" colspan="1">M2&#x02013;M4</td><td align="left" rowspan="1" colspan="1">Persistent hyperpolarization</td><td align="left" rowspan="1" colspan="1">Rat SSC</td><td align="left" rowspan="1" colspan="1">100 &#x003bc;M ACh, puff (Eggermann and Feldmeyer, <xref rid="B41" ref-type="bibr">2009</xref>)</td></tr><tr><td align="left" rowspan="1" colspan="1">L4 SS</td><td align="left" rowspan="1" colspan="1">M4 (soma)</td><td align="left" rowspan="1" colspan="1">Persistent hyperpolarization</td><td align="left" rowspan="1" colspan="1">Rat SSC</td><td align="left" rowspan="1" colspan="1">100 &#x003bc;M ACh, puff (Eggermann and Feldmeyer, <xref rid="B41" ref-type="bibr">2009</xref>)</td></tr><tr><td align="left" rowspan="1" colspan="1">L1 BC</td><td align="left" rowspan="1" colspan="1">Muscarinic</td><td align="left" rowspan="1" colspan="1">Depolarization</td><td align="left" rowspan="1" colspan="1">Mouse V1</td><td align="left" rowspan="1" colspan="1"><italic>In vivo</italic> 2-photon imaging (Alitto and Dan, <xref rid="B3" ref-type="bibr">2013</xref>)</td></tr><tr><td align="left" rowspan="1" colspan="1">L1 DBC</td><td align="left" rowspan="1" colspan="1">Muscarinic</td><td align="left" rowspan="1" colspan="1">Depolarization</td><td align="left" rowspan="1" colspan="1">1. Mouse V1<break/> 2. Rat PFC</td><td align="left" rowspan="1" colspan="1">1. <italic>In vivo</italic> 2-photon imaging (Alitto and Dan, <xref rid="B3" ref-type="bibr">2013</xref>)<break/> 2. 10 &#x003bc;M CCh or 3 &#x003bc;M muscarine bath application (Kawaguchi, <xref rid="B69" ref-type="bibr">1997</xref>)</td></tr><tr><td align="left" rowspan="1" colspan="1">L23 DBC</td><td align="left" rowspan="1" colspan="1">M2</td><td align="left" rowspan="1" colspan="1">1. Hyperpolarization<break/> 2. Hyperpolarization + slow depolarization</td><td align="left" rowspan="1" colspan="1">1. Rat SSC<break/> 2. Rat PFC</td><td align="left" rowspan="1" colspan="1">1. 100 &#x003bc;M ACh focally applied (Gulledge et al., <xref rid="B52" ref-type="bibr">2007</xref>)<break/> 2. 10 &#x003bc;M CCh or 3 &#x003bc;M muscarine bath application (Kawaguchi, <xref rid="B69" ref-type="bibr">1997</xref>)</td></tr><tr><td align="left" rowspan="1" colspan="1">L23 MC</td><td align="left" rowspan="1" colspan="1">M1&#x02013;M3</td><td align="left" rowspan="1" colspan="1">Depolarization</td><td align="left" rowspan="1" colspan="1">Mouse SSC</td><td align="left" rowspan="1" colspan="1">1. Mu&#x000f1;oz et al. (<xref rid="B99" ref-type="bibr">2017</xref>; M1- M3 KO lines)<break/> 2. Optogenetics (Dasgupta et al., <xref rid="B33" ref-type="bibr">2018</xref>)</td></tr><tr><td rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Muscarinic</td><td align="left" rowspan="1" colspan="1">Depolarization</td><td align="left" rowspan="1" colspan="1">Mouse V1</td><td align="left" rowspan="1" colspan="1">1 &#x003bc;M/10 mM ACh application (Chen et al., <xref rid="B25" ref-type="bibr">2015</xref>)</td></tr><tr><td align="left" rowspan="1" colspan="1">L23 BC</td><td rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Not responsive (NR)</td><td align="left" rowspan="1" colspan="1">1. Rat SSC<break/> 2. Rat PFC</td><td align="left" rowspan="1" colspan="1">1. 100 &#x003bc;M ACh focally applied (Gulledge et al., <xref rid="B52" ref-type="bibr">2007</xref>)<break/> 2. 10 &#x003bc;M CCh or 3 &#x003bc;M muscarine bath application (Kawaguchi, <xref rid="B69" ref-type="bibr">1997</xref>)</td></tr><tr><td align="left" rowspan="1" colspan="1">L5 BC</td><td rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">NR</td><td align="left" rowspan="1" colspan="1">Rat SSC</td><td align="left" rowspan="1" colspan="1">100 &#x003bc;M ACh focally applied (Gulledge et al., <xref rid="B52" ref-type="bibr">2007</xref>)</td></tr><tr><td align="left" rowspan="1" colspan="1">L5 MC</td><td align="left" rowspan="1" colspan="1">Muscarinic</td><td align="left" rowspan="1" colspan="1">NR/slight depolarization</td><td align="left" rowspan="1" colspan="1">Rat SSC</td><td align="left" rowspan="1" colspan="1">100 &#x003bc;M ACh focally applied (Gulledge et al., <xref rid="B52" ref-type="bibr">2007</xref>)</td></tr></tbody></table><table-wrap-foot><p><italic>The table links the distribution and localization (when known, in brackets) of muscarinic receptors across neocortical cell types, with respect to cortical layers, with the effect of their activation. The effect of receptor activation is represented in terms of variation of membrane potential. Age of the specimen is given in brackets, when known. When biphasic effects occur, they are listed as multiple effects. Inclusion criteria for the listed studies comprise: (1) recordings performed in the rodent neocortex; (2) knowledge of the morphological type involved; and (3) knowledge of the receptor subtype involved in the response. Abbreviations: PC, pyramidal cell; SS, spiny-stellate cell; IN, interneuron; MC, Martinotti cell; BC, basket cell; DBC, double-bouquet cell; NGFC, neurogliaform cell; BPC, bipolar cell, NBC, nest basket cell; RS, regular spiking. PMC, primary motor cortex; V1, primary visual area; PFC, prefrontal cortex; mPFC, medial prefrontal cortex; EC, entorhinal cortex; SSC, somatosensory cortex, ACh, acetylcholine; CCh, carbachol</italic>.</p></table-wrap-foot></table-wrap><p>In L5PCs, transient activation of M1-type mAChRs induces calcium release from IP<sub>3</sub>-sensitive intracellular calcium stores and subsequent activation of an apamin-sensitive, SK-type calcium-activated potassium conductance (Gulledge et al., <xref rid="B52" ref-type="bibr">2007</xref>). Conversely, M4-mediated activation of a potassium conductance (K<sub>ir3</sub>) in L4SS generates a persistent membrane hyperpolarization and induces suppression of neurotransmitter release (<xref rid="T1" ref-type="table">Table 1</xref>, <xref ref-type="fig" rid="F1">Figure 1</xref>). The observed hyperpolarizing response is supported by a decrease in presynaptic calcium conductance, at synapses between L4PCs and also at synapses between L4PCs and L23PCs (see <xref rid="T3" ref-type="table">Table 3</xref>, <xref ref-type="fig" rid="F2">Figure 2</xref>; Eggermann and Feldmeyer, <xref rid="B41" ref-type="bibr">2009</xref>). Focal application of ACh onto the soma of L5PCs evokes a biphasic response in which a transient membrane hyperpolarization precedes a slower and longer-lasting depolarization. Pharmacological evidence suggests that this effect is mediated by M1 receptors. Compared with the pressure application of ACh, activation of cholinergic synapses with brief bursts provides relatively weak activation of mAChRs that often fails to affect the somatic membrane potential at rest (Hedrick and Waters, <xref rid="B56" ref-type="bibr">2015</xref>). One possible interpretation of these results might be that synaptically released ACh activates first nAChRs and usually fails to activate mAChRs, whereas pressure ejection onto the soma recruits primarily mAChRs.</p><table-wrap id="T2" position="float"><label>Table 2</label><caption><p>Effect of nAChRs activation on membrane potential in various neocortical cell types.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1">Cell type</th><th align="left" rowspan="1" colspan="1">Receptor</th><th align="left" rowspan="1" colspan="1">Effect</th><th align="left" rowspan="1" colspan="1">Area</th><th align="left" rowspan="1" colspan="1">Technique&#x02014;Reference</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">L5 PC</td><td align="left" rowspan="1" colspan="1">&#x003b1;<sub>4</sub>&#x003b2;2 (soma and main dendrite)</td><td align="left" rowspan="1" colspan="1">Medium depolarization</td><td align="left" rowspan="1" colspan="1">Mouse PMC/V1/PFC</td><td align="left" rowspan="1" colspan="1">Optogenetics (Hedrick and Waters, <xref rid="B56" ref-type="bibr">2015</xref>)</td></tr><tr><td rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">&#x003b1;4 &#x003b1;5</td><td align="left" rowspan="1" colspan="1">Depolarization Persistent spiking (starting from subthreshold)</td><td align="left" rowspan="1" colspan="1">Mouse PMC/V1/PFC</td><td align="left" rowspan="1" colspan="1">Optogenetics (Hedrick and Waters, <xref rid="B56" ref-type="bibr">2015</xref>)</td></tr><tr><td align="left" rowspan="1" colspan="1">L6 PC</td><td align="left" rowspan="1" colspan="1">&#x003b1;4 &#x003b1;5 (soma and main dendrite)</td><td align="left" rowspan="1" colspan="1">Depolarization</td><td align="left" rowspan="1" colspan="1">Mouse PMC/V1/PFC</td><td align="left" rowspan="1" colspan="1">Optogenetics (Hedrick and Waters, <xref rid="B56" ref-type="bibr">2015</xref>)</td></tr><tr><td rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">&#x003b1;<sub>4</sub>&#x003b2;<sub>2</sub></td><td align="left" rowspan="1" colspan="1">Depolarization</td><td align="left" rowspan="1" colspan="1">Rat PFC (p7&#x02013;p27)</td><td align="left" rowspan="1" colspan="1">Kassam et al. (<xref rid="B67" ref-type="bibr">2008</xref>; bath application of 10 &#x003bc;M ACh to 1 mM)</td></tr><tr><td align="left" rowspan="1" colspan="1">L1 NGFC</td><td align="left" rowspan="1" colspan="1">Nicotinic (non-&#x003b1;7)</td><td align="left" rowspan="1" colspan="1">Depolarization (from RP) Suppression of activity (from subthreshold)</td><td align="left" rowspan="1" colspan="1">Rat SSC</td><td align="left" rowspan="1" colspan="1">Iontophoretic application or bath application of 100 &#x003bc;M ACh (Brombas et al., <xref rid="B18" ref-type="bibr">2014</xref>)</td></tr><tr><td align="left" rowspan="1" colspan="1">L1 BC</td><td align="left" rowspan="1" colspan="1">Nicotinic</td><td align="left" rowspan="1" colspan="1">Suppression of activity (at low levels of cortical desynchronization)</td><td align="left" rowspan="1" colspan="1">Mouse V1</td><td align="left" rowspan="1" colspan="1"><italic>In vivo</italic> 2-photon imaging (Alitto and Dan, <xref rid="B3" ref-type="bibr">2013</xref>)</td></tr><tr><td align="left" rowspan="1" colspan="1">L1 INs</td><td align="left" rowspan="1" colspan="1">Nicotinic</td><td align="left" rowspan="1" colspan="1">Fast depolarization (from RP)</td><td align="left" rowspan="1" colspan="1">Rat SSC</td><td align="left" rowspan="1" colspan="1">100 &#x003bc;M ACh focally applied (Christophe et al., <xref rid="B26" ref-type="bibr">2002</xref>) and (Gulledge et al., <xref rid="B52" ref-type="bibr">2007</xref>)</td></tr><tr><td align="left" rowspan="1" colspan="1">NBC</td><td align="left" rowspan="1" colspan="1">Nicotinic</td><td align="left" rowspan="1" colspan="1">Depolarization</td><td align="left" rowspan="1" colspan="1">Rat SSC</td><td align="left" rowspan="1" colspan="1">100 &#x003bc;M ACh focally applied (Gulledge et al., <xref rid="B52" ref-type="bibr">2007</xref>)</td></tr><tr><td align="left" rowspan="1" colspan="1">BPC</td><td align="left" rowspan="1" colspan="1">Nicotinic</td><td align="left" rowspan="1" colspan="1">Depolarization</td><td align="left" rowspan="1" colspan="1">Rat SSC</td><td align="left" rowspan="1" colspan="1">100 &#x003bc;M ACh focally applied (Gulledge et al., <xref rid="B52" ref-type="bibr">2007</xref>)</td></tr><tr><td align="left" rowspan="1" colspan="1">DBC</td><td align="left" rowspan="1" colspan="1">Nicotinic</td><td align="left" rowspan="1" colspan="1">Depolarization</td><td align="left" rowspan="1" colspan="1">Rat PFC</td><td align="left" rowspan="1" colspan="1">10 &#x003bc;M CCh or 3 &#x003bc;M muscarine bath application (Kawaguchi, <xref rid="B69" ref-type="bibr">1997</xref>)</td></tr><tr><td align="left" rowspan="1" colspan="1">L23 MC</td><td align="left" rowspan="1" colspan="1">Nicotinic</td><td align="left" rowspan="1" colspan="1">Depolarization</td><td align="left" rowspan="1" colspan="1">Mouse V1</td><td align="left" rowspan="1" colspan="1">1 &#x003bc;M/10 mM ACh application (Chen et al., <xref rid="B25" ref-type="bibr">2015</xref>)</td></tr><tr><td rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Nicotinic</td><td align="left" rowspan="1" colspan="1">Depolarization</td><td align="left" rowspan="1" colspan="1">Rat SSC</td><td align="left" rowspan="1" colspan="1">Optogenetics (Dasgupta et al., <xref rid="B33" ref-type="bibr">2018</xref>)</td></tr><tr><td rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">&#x003b1;4&#x003b2;2</td><td align="left" rowspan="1" colspan="1">Depolarization</td><td align="left" rowspan="1" colspan="1">Mouse S1 and mPFC</td><td align="left" rowspan="1" colspan="1">Optogenetics or 1 mM ACh bath-application (Obermayer et al., <xref rid="B103" ref-type="bibr">2018</xref>)</td></tr><tr><td align="left" rowspan="1" colspan="1">L23 BC</td><td align="left" rowspan="1" colspan="1">Nicotinic</td><td align="left" rowspan="1" colspan="1">Some are depolarized Some are hyperpolarized</td><td align="left" rowspan="1" colspan="1">Mouse V1</td><td align="left" rowspan="1" colspan="1"><italic>In vivo</italic> 2-photon imaging (Alitto and Dan, <xref rid="B3" ref-type="bibr">2013</xref>)</td></tr><tr><td align="left" rowspan="1" colspan="1">L23 CHAT<sup>+</sup> BPC</td><td align="left" rowspan="1" colspan="1">&#x003b1;4&#x003b2;2</td><td align="left" rowspan="1" colspan="1">Depolarization</td><td align="left" rowspan="1" colspan="1">Mouse SSC (P20&#x02013;P40)</td><td align="left" rowspan="1" colspan="1">Optogenetics (Arroyo et al., <xref rid="B8" ref-type="bibr">2012</xref>)</td></tr><tr><td align="left" rowspan="1" colspan="1">L23 BPC</td><td align="left" rowspan="1" colspan="1">&#x003b1;4&#x003b2;2 and &#x003b1;7</td><td align="left" rowspan="1" colspan="1">Depolarization</td><td align="left" rowspan="1" colspan="1">Mouse and rat SSC</td><td align="left" rowspan="1" colspan="1">Optogenetics (Arroyo et al., <xref rid="B8" ref-type="bibr">2012</xref>) and (Dasgupta et al., <xref rid="B33" ref-type="bibr">2018</xref>); 100 &#x003bc;M ACh focally applied (Gulledge et al., <xref rid="B52" ref-type="bibr">2007</xref>)</td></tr><tr><td align="left" rowspan="1" colspan="1">L5 MC</td><td align="left" rowspan="1" colspan="1">&#x003b1;4&#x003b2;2</td><td align="left" rowspan="1" colspan="1">Depolarization</td><td align="left" rowspan="1" colspan="1">Mouse S1 and mPFC</td><td align="left" rowspan="1" colspan="1">Optogenetics or 1 mM ACh bath-application (Obermayer et al., <xref rid="B103" ref-type="bibr">2018</xref>)</td></tr></tbody></table><table-wrap-foot><p><italic>The table links the distribution and localization (when known, in brackets) of nicotinic receptors across neocortical cell types, with respect to cortical layers, with the effect of their activation. The effect of receptor activation is represented in terms of variation of membrane potential. Age of the specimen is given in brackets, when known. When biphasic effects occur, they are listed as multiple effects. Inclusion criteria for the listed studies comprise: (1) recordings performed in the rodent neocortex, (2) knowledge of the morphological type involved and (3) knowledge of the receptor subtype involved in the response. Abbreviations: PC, pyramidal cell; SS, spiny-stellate cell; IN, interneuron; MC, Martinotti cell; BC, basket cell; DBC, double-bouquet cell; NGFC, neurogliaform cell; BPC, bipolar cell, NBC, nest basket cell; RS, regular spiking. PMC, primary motor cortex; V1, primary visual area; PFC, prefrontal cortex; SSC, somatosensory cortex, ACh, acetylcholine; CCh, carbachol; RP, resting potential; NR, not responsive</italic>.</p></table-wrap-foot></table-wrap><table-wrap id="T3" position="float"><label>Table 3</label><caption><p>Cholinergic mediated modulation of neocortical synaptic dynamics.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1">Connection type</th><th align="left" rowspan="1" colspan="1">Receptor</th><th align="left" rowspan="1" colspan="1">Effect</th><th align="left" rowspan="1" colspan="1">Area</th><th align="left" rowspan="1" colspan="1">Technique&#x02014;Reference</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">L5 PC-L5 PC</td><td align="left" rowspan="1" colspan="1">Muscarinic</td><td align="left" rowspan="1" colspan="1">Reduction in depression rate of consecutive EPSPs</td><td align="left" rowspan="1" colspan="1">Rat SSC</td><td align="left" rowspan="1" colspan="1">Bath application of 50 &#x003bc;M ACh (Tsodyks and Markram, <xref rid="B217" ref-type="bibr">1997</xref>)</td></tr><tr><td rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">M1 (perisomatic)</td><td align="left" rowspan="1" colspan="1">Enhancement of EPSCs</td><td align="left" rowspan="1" colspan="1">Rat SSC (p14&#x02013;p16)</td><td align="left" rowspan="1" colspan="1">1&#x02013;10 &#x003bc;M ACh local puff (Nu&#x000f1;ez et al., <xref rid="B211" ref-type="bibr">2012</xref>)</td></tr><tr><td rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">M2 (basal dendrites)</td><td align="left" rowspan="1" colspan="1">Reduction of IPSCs</td><td align="left" rowspan="1" colspan="1">Rat SSC (p14&#x02013;p16)</td><td align="left" rowspan="1" colspan="1">50&#x02013;100 &#x003bc;M ACh local puff (Nu&#x000f1;ez et al., <xref rid="B211" ref-type="bibr">2012</xref>)</td></tr><tr><td rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Nicotinic</td><td align="left" rowspan="1" colspan="1">Increase in EPSPs</td><td align="left" rowspan="1" colspan="1">Rat SSC (p14&#x02013;p16)</td><td align="left" rowspan="1" colspan="1">1&#x02013;10 &#x003bc;M ACh local puff (Nu&#x000f1;ez et al., <xref rid="B211" ref-type="bibr">2012</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">L5 PC-L5 MC</td><td align="left" rowspan="1" colspan="1">Nicotinic heteromeric</td><td align="left" rowspan="1" colspan="1">Decrease in onset delay, increase in time course; no change in EPSP size</td><td align="left" rowspan="1" colspan="1">Mouse S1 and mPFC</td><td align="left" rowspan="1" colspan="1">Optogenetics or 1 mM ACh bath-application (Obermayer et al., <xref rid="B103" ref-type="bibr">2018</xref>)</td></tr><tr><td align="left" rowspan="1" colspan="1">L4 PC-L4 PC</td><td align="left" rowspan="1" colspan="1">M4</td><td align="left" rowspan="1" colspan="1">Reduction in first EPSP amplitude</td><td align="left" rowspan="1" colspan="1">Rat SSC</td><td align="left" rowspan="1" colspan="1">Bath application of 100 &#x003bc;M ACh (Eggermann and Feldmeyer, <xref rid="B41" ref-type="bibr">2009</xref>)</td></tr><tr><td align="left" rowspan="1" colspan="1">L4 SS-L4 SS</td></tr><tr><td align="left" rowspan="1" colspan="1">L4 PC-L23 PC</td><td align="left" rowspan="1" colspan="1">M4</td><td align="left" rowspan="1" colspan="1">Reduction in first EPSP amplitude</td><td align="left" rowspan="1" colspan="1">Rat SSC</td><td align="left" rowspan="1" colspan="1">Bath application of 100 &#x003bc;M ACh (Eggermann and Feldmeyer, <xref rid="B41" ref-type="bibr">2009</xref>)</td></tr><tr><td align="left" rowspan="1" colspan="1">L23 PC-L23 PC</td><td align="left" rowspan="1" colspan="1">M1/M3</td><td align="left" rowspan="1" colspan="1">Reduction in EPSC amplitude</td><td align="left" rowspan="1" colspan="1">Rat A1 (p21&#x02013;p28)</td><td align="left" rowspan="1" colspan="1">Bath application of 10 &#x003bc;M oxotremorine or muscarine (Atzori et al., <xref rid="B201" ref-type="bibr">2005</xref>)</td></tr><tr><td rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Muscarinic (apical dendrite)</td><td align="left" rowspan="1" colspan="1">Reduction in EPSP amplitude</td><td align="left" rowspan="1" colspan="1">Rat PFC</td><td align="left" rowspan="1" colspan="1">Iontophoretic application of 0.05 M muscarine (Vidal and Changeux, <xref rid="B218" ref-type="bibr">1993</xref>)</td></tr><tr><td rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Nicotinic (apical dendrite)</td><td align="left" rowspan="1" colspan="1">Increase in EPSPs</td><td align="left" rowspan="1" colspan="1">Rat PFC</td><td align="left" rowspan="1" colspan="1">Iontophoretic application of 0.05 M muscarine (Vidal and Changeux, <xref rid="B218" ref-type="bibr">1993</xref>)</td></tr><tr><td align="left" rowspan="1" colspan="1">TC fibers-L4 PC</td><td align="left" rowspan="1" colspan="1">Muscarinic</td><td align="left" rowspan="1" colspan="1">Increase in EPSP depression rate</td><td align="left" rowspan="1" colspan="1">Rats and mice TC slice (p21-p28)</td><td align="left" rowspan="1" colspan="1">Bath application of 5&#x02013;10 &#x003bc;M muscarine (Gil et al., <xref rid="B46" ref-type="bibr">1997</xref>)</td></tr><tr><td align="left" rowspan="1" colspan="1">CHAT<sup>+</sup> fibers&#x02014;L4 PC</td><td align="left" rowspan="1" colspan="1">Muscarinic</td><td align="left" rowspan="1" colspan="1">IPSC</td><td align="left" rowspan="1" colspan="1">Mouse TC slice (p12&#x02013;p16)</td><td align="left" rowspan="1" colspan="1">Optogenetic activation (Dasgupta et al., <xref rid="B33" ref-type="bibr">2018</xref>)</td></tr><tr><td align="left" rowspan="1" colspan="1">L23 PC-L23 MC</td><td align="left" rowspan="1" colspan="1">Nicotinic</td><td align="left" rowspan="1" colspan="1">Increase in EPSPs</td><td align="left" rowspan="1" colspan="1">Mouse SSC</td><td align="left" rowspan="1" colspan="1">Bath application of 20 &#x003bc;M CCh (Urban-Ciecko et al., <xref rid="B136" ref-type="bibr">2018</xref>) and optogenetics</td></tr><tr><td rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Nicotinic heteromeric</td><td align="left" rowspan="1" colspan="1">No change in EPSP size</td><td align="left" rowspan="1" colspan="1">Mouse S1 and mPFC</td><td align="left" rowspan="1" colspan="1">Optogenetics or 1 mM ACh bath-application (Obermayer et al., <xref rid="B103" ref-type="bibr">2018</xref>)</td></tr><tr><td align="left" rowspan="1" colspan="1">L1 NGF-L23 PC</td><td align="left" rowspan="1" colspan="1">M1 (perisomatic)</td><td align="left" rowspan="1" colspan="1">Connection is silenced (L23 PC is disinhibited)</td><td align="left" rowspan="1" colspan="1">Rat SSC (p24&#x02013;p31)</td><td align="left" rowspan="1" colspan="1">Iontophoretic application or bath application of 100 &#x003bc;M ACh (Brombas et al., <xref rid="B18" ref-type="bibr">2014</xref>)</td></tr><tr><td rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Nicotinic (non &#x003b1;7)</td><td align="left" rowspan="1" colspan="1">Connection is silenced</td><td align="left" rowspan="1" colspan="1">Rat SSC (p24&#x02013;p31)</td><td align="left" rowspan="1" colspan="1">Iontophoretic application or bath application of 100 &#x003bc;M ACh (Brombas et al., <xref rid="B18" ref-type="bibr">2014</xref>)</td></tr><tr><td align="left" rowspan="1" colspan="1">L23 BC-L5 PC</td><td align="left" rowspan="1" colspan="1">Muscarinic</td><td align="left" rowspan="1" colspan="1">Reduction in IPSPs amplitudes (connection is silenced)</td><td align="left" rowspan="1" colspan="1">Mouse SSC</td><td align="left" rowspan="1" colspan="1">Bath application of 10 &#x003bc;M muscarine (Kruglikov and Rudy, <xref rid="B78" ref-type="bibr">2008</xref>)</td></tr><tr><td align="left" rowspan="1" colspan="1">L5 BC-L5 PC</td><td align="left" rowspan="1" colspan="1">M2/M4</td><td align="left" rowspan="1" colspan="1">Reduction in u-IPSC amplitude</td><td align="left" rowspan="1" colspan="1">Mouse SSC</td><td align="left" rowspan="1" colspan="1">Bath application of 10 &#x003bc;M muscarine (Kruglikov and Rudy, <xref rid="B78" ref-type="bibr">2008</xref>)</td></tr><tr><td rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Muscarinic</td><td align="left" rowspan="1" colspan="1">Reduction in u-IPSC amplitude</td><td align="left" rowspan="1" colspan="1">Rat insular cortex</td><td align="left" rowspan="1" colspan="1">Bath application of 10 &#x003bc;M CCh (Yamamoto et al., <xref rid="B219" ref-type="bibr">2010</xref>)</td></tr><tr><td align="left" rowspan="1" colspan="1">L5 MC-L5 PC</td><td align="left" rowspan="1" colspan="1">Nicotinic heteromeric</td><td align="left" rowspan="1" colspan="1">Decrease in onset delay, no change in IPSP size</td><td align="left" rowspan="1" colspan="1">Mouse S1 and mPFC</td><td align="left" rowspan="1" colspan="1">Optogenetics or 1 mM ACh bath-application (Obermayer et al., <xref rid="B103" ref-type="bibr">2018</xref>)</td></tr><tr><td rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Nicotinic</td><td align="left" rowspan="1" colspan="1">Increase in IPSP size</td><td align="left" rowspan="1" colspan="1">Mouse A1</td><td align="left" rowspan="1" colspan="1">Bath application of 10 &#x003bc;M CCh (Hilscher et al., <xref rid="B60" ref-type="bibr">2017</xref>)</td></tr><tr><td align="left" rowspan="1" colspan="1">L5 BC-L5 BC</td><td align="left" rowspan="1" colspan="1">Muscarinic</td><td align="left" rowspan="1" colspan="1">Decrease in IPSCs amplitudes</td><td align="left" rowspan="1" colspan="1">Rat insular cortex</td><td align="left" rowspan="1" colspan="1">Bath application of 10 &#x003bc;M CCh (Yamamoto et al., <xref rid="B219" ref-type="bibr">2010</xref>)</td></tr><tr><td align="left" rowspan="1" colspan="1">L5 RS IN-L5 PC</td><td align="left" rowspan="1" colspan="1">Muscarinic</td><td align="left" rowspan="1" colspan="1">Decrease in IPSCs amplitudes</td><td align="left" rowspan="1" colspan="1">Rat insular cortex</td><td align="left" rowspan="1" colspan="1">Bath application of 10 &#x003bc;M CCh (Yamamoto et al., <xref rid="B219" ref-type="bibr">2010</xref>)</td></tr><tr><td align="left" rowspan="1" colspan="1">L5 BC-L5 RS IN</td><td align="left" rowspan="1" colspan="1">Muscarinic</td><td align="left" rowspan="1" colspan="1">Increase in first IPSCs amplitudes</td><td align="left" rowspan="1" colspan="1">Rat insular cortex</td><td align="left" rowspan="1" colspan="1">Bath application of 10 &#x003bc;M CCh (Yamamoto et al., <xref rid="B219" ref-type="bibr">2010</xref>)</td></tr><tr><td align="left" rowspan="1" colspan="1">L5 RS IN-L5 RS IN</td><td align="left" rowspan="1" colspan="1">Muscarinic</td><td align="left" rowspan="1" colspan="1">Increase in first IPSCs amplitudes</td><td align="left" rowspan="1" colspan="1">Rat insular cortex</td><td align="left" rowspan="1" colspan="1">Bath application of 10 &#x003bc;M CCh (Yamamoto et al., <xref rid="B219" ref-type="bibr">2010</xref>)</td></tr></tbody></table><table-wrap-foot><p><italic>The table links the distribution and localization (when known, in brackets) of nicotinic and muscarinic receptors across neocortical cell types, with respect to cortical layers, with the effect of their activation on synaptic dynamics. Effect is represented in terms of increase or decrease in PSP/PSC size. Age of the specimen is given in brackets, when known. Inclusion criteria for the listed studies comprise: (1) recordings performed in the rodent neocortex; (2) knowledge of the pre and post synaptic morphological types involved; and (3) knowledge of the receptor subtype involved. Abbreviations: PC, pyramidal cell; SS, spiny-stellate cell; IN, interneuron; MC, Martinotti cell; BC, basket cell; DBC, double-bouquet cell; NGFC, neurogliaform cell; BPC, bipolar cell, NBC, nest basket cell; RS, regular spiking. A1, primary auditory area; PFC, prefrontal cortex; SSC, somatosensory cortex; TC thalamo-cortical; ACh, acetylcholine; CCh, carbachol; EPSP, excitatory post-synaptic potential; IPSP, inhibitory post-synaptic potential; EPSC, excitatory post-synaptic current; IPSC, inhibitory post-synaptic current</italic>.</p></table-wrap-foot></table-wrap><p>Muscarinic activation modulates K<sup>+</sup> conductances (McCormick, <xref rid="B210" ref-type="bibr">1992</xref>), but the reversal potential for K<sup>+</sup> is approximately &#x02212;90 mV: mAChR activation, therefore, exerts a little effect at resting membrane potential. However, when a neuron is depolarized, the observable mAChR-mediated hyperpolarization and subsequent depolarization are larger. The reported biphasic effect affects both cortico-pontine (CPn) and commissural (COM) pyramidal neurons; however, COM neurons show a more pronounced inhibitory phase, while CPn neurons have a larger and longer-lasting depolarizing phase (Baker et al., <xref rid="B11" ref-type="bibr">2018</xref>). While these effects have been characterized thoroughly in deep-layers PCs, others report that ACh has limited ability to inhibit superficial PCs <italic>via</italic> changes in membrane potential (Gulledge et al., <xref rid="B52" ref-type="bibr">2007</xref>).</p><p>Cortical inhibitory interneurons are, as well as PCs, a prominent target of cholinergic neuromodulation. The ways in which ACh modulates the dynamics of local interneurons have not been completely clarified yet, because the effects of BF cholinergic stimulation and bath application of cholinergic agonists (<xref rid="T1" ref-type="table">Table 1</xref>) strongly depend on the inhibitory cell-type.</p><p>Exogenous application is unlikely to mimic accurately the spatiotemporal profile of ACh release from cholinergic axons, and furthermore, there seems to be no agreement within the neuroscientific community on which concentration of cholinergic agonists should be used to promote activation of the cholinergic receptors. The applied dose ranges from 10 to 100 micromolar across different experimental groups, and in other cases, it even spans the millimolar range. These discrepancies arise from the fact that to measure the physiological extracellular concentration of ACh is experimentally challenging, because of the prompt intervention of hydrolases in the synaptic cleft. Application of acetylcholinesterase inhibitors cannot be avoided, making it extremely difficult to detect physiological levels of ACh in the extracellular space. Moreover, while mAChR agonists have been extensively used and are known to generate a multitude of responses in cortical neurons, much fewer studies (Hedrick and Waters, <xref rid="B56" ref-type="bibr">2015</xref>; Dasgupta et al., <xref rid="B33" ref-type="bibr">2018</xref>) have discerned muscarinic responses evoked by endogenous ACh release (see <xref ref-type="fig" rid="F1">Figures 1</xref>, <xref ref-type="fig" rid="F2">2</xref>).</p><p>Cholecystokinin-immunoreactive (CCK) cells are affected heterogeneously by cholinergic agonists depending on their sizes. For example, small CCK cells are promptly depolarized by cholinergic inputs, while bigger CCK cells show a biphasic response comprising an initial hyperpolarization and a subsequent depolarization similarly to PCs (Kawaguchi, <xref rid="B69" ref-type="bibr">1997</xref>). There is a general consensus (Gulledge et al., <xref rid="B52" ref-type="bibr">2007</xref>; Kruglikov and Rudy, <xref rid="B78" ref-type="bibr">2008</xref>; Poorthuis et al., <xref rid="B106" ref-type="bibr">2013</xref>) that cholinergic modulation of fast-spiking PV positive (PV<sup>+</sup>) interneurons does not produce any effect on membrane excitability (<xref rid="T1" ref-type="table">Table 1</xref>). However, evidence also shows the opposite. For example, Alitto and Dan (<xref rid="B3" ref-type="bibr">2013</xref>) report in their review that PV<sup>+</sup> interneurons are depolarized <italic>via</italic> muscarinic activation, but when mAChRs are blocked by antagonist application, the excitation is converted to inhibition; in turn inhibition of PV<sup>+</sup> cells is converted to excitation when nAChRs are blocked, suggesting that excitation and inhibition compete in the same population of PV<sup>+</sup> interneurons through the activity of the different receptors.</p><p>The subpopulation of dendrite-targeting interneurons, that is identified as somatostatin (Sst) expressing (Sst<sup>+</sup>) interneurons (MCs), can be depolarized by activation of mAChRs (Fanselow et al., <xref rid="B43" ref-type="bibr">2008</xref>). However, some studies report that only very few Sst<sup>+</sup> interneurons display excitation or inhibition in response to BF stimulation and that the inhibitory cells displaying the strongest excitation by ACh are L1 and VIP<sup>+</sup> interneurons). Recent findings outlined by Mu&#x000f1;oz et al. (<xref rid="B99" ref-type="bibr">2017</xref>) challenge these results. In their study, they claim that cholinergic modulation of Sst<sup>+</sup> interneurons <italic>via</italic> M1 and/or M3 mAChRs provides a major excitatory drive to these cells during whisking activity.</p><p>VIP expressing interneurons are highly responsive to cholinergic inputs and show a mixed activation profile that is partially blocked by both nicotinic and muscarinic receptor antagonists (Kawaguchi and Kubota, <xref rid="B70" ref-type="bibr">1997</xref>).</p><p>In summary, muscarinic activation has differential effects on membrane potential, based on which subtypes are expressed in a specific cell-type and in cellular compartments. These heterogeneous responses might play different roles in neocortical information processing: the initial hyperpolarizing phase observed in PCs and some CCK<sup>+</sup> cells could be used to push the cell away from threshold, while the subsequent depolarization selectively augments inputs that are strong enough to reach threshold, therefore increasing the SNR, and at the same time promoting synchronization of neural activity. At the same time, the presynaptic inhibition of excitatory feedback could serve as a mechanism to prevent interference during the encoding of new stimuli and reduce top-down influences on perceptive processes. In addition, muscarinic receptors contribute to the generation of the gamma rhythm by inducing synchronized oscillations in both excitatory and inhibitory neurons (Heys et al., <xref rid="B59" ref-type="bibr">2012</xref>).</p><p>Another class of receptors contributes to cholinergic signaling in the neocortex. Nicotinic receptors exert fast cortical actions, playing a key role in many cognitive processes (Dani and Bertrand, <xref rid="B31" ref-type="bibr">2007</xref>), as described in the following section (Dani and Bertrand, <xref rid="B31" ref-type="bibr">2007</xref>).</p></sec><sec id="s8"><title>Nicotinic Receptors</title><p>ACh is primarily regarded as a neuromodulator rather than a neurotransmitter in the CNS because its physiological effects have a latency of onset of tens of milliseconds to minutes (Van der Zee and Luiten, <xref rid="B137" ref-type="bibr">1999</xref>). This great variability in the response of cortical neurons to ACh stimulation originates from the fact that there are two main types of ACh receptor proteins. Neuronal nicotinic receptors (nAChRs) are ionotropic receptors which are composed of combinations of twelve different nAChR subunits: &#x003b1;2 to &#x003b1;10 and &#x003b2;2, &#x003b2;3, &#x003b2;4. Each receptor is made of five subunits. It is generally assumed that nicotinic actions are fast and precise; however, the depolarization rate produced by the opening of the nicotinic channel can vary depending on the specific subunit composition. Because mAChR signaling acts through G-proteins, mAChR signaling might be expected to be slower than ionic nAChR signaling. However, homomeric (&#x003b1;7) nAChRs can also mediate slow responses, and the time course of muscarinic action may also vary widely, depending on the signal pathways involved (Mu&#x000f1;oz and Rudy, <xref rid="B98" ref-type="bibr">2014</xref>).</p><p>The nicotinic branch of the AChR family can be further divided into at least two classes, based on the affinity that their binding sites have for nicotine itself or the snake toxin &#x003b1;-bungarotoxin. At their simplest neuronal nAChRs are homomeric (constituted from five identical subunits) while the more complex forms are heteromeric, composed of at least one &#x003b1; and one &#x003b2; subtype. Binding studies using [<sup>3</sup>H]-nicotine have shown that high-affinity nAChR binding sites are very common for the human cerebral cortex, while autoradiographic labeling of nAChRs shows an inhomogeneous distribution over architectonically identified cortical areas of the rat brain, with highest concentrations in the medial PFC (mPFC) and generally frontal areas.</p><p>As for mAChRs, the expression of different subunit combinations varies across layers and across cortical areas. Given the involvement of the nicotinergic system in the treatment of tobacco addiction, many studies have been performed in the human brain. Most data on the distribution of nAChRs has been obtained from human autopsy tissue homogenates using techniques such as ligand binding, RT-PCR, immunoprecipitation, and Western blot.</p><p>Currently-available nAChR agonists and antagonists used for receptor auto-radiography are not subtype specific, although they act on nAChR subtypes with a distinct profile: labeling experiments carried out with different probes revealed that nAChRs are widely expressed in the cortex, both at the level of gray and white matter; many fibers show immunoreactivity at the neuropil level (Schr&#x000f6;der, <xref rid="B120" ref-type="bibr">1992</xref>). Five &#x003b1; subunits (3&#x02013;7) and three &#x003b2; subunits (2&#x02013;4) are expressed in the human brain. The expression of &#x003b1;4 and &#x003b2;2 subunits in the frontal cortex, parietal cortex, and temporal cortex shows a characteristic laminar distribution. Higher receptor binding is observed in layers 1, 3 and 5. These results are in agreement with the observed distribution of &#x003b1;3 and &#x003b1;4 mRNAs that are mostly found in PCs of layer 2/3 and layer 5 of the frontal cortex (Wevers, <xref rid="B142" ref-type="bibr">2011</xref>). However, other studies report that the &#x003b1;3 mRNA is exclusively expressed in layer 4, while &#x003b1;4 subunit is moderately expressed in all layers (Radnikow and Feldmeyer, <xref rid="B109" ref-type="bibr">2018</xref>). The &#x003b1;7 subunit is found mostly in layer 1&#x02013;3 and 5 and is virtually absent in layer 4, while &#x003b1;4 and &#x003b2;2 immunoreactive fibers were observed in layer 4 of the PFC (Sparks et al., <xref rid="B125" ref-type="bibr">2018</xref>). The &#x003b1;2 subunit is a characteristic feature of L5MCs that project to layer 1 and specifically target L5TTPCs (Hilscher et al., <xref rid="B60" ref-type="bibr">2017</xref>). The detection of nicotinic subunits is possible because of the existence of specific antisubunit-antibodies and the introduction of nAChR subunit-Cre mouse lines. Nevertheless, nicotinic receptors are made up of multiple subunits and are either homomeric or heteromeric. The most abundant receptor subtypes in the neocortex are the homomeric receptor &#x003b1;7 and the heteromeric &#x003b1;4&#x003b2;2 channel (which is often associated with the regulatory subunit &#x003b1;5; Radnikow and Feldmeyer, <xref rid="B109" ref-type="bibr">2018</xref>). Nicotinic receptors can be activated both <italic>via</italic> volume transmission and fast synaptic activity (Dani and Bertrand, <xref rid="B31" ref-type="bibr">2007</xref>; Hedrick and Waters, <xref rid="B56" ref-type="bibr">2015</xref>; Hay et al., <xref rid="B55" ref-type="bibr">2016</xref>).</p></sec><sec id="s9"><title>Pre-synaptic Localization</title><p>None of the studies mentioned above investigates the precise cellular localization of cholinergic receptors, which is crucial in determining the outcome of the response. This is especially true for nAChRs, because their activation directly leads to a cation influx into the cell, and immediately results in a voltage change in the underlying compartment.</p><p>nAChRs are expressed on glutamatergic inputs to layer 5, mostly contacting layer 5 interneurons and L5/L6 PCs. L5PCs and L6PCs are modulated by &#x003b1;7 and &#x003b2;2 nAChRs, respectively, while L23PCs and glutamatergic inputs to these cells do not contain nAChRs. Interneurons across layers contain mixed combinations of nAChRs (Poorthuis et al., <xref rid="B106" ref-type="bibr">2013</xref>). Some subtypes, such as &#x003b1;7 homomeric receptors, are preponderantly expressed in presynaptic areas, whereas heteromeric receptors are more expressed on cell bodies and main dendrites (Bertrand, <xref rid="B16" ref-type="bibr">2010</xref>). Cholinergic axons that diffusely innervate the cortex are thought to make <italic>en passant</italic> connections in the area of the main dendrite of the PCs from layer 5 and VI, therefore causing a volume release of ACh. Pre-synaptically, nAChRs generally increase the release of GABA and glutamate (Dani and Bertrand, <xref rid="B31" ref-type="bibr">2007</xref>). However, both nAChR and mAChRs can reduce EPSPs by acting pre-synaptically (Levy et al., <xref rid="B82" ref-type="bibr">2006</xref>).</p></sec><sec id="s10"><title>Post-synaptic Localization</title><p>The distribution of nAChRs at the light and electron microscopic level was studied in the human cerebral cortex using anti-nAChR monoclonal antibody (mAb) WF-6, which is not subunit selective (Schr&#x000f6;der et al., <xref rid="B121" ref-type="bibr">1990</xref>): nAChR immunoreactivity revealed a pattern for the frontal and temporal cortex that was very similar to that obtained with the auto-radiography. In the frontal cortex, <italic>in situ</italic> hybridization techniques display numerous labeled neurons, mostly PCs bearing the &#x003b1;7 mRNA in the cell body and in the apical dendrite. In the motor cortex, many PCs showed signals in the proximal part of their apical dendrite.</p><p>As reported by Schr&#x000f6;der et al. (<xref rid="B122" ref-type="bibr">1989</xref>) and Schr&#x000f6;der (<xref rid="B120" ref-type="bibr">1992</xref>) nAChR localization is predominant in L23 and L5 PCs; a few nAChR-expressing fusiform cells can be detected in layer 4 and VI. Many PCs show nAChRs on basal dendrites that originate in layer 5, cross the superficial layers of the cortex perpendicular to the pial surface, and branch between layers 1 and 2. Immuno-precipitate is detectable both in cell bodies and in their apical dendrites, in branches of various diameters, and in the PSD of synaptic junctions. In a double-labeling approach conducted in the temporal cortex, it was further demonstrated that PV<sup>+</sup> interneurons express &#x003b1;4 and &#x003b1;7 subunit protein (Wevers, <xref rid="B142" ref-type="bibr">2011</xref>). Double-labeling studies have shown that at least 30% of cortical neurons contain both nAChR and mAChR proteins, the majority of these being PCs. In the human cortex, nicotinic immuno-staining in individual neurons appears generally comparable to that seen in the rodent model (Schr&#x000f6;der et al., <xref rid="B122" ref-type="bibr">1989</xref>; Schr&#x000f6;der, <xref rid="B120" ref-type="bibr">1992</xref>): as in the rat occipital cortex, nAChRs can be detected on the cell bodies and dendrites of L23 and L5 PCs.</p><p>Most studies agree that nAChRs are preferentially found in infragranular layers, mostly at the level of L5 and L6PCs, but also at the level of inhibitory interneurons; CB-immunoreactive neurons, as well as PV<sup>+</sup> neurons all express nAChRs, while that is not true for CR-ir neurons (Coppola and Disney, <xref rid="B27" ref-type="bibr">2018</xref>); furthermore, nAChRs are expressed at the level of layer 2/3 as well, both in PC bodies and in the apical dendrites of deeper-layer placed cells. However, only a small subset of layer 2/3 excitatory neurons and no layer 4 neurons express nAChRs; layer 6 expression profile can be set apart from the rest, given that these neurons predominantly express the slowly desensitizing heteromeric &#x003b1;4&#x003b2;2 channel (Radnikow and Feldmeyer, <xref rid="B109" ref-type="bibr">2018</xref>).</p><p>The distribution of nAChRs and the subunits combination, therefore, depends on cell-types, laminar position and on the cortical area studied, similarly to mAChRs; nowadays the possibility of systematically studying the distribution profile of cholinergic receptors has greatly increased, due to the advancement in the production of anti-subunit-specific-antisera and to the development of better immunoprecipitation and ligand binding techniques. Such studies exist and are quite informative as regards, for instance, the striatum (Zoli et al., <xref rid="B149" ref-type="bibr">2002</xref>), but a comprehensive and detailed investigation of the expression of subunits in the neocortex is still lacking. Nicotinic activation prevalently modulates the excitability of deep cortical layers: in the next section, we move on and explore the contribution of nicotinic stimulation to local circuit properties and examine studies that investigated the involvement of the nicotinergic system in the modulation of neocortical activity.</p></sec><sec id="s11"><title>Regulation of Neuronal and Synaptic Physiology</title><p>Even though nAChRs are predominantly expressed pre-synaptically, where their activation modulates neurotransmitter release through calcium influx or terminal depolarization (Nashmi and Lester, <xref rid="B100" ref-type="bibr">2006</xref>), there is evidence that nAChRs may also influence post-synaptic signaling and that these effects vary based on the subcellular localization of the receptor (<xref rid="T2" ref-type="table">Tables s 2</xref>, <xref rid="T3" ref-type="table">3</xref>). nAChRs expressed on distal dendrites are thought to cause the generation of fast excitatory post-synaptic potentials since activation of nAChRs on distal apical dendrites promotes PC depolarization and leads to an increase in action potential firing. On the contrary, activation of nAChRs on the proximal apical dendrites (closer to the cell body) reduces membrane impedance and shunts signal incoming from the apical tuft: when the nAChRs opens, the membrane resistance of the PC decreases and signals incoming from the apical dendrites get attenuated (Dani and Bertrand, <xref rid="B31" ref-type="bibr">2007</xref>).</p><p>Optogenetic activation of cortical cholinergic input generates an increase in membrane excitability (<xref rid="T2" ref-type="table">Table 2</xref>) mediated by nAChRs and promotes spiking in L5PCs (Hedrick and Waters, <xref rid="B56" ref-type="bibr">2015</xref>). When the stimulation is paired with additional depolarization, spiking activity becomes persistent and can be blocked by BAPTA application, suggesting that the observed depolarization is mediated by intracellular Ca<sup>++</sup> transients. As suggested by kinetic analysis it is likely that non-&#x003b1;7 nAChRs determine this response. The depolarizing response spans all layers, but occurs with laminar and regional differences; additionally, the effect of the depolarization can be moderate and transitory or pronounced and persistent depending on the cell membrane potential. Although the modulatory effect was found to be stronger in deeper layers, the authors report that it was similar in M1, V1 and prefrontal (PF) cortices. The preferential modulation of deep neocortical layers is likely to influence the flow of excitation occurring throughout the neocortex that originates in layer 4 and then propagates to the superficial layers, whose role is to modify the output of layer 5. Altogether this study showed that nAChR activation increases the excitability of neocortical PCs; in the light of previous evidence that &#x003b1;4 and &#x003b1;5 subunits are highly expressed in layer 6 (Tribollet et al., <xref rid="B132" ref-type="bibr">2004</xref>), and nAChR-mediated responses in layer 6 of the PFC have already been reported by many studies (Kassam et al., <xref rid="B67" ref-type="bibr">2008</xref>; Bailey et al., <xref rid="B10" ref-type="bibr">2010</xref>; Poorthuis et al., <xref rid="B106" ref-type="bibr">2013</xref>), the authors suggest that the presence of &#x003b1;4 and &#x003b1;5-mediated PSPs could be a characteristic feature of L6PCs across neocortical regions (see <xref rid="T2" ref-type="table">Table 2</xref>, <xref ref-type="fig" rid="F1">Figure 1</xref>).</p><p>Pyramidal-to-PCs connections in layer 5 can be potentiated by using an spike-timing-dependent-plasticity (STDP) protocol. Bath-application of 10 &#x003bc;M (or 300 nM) nicotine impairs L5PC to L5PC potentiation and favors the induction of LTD. When monitoring spontaneous synaptic events, application of nicotine increases the frequency and amplitude of sEPSCs. Evoked excitatory post-synaptic currents (EPSCs) behave differently and are reduced in amplitude by nicotine. However, puffing nicotine directly on PCs fails to elicit an inward current, and application of gabazine prevents the de-potentiation. Therefore, the effects of nicotine on L5PC to L5PC synapses should be attributed to an enhancement of GABAergic transmission, rather than the direct activation of a PCs (Couey et al., <xref rid="B28" ref-type="bibr">2007</xref>).</p><p>nAChRs are known to be distributed throughout the dendritic trees of cortical PCs (van der Zee et al., <xref rid="B138" ref-type="bibr">1992</xref>), but a comprehensive mapping of cholinergic synapses apposition remains elusive. To provide concomitant information on receptor localization while recording electrical responses more researchers should apply the strategy used by Hedrick and Waters (<xref rid="B56" ref-type="bibr">2015</xref>), who measured nicotinic PSPs during restricted illumination of the slice: illumination of the tuft dendrites failed to evoke a nicotinic PSP at the soma and therefore the authors concluded that nAChRs that contribute to the somatic depolarization are likely to be within 300 &#x003bc;m of the soma and many are probably located in the proximal 50 &#x003bc;m of the apical and basal arbor. This technique sheds light on the compartmental origin of the observed response and it is immensely useful to causally link the distribution of cholinergic receptors and their physiological role. A subsequent investigation should combine this strategy with pharmacological inactivation of specific receptor subunits and provide further proof that PCs responses to cholinergic inputs in different layers are mediated by specific receptor subunits and that their distribution profile is greatly involved in determining the outcome of neural computations.</p><p>Although nAChRs are mainly found on PCs, there is extensive evidence that nAChRs are expressed on the membrane of cortical interneurons (<xref rid="T2" ref-type="table">Table 2</xref>), such as MC, chandelier cells (ChCs) and basket cells (BCs), where they contribute to the modulation of GABAergic signaling (Couey et al., <xref rid="B28" ref-type="bibr">2007</xref>; Wevers, <xref rid="B142" ref-type="bibr">2011</xref>). The subpopulation of serotonin receptor 5-HT3aR expressing GABAergic interneurons is depolarized by ACh <italic>via</italic> nAChRs (Gulledge et al., <xref rid="B52" ref-type="bibr">2007</xref>; Poorthuis et al., <xref rid="B106" ref-type="bibr">2013</xref>); this embryologically distinguished subpopulation, that accounts for about 30% of the total number of cortical inhibitory interneurons, is heterogeneous and includes all the VIP<sup>+</sup> interneurons, as well as the VIP<sup>&#x02212;</sup> neurogliaform cells (NGCs; Rudy et al., <xref rid="B112" ref-type="bibr">2011</xref>). VIP<sup>+</sup> interneurons show a mixed activation profile in which both nicotinic and muscarinic receptors are involved (<xref ref-type="fig" rid="F1">Figure 1</xref>; Kawaguchi, <xref rid="B69" ref-type="bibr">1997</xref>).</p><p>Prominent nAChRs expression is a hallmark of layer 1 inhibitory interneurons both in rodents and humans (Letzkus et al., <xref rid="B80" ref-type="bibr">2011</xref>; Alitto and Dan, <xref rid="B3" ref-type="bibr">2013</xref>) and endogenous cholinergic release is known to rapidly recruit this receptor subpopulation during locomotion and attentive processes. These fast, nicotinic responses are mediated by &#x003b1;7 and &#x003b2;2 containing receptors (Poorthuis et al., <xref rid="B108" ref-type="bibr">2018</xref>). When at rest, all layer 1 interneurons are depolarized <italic>via</italic> nicotinic activation (<xref ref-type="fig" rid="F1">Figure 1</xref>, <xref rid="T2" ref-type="table">Table 2</xref>); however, when these interneurons are engaged in repetitive firing, ACh inhibits the activity of L1 NGCs (Brombas et al., <xref rid="B18" ref-type="bibr">2014</xref>). Conversely, single bouquet cells (SBCs) are activated by ACh in the regime of repetitive firing (Jiang et al., <xref rid="B63" ref-type="bibr">2013</xref>). Layer 1 interneurons responses are abolished by application of nAChR antagonists (<xref ref-type="fig" rid="F1">Figure 1</xref>; Christophe et al., <xref rid="B26" ref-type="bibr">2002</xref>).</p><p>ACh enhances the activation of neocortical deep-layers PCs by ascending thalamic inputs <italic>via</italic> mAChR-mediated depolarization and subsequent enhanced glutamate release from thalamocortical terminals in layer 4 (Gil et al., <xref rid="B46" ref-type="bibr">1997</xref>; Metherate and Hsieh, <xref rid="B92" ref-type="bibr">2004</xref>; Disney et al., <xref rid="B36" ref-type="bibr">2007</xref>), but it also releases inhibition on superficial layers PCs. There is extensive evidence that ACh mediates activation of layer 1 and layer 2/3 non-fast spiking PV<sup>&#x02212;</sup> cortical interneurons <italic>via</italic> non-&#x003b1;7 nAChRs. These interneurons, in turn, inhibit MCs and BCs that directly target PCs: nAChR-mediated inhibition of superficial interneurons reduces inhibition of superficial PCs (Gulledge et al., <xref rid="B52" ref-type="bibr">2007</xref>; Arroyo et al., <xref rid="B8" ref-type="bibr">2012</xref>; Brombas et al., <xref rid="B18" ref-type="bibr">2014</xref>). Photostimulation of ChAT<sup>+</sup> neurons in the BF evokes a prolonged disynaptic inhibition in PCs; pharmacological manipulation of the response suggests that it is supported by non-&#x003b1;7 mediated excitation of specific interneurons subtypes. This finding indicates that nicotinic cholinergic input originating from BF fibers is also comprised of a slow component. The observed delayed barrage of inhibitory post-synaptic current (IPSC) in L23PCs exhibits a long latency (of about 26 ms) characteristic of dysynaptic inhibition. Layer 1 and layer 2/3 inhibitory interneurons, and in particular in late-spiking cells and L23 ChAT<sup>+</sup> bipolar cells are responsible for this phenomenon (Arroyo et al., <xref rid="B8" ref-type="bibr">2012</xref>). In agreement with previous reports (Poorthuis et al., <xref rid="B107" ref-type="bibr">2014</xref>) fast-spiking cells such as BCs and ChCs do not exhibit EPSPs in response to optogenetic stimulation of ChAT<sup>+</sup> BF neurons, but rather respond similarly to PCs and are swamped by an IPSC barrage as well. While layer 1 and layer 2/3 late spiking cells (LS) exhibit both a fast and a slow response, L23 ChAT bipolar cells display only a slow response. This study demonstrates that the fast and slow components are mediated by &#x003b1;7 receptors and non-&#x003b1;7 receptors, respectively, and that non-&#x003b1;7 receptor-mediated excitation elicits action potentials in cortical interneurons that in turn produce a delayed and prolonged wave of inhibition in L23PCs and FS cells. One proposed explanation for the slow response is that it may arise from a cholinergic bulk transmission and that it may sustain the high metabolic demand of processes such as attention and memory (Cauli et al., <xref rid="B23" ref-type="bibr">2004</xref>). Cortical ChAT<sup>+</sup>/VIP<sup>+</sup> interneurons have been shown to dilate local microvasculature to increase blood supply during periods of elevated neuronal activity (Kocharyan et al., <xref rid="B75" ref-type="bibr">2008</xref>) during the execution of memory and attention tasks, following electrical BF stimulation. The fast component of the cholinergic response may also be implicated in the emergence of a broader phenomenon like synchronized neuronal activity; it has been shown that LS cells are connected <italic>via</italic> gap junctions, and this fast response may thus play a fundamental role in the emergence of network oscillations that sustain plasticity and attention mechanisms.</p><p>Couey et al. (<xref rid="B28" ref-type="bibr">2007</xref>) realized that the effect of nicotine on L5PC to L5PC connections is mostly due to an enhancement of GABAergic transmission, and they decided to dissect the effects of nicotine on three different interneurons types. First, they looked at the activity of FS cells in layer 5, and observed no effect when adding nicotine to the bath; later they stained the cells for certain neuropeptides and several nAChR subunits and found an extremely low amount of mRNA coding for nicotinic subunits in FS cells, which might explain their unresponsiveness. Once again, another piece of evidence emerges confirming that (putative) BCs have a tendency not to respond to the application of cholinergic agonists. The authors identified another type of interneuron as a regular-spiking-non-PC (RSNPC), and observed a fast inward current after application of nicotine. LTS cells (putative MC) showed an even bigger inward current response; in both cell-types the most abundantly stained nicotinic subunit was &#x003b1;4, but &#x003b2;2 and &#x003b1;7 were also present. In this study, nicotine application increases the frequency and amplitude of spontaneous EPSCs in putative BCs and MCs; as for putative ChC (RSNP) a decrease in the frequency, but not the amplitude of sEPSCs can be observed (Couey et al., <xref rid="B28" ref-type="bibr">2007</xref>).</p><p>Pyramidal to SST<sup>+</sup> interneurons neocortical connections are relatively weak, but local excitatory input to SST neurons is selectively enhanced during cholinergic modulation of network activity. In a recent 2018 study, it was shown that endogenous ACh release activates presynaptic nAChRs and boosts glutamatergic input in a target-cell specific manner (Urban-Ciecko et al., <xref rid="B136" ref-type="bibr">2018</xref>). Thus, there is evidence that local excitatory input to SST neurons is selectively enhanced during nicotinic modulation of network activity (<xref rid="T2" ref-type="table">Table 2</xref>, <xref ref-type="fig" rid="F2">Figure 2</xref>). In a recent study by Obermayer et al. (<xref rid="B103" ref-type="bibr">2018</xref>) examined PC-MC-PC disynaptic connections in both layer 2/3 and layer 5 and found that the typical delayed disynaptic inhibitory response in the post-synaptic PC is faster and stronger when cholinergic inputs are activated optogenetically, or by means of 1 mM ACh bath application. When looking at the activity of a single MC, they observed that ACh inputs lead to a significant decrease of the onset delay of AP firing and increases the number of APs fired in MCs, which can account for the earlier onset and prolonged duration of disynaptic inhibition. This effect was abolished by application of 10 &#x003bc;M DH&#x003b2;E demonstrating that it is mediated by heteromeric nicotinic receptors (<xref rid="T2" ref-type="table">Table 2</xref>, <xref ref-type="fig" rid="F2">Figure 2</xref>). However, when they recorded from synaptically connected PC-MC pairs during concurrent activation of cholinergic fibers, they could only observe an increase in the membrane depolarization level, but not in EPSP sizes. The same effect was found in MC-PC connections, and this as well was confirmed to be nicotinic in nature, contradicting the result obtained by Urban-Ciecko and others and others. The setups of the two experiments are comparable: both studies were performed in the adult mouse somatosensory cortex. However, the first remarkable difference lies in the nature of the cholinergic input used in the two experiments: while Obermayer et al. (<xref rid="B103" ref-type="bibr">2018</xref>) used bath-application of 1 mM ACh and optogenetic activation, Urban-Ciecko et al. (<xref rid="B136" ref-type="bibr">2018</xref>) decided to record activity in the presence of 20 &#x003bc;M CCh, a non-hydrolyzable analogue of ACh. Not only the two concentrations differ by two orders of magnitude, but the two cholinergic agonists work in fundamentally different ways. While ACh is almost immediately hydrolyzed by the cholinesterase in the synaptic cleft (within a few milliseconds), carbachol has a much more prolonged effect (Katz and Miledi, <xref rid="B68" ref-type="bibr">1973</xref>). Nevertheless, the results obtained by bath-application of ACh are in agreement with the results achieved by optogenetic activation of the cholinergic system, which is supposed to be a more physiological way of stimulating cholinergic release (Obermayer et al., <xref rid="B103" ref-type="bibr">2018</xref>).</p><p>Interestingly, optogenetic activation of cholinergic inputs did not affect the typical fast disynaptic post-PC response mediated by BCs, which provides yet another example of how BCs tend to be unresponsive to cholinergic release in both layer 2/3 and layer 5, or more generally show a more heterogeneous response profile to ACh inputs (Obermayer et al., <xref rid="B103" ref-type="bibr">2018</xref>). This could be explained by the lack of a precise morphological identification of various subtypes of BCs, which could express cholinergic receptors in different subcellular locations or in a different amount, and therefore show differential responses to ACh inputs. These findings indicate that subcortical neuromodulatory projections recruit nicotinic receptors to alter network function through increased inhibition and provide a potential mechanism by which attention controls the gain of local circuits.</p></sec><sec id="s12"><title>Nicotinic and Muscarinic Kinetics</title><p>What are the receptor affinities to various agonists and can this be related to the actual amount of nicotinergic modulation? The relative activation of receptors vs. the concentration of agonist has been measured (<xref rid="T4" ref-type="table">Table 4</xref>).</p><table-wrap id="T4" position="float"><label>Table 4</label><caption><p>Nicotinic homomeric and heteromeric receptors kinetics.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1">Receptor type</th><th align="left" rowspan="1" colspan="1">Single channel conductance</th><th align="left" rowspan="1" colspan="1">Open time</th><th align="left" rowspan="1" colspan="1">PO<sub>max</sub></th><th align="left" rowspan="1" colspan="1">EC50 for ACh or nicotine</th><th align="left" rowspan="1" colspan="1">Kinetics</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Nicotinic heteromeric (&#x003b1;3)2(&#x003b2;4)3</td><td align="left" rowspan="1" colspan="1">29 pS</td><td align="left" rowspan="1" colspan="1">0.71 &#x000b1; 0.14 and 3.5 &#x000b1; 0.4 ms</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Nicotinic heteromeric (&#x003b1;3)2(&#x003b2;4)3</td><td align="left" rowspan="1" colspan="1">29 pS (Stetzer et al., <xref rid="B216" ref-type="bibr">1996</xref>), 18.2 &#x000b1; 0.46 (Rovira et al., <xref rid="B212" ref-type="bibr">1998</xref>)</td><td align="left" rowspan="1" colspan="1">147 ms (Stetzer et al., <xref rid="B216" ref-type="bibr">1996</xref>)</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">(&#x003b1;3&#x003b2;2)2&#x003b1;5</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">EC50 ACh 1.70&#x02013;1.83 &#x003bc;M for ACh EC50 Nicotine 2.91 &#x003bc;M IC50 Nicotine 2.92 &#x003bc;M (Kuryatov et al., <xref rid="B207" ref-type="bibr">2011</xref>)</td><td align="left" rowspan="1" colspan="1">Fast: 40&#x02013;121 ms; slow: 274&#x02013;1039 ms (Figl and Cohen, <xref rid="B203" ref-type="bibr">2000</xref>)</td></tr><tr><td align="left" rowspan="1" colspan="1">(&#x003b1;3&#x003b2;4)2 &#x003b1;5</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">EC50 Ach 115&#x02013;122 &#x003bc;M EC50 Nicotine 4.64 IC50 Nicotine 16.7 &#x003bc;M (Kuryatov et al., <xref rid="B207" ref-type="bibr">2011</xref>)</td><td rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Nicotinic heteromeric (&#x003b1;4)2(&#x003b2;2)3</td><td align="left" rowspan="1" colspan="1">31.3 pS, 40.5 pS (high state) and 21.9 pS (low; Hales et al., <xref rid="B205" ref-type="bibr">2006</xref>)</td><td align="left" rowspan="1" colspan="1">207 &#x000b1; 38 ms (Hsiao et al., <xref rid="B206" ref-type="bibr">2008</xref>)</td><td align="left" rowspan="1" colspan="1">0.8 (Li and Steinbach, <xref rid="B208" ref-type="bibr">2010</xref>)</td><td align="left" rowspan="1" colspan="1">High affinity is 1.6 &#x003bc;M, low affinity is 62 &#x003bc;M (Buisson and Bertrand, <xref rid="B202" ref-type="bibr">2001</xref>) EC50 for ACh in activating &#x003b1;7 is 3 &#x003bc;M (Albuquerque et al., <xref rid="B1" ref-type="bibr">2000</xref>)</td><td align="left" rowspan="1" colspan="1">Fast 4&#x02013;6 ms; slow 30&#x02013;53 ms (Figl and Cohen, <xref rid="B203" ref-type="bibr">2000</xref>)</td></tr><tr><td align="left" rowspan="1" colspan="1">Nicotinic heteromeric (&#x003b1;4&#x003b2;2)2 &#x003b1;5</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">EC50 ACh 1.44&#x02013;1.64 &#x003bc;M for variants tested EC50 Nicotine 0.62 &#x003bc;M IC50 Nicotine 0.0872 &#x003bc;M (Kuryatov et al., <xref rid="B207" ref-type="bibr">2011</xref>)</td><td rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Nicotinic homomeric (&#x003b1;7)5</td><td align="left" rowspan="1" colspan="1">82.9 pS (Albuquerque et al., <xref rid="B1" ref-type="bibr">2000</xref>)</td><td align="left" rowspan="1" colspan="1">108 &#x003bc;s and 92.7 &#x003bc;s for channels activated by 11 and 10 mM Ach, respectively (Albuquerque et al., <xref rid="B1" ref-type="bibr">2000</xref>)</td><td rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Choline: EC50 1.6 mM; IC50 37 &#x003bc;M (Alkondon and Albuquerque, <xref rid="B4" ref-type="bibr">2004</xref>). 200 &#x003bc;M ACh (Buisson and Bertrand, <xref rid="B202" ref-type="bibr">2001</xref>). EC50 for ACh in activating &#x003b1;7 130 &#x003bc;M (Albuquerque et al., <xref rid="B1" ref-type="bibr">2000</xref>)</td><td rowspan="1" colspan="1"/></tr></tbody></table><table-wrap-foot><p><italic>The table lists properties of nicotinic homomeric and heteromeric receptors (single-channel conductance, open time and open probability and EC50 and kinetics)</italic>.</p></table-wrap-foot></table-wrap><p>Muscarine reversibly reduces Ca<sup>2+</sup> currents in a dose-dependent manner. The modulation is rapid, with an onset time constant of 1.2 s. A slowly developing component of the modulation also is observed, with a time constant of 17 s. Under elevated Ca<sup>2+</sup> conditions, the fast component is due to a reduction in both N- and P-type calcium currents, whereas the slow component involves L-type current (Stewart et al., <xref rid="B127" ref-type="bibr">1999</xref>). Receptor properties such as conductance, open time, and sensitivity to ACh depend on the nicotinic subunit composition (<xref rid="T4" ref-type="table">Table 4</xref>). (&#x003b1;4)2(&#x003b2;2)3 nAChRs are sensitive to micromolar scale changes, while (&#x003b1;7)5 receptors have a half-maximal sensitivity of more than a hundred micromolar. Extracellular choline is normally 3&#x02013;5 &#x003bc;M but can attain 20 &#x003bc;M in some pathological cases. However, ACh reaches the millimolar range at the site of release (Alkondon and Albuquerque, <xref rid="B4" ref-type="bibr">2004</xref>). Responses mediated by &#x003b1;<sub>7</sub> nAChRs are short-lasting, whereas those mediated by &#x003b1;<sub>4</sub>&#x003b2;<sub>2</sub> nAChRs are long-lasting. This is because the mean open time of &#x003b1;<sub>7</sub> nAChRs is shorter than that of &#x003b1;<sub>4</sub>&#x003b2;<sub>2</sub> nAChRs. Also, &#x003b1;<sub>7</sub> nAChRs desensitize much faster than &#x003b1;<sub>4</sub>&#x003b2;<sub>2</sub> nAChRs (Alkondon et al., <xref rid="B5" ref-type="bibr">1999</xref>).</p><p>An interesting hypothesis was put forward by Albuquerque et al. (<xref rid="B1" ref-type="bibr">2000</xref>). &#x003b1;<sub>7</sub> but not &#x003b1;<sub>4</sub>&#x003b2;<sub>2</sub> nAChRs can be fully activated by choline (Nguyen et al., <xref rid="B102" ref-type="bibr">1995</xref>; Alkondon et al., <xref rid="B5" ref-type="bibr">1999</xref>). Choline and acetate are the products of hydrolyzation of synaptically released ACh by ACh-esterase in the synaptic cleft. This process occurs quickly, but reuptake of choline into presynaptic terminals is slow. Therefore, the ACh concentration in the synaptic cleft should decay rapidly, with only low levels of diffusing ACh reaching peri-synaptic sites. But choline levels should rapidly rise in the synaptic cleft with high levels of diffusing choline reaching peri-synaptic sites. This implies that extrasynaptically located &#x003b1;4&#x003b2;2 nAChRs (i.e., the high affinity nAChRs) could be activated by diffusing, low levels of ACh, extrasynaptically located while low-affinity &#x003b1;7 nAChRs may be activated by diffusing choline. Thus, &#x003b1;7 and &#x003b1;4&#x003b2;2 nAChRs might exhibit differential control (Albuquerque et al., <xref rid="B1" ref-type="bibr">2000</xref>).</p></sec><sec id="s13"><title>Subcellular Nicotinic and Muscarinic Pathways</title><p>ACh affects membrane conductance through several subcellular pathways, as illustrated in <xref ref-type="fig" rid="F4">Figure 4</xref>, leading to both hyperpolarizing and depolarizing effects (<xref rid="T1" ref-type="table">Tables s 1</xref>, <xref rid="T2" ref-type="table">2</xref>). ACh can act on both pre and post-synaptic membranes, binding to muscarinic and nicotinic receptors. The interplay among intracellular pathways leads to a dynamically changing outcome, such as the transient hyperpolarization and following long-term depolarization resulting from the binding of ACh to M1 mAChR (Dasari et al., <xref rid="B32" ref-type="bibr">2017</xref>). When ACh interacts with M1, the exchange of coupled GDP for GTP produces the dissociation of the G-protein complex from the receptor. The released &#x003b1; subunit of the Gq protein then activates the enzyme phospholipase C (PLC &#x003b2;) which hydrolyzes phosphatidyl-inositol 4,5 bisphosphate (PIP<sub>2</sub>), leading to its dissociation from the membrane and the subsequent formation of diacylglycerol (DAG) and IP<sub>3</sub>. IP<sub>3</sub> initiates calcium ions release from the endoplasmic reticulum (ER), serving as a trigger for this process. Refilling of the ER with Ca<sup>2+</sup>ions is then obtained by the activity of the sarco-ER Ca<sup>2+</sup>-ATPase (SERCA). Extracellular calcium ions are therefore crucial for the maintenance of calcium cycling. M1 activation facilitates voltage-dependent refilling of calcium stores by promoting excitation. Thus, fine-tuned calcium dynamics govern complex reciprocal relations among many different proteins contributing to changes in membrane potential. Ultimately, changes in K<sup>+</sup>, Ca<sup>2+</sup>-activated K<sup>+</sup>-currents and non-specific cationic currents support a shift from transient hyperpolarization to a sustained excitation.</p><fig id="F4" position="float"><label>Figure 4</label><caption><p>Subcellular nicotinic and muscarinic signaling processes at the glutamatergic synapse being modulated by ACh. Only the main relevant pathways and components are shown. Receptor subtypes which are less expressed on pre and post-synaptic membranes and related downstream processes are shown in semi-transparent colors. Abbreviations: ACh, acetylcholine; ACh Esterase, acetylcholinesterase; M1-M5, muscarinic acetylcholine receptor types 1&#x02013;5; nAChR (&#x003b1;7, &#x003b1;4&#x003b2;2), nicotinic acetylcholine receptor (types &#x003b1;7, &#x003b1;4&#x003b2;2); VGCC, voltage-gated calcium channel; KA, kainate receptor; GIRK, G-protein activated inward rectifier K<sup>+</sup> channel; PKA, protein kinase A; CaM, calmodulin; AC, adenylyl cyclase; DAG, diacylglycerol; PKC, protein kinase C; NOS, NO-synthase; HO-2, heme oxygenase 2; sGC, soluble guanylyl cyclase; PKG, cGMP-dependent protein kinase; HCN, hyperpolarization-activated cyclic nucleotide-gated channel; TRPC1, transient receptor potential cation channel 1; mGluR, metabotropic glutamate receptor; Pyk2, protein-tyrosine kinase 2; PiP2, phosphoinositol-1,4,5-biphosphate; PLC &#x003b2;, phospholipase C &#x003b2;; IP<sub>3</sub>, inositol triphosphate; IP<sub>3</sub>R, IP<sub>3</sub> receptor; RyR, ryanodine receptor; SERCA, sarco-endoplasmic reticulum Ca<sup>2+</sup>-ATPase.</p></caption><graphic xlink:href="fncir-13-00024-g0004"/></fig><p>Meanwhile, DAG together with Ca<sup>2+</sup> ions activate kinases such as protein kinase C (PKC), causing multiple downstream effects. PKC controls the function of many proteins including members of both pre and post-synaptic membranes. PKC is also involved in synaptic plasticity regulation and causes the internalization of AMPARs and NMDARs, leading to LTD phenomena (Callender and Newton, <xref rid="B20" ref-type="bibr">2017</xref>).</p><p>PKC can also phosphorylate metabotropic glutamate receptor 5 (mGluR5; Hwang et al., <xref rid="B61" ref-type="bibr">2005</xref>) as well as many other proteins. Moreover, PKC activates heme-oxygenase 2 (HO-2; Artinian et al., <xref rid="B9" ref-type="bibr">2001</xref>) and inhibits NO-synthase (NOS), interfering with the calcium/calmodulin activation of NOS enzyme (Borda et al., <xref rid="B17" ref-type="bibr">1998</xref>). These effects contribute to the downstream processes involving carbon monoxide (CO) and nitric oxide (NO) as interacting messengers (Mathes and Thompson, <xref rid="B89" ref-type="bibr">1996</xref>; Artinian et al., <xref rid="B9" ref-type="bibr">2001</xref>). Long-term effects of PKC activation include changes in DNA transcription that are mediated by MAPK/Erk signaling. Furthermore, there is recent evidence for the direct interaction of M3 mAChR with PLC &#x003b2;, which increases signaling efficiency (Kan et al., <xref rid="B66" ref-type="bibr">2014</xref>).</p><p>The downstream signaling pathways of M3 and M5 receptors overlap with that of M1, and therefore they are grouped as M1-like receptors; similarly, M2-type mAChRs comprise both M2 and M4 receptors. Binding of ACh to M2-type mAChRs results in the inhibition of adenylyl cyclase (AC) by the &#x003b1; subunit of G<sub>i/o</sub> protein and in the subsequent reduction of cAMP levels (Mu&#x000f1;oz and Rudy, <xref rid="B98" ref-type="bibr">2014</xref>). However, there are some differences between the G<sub>i</sub> and G<sub>o</sub> mechanisms of AC regulation (Jiang and Bajpayee, <xref rid="B62" ref-type="bibr">2009</xref>). The &#x003b2;&#x003b3;-complex of the dissociated G-protein can activate the G-protein activated inward rectifier K<sup>+</sup> channels (GIRK) and inhibit voltage-gated calcium channels (VGCCs). Moreover, G<sub>o</sub> proteins can also regulate Na<sup>+</sup> channels (Jiang and Bajpayee, <xref rid="B62" ref-type="bibr">2009</xref>). Particular effects of M1 and M2 receptors on different ion channels have been already summarized by Thiele et al. (<xref rid="B131" ref-type="bibr">2012</xref>).</p><p>A significant increase in intracellular calcium concentration comes from the direct flow of ions due to the permeability of nAChRs to Ca<sup>2+</sup>. However, nAChR activation also leads to the activation of VGCC and subsequent Ca<sup>2+</sup> influx. (Dajas-Bailador and Wonnacott, <xref rid="B29" ref-type="bibr">2004</xref>; Shen and Yakel, <xref rid="B123" ref-type="bibr">2009</xref>). Moreover, functional cross-talk among presynaptic nAChRs has been shown to affect signal transduction (Marchi and Grilli, <xref rid="B88" ref-type="bibr">2010</xref>). Therefore, the action of one receptor might depend on the function of co-existing receptor subtypes in the same cell. The interaction between presynaptic nicotinic receptors with other ionotropic or metabotropic receptors serves the purpose of producing an integrated response.</p></sec><sec id="s14"><title>Transcriptome Cell-Specific Prediction of Cholinergic Receptors</title><p>In recent years, a wealth of transcriptomic data from the mouse brain has become available (Saunders et al., <xref rid="B119" ref-type="bibr">2018</xref>; Zeisel et al., <xref rid="B147" ref-type="bibr">2018</xref>). Many different cell types may exist; one study found 565 different cell groups, for example (Saunders et al., <xref rid="B119" ref-type="bibr">2018</xref>). Since a standard classification of cortical cell types is still emerging, most articles employ different approaches to arrive at cell type specific transcriptomes.</p><p>We examined a representative data set from the somatosensory cortex in order to interpret possible cell-specific differences in cholinergic receptor expression (<xref ref-type="fig" rid="F5">Figure 5</xref>). We chose this data set since excitatory cell types are mapped to layer-specific types, allowing the easiest comparison with the types referenced in this review. In this dataset, normalized expression of M1 receptors is highest in L4 PCs. There is a strong expression of M2 in deep layer neurons, particularly in layer 5a. M3 is highly expressed in layer 2/3 and layer 5a, while M4 is highest in layer 4. &#x003b1;3 nAChR subunits are highest in layer 4, but also in the deep layers. &#x003b2; subunit expression is highest in layer 6 and layer 6a neurons. Inhibitory interneuron expression of cholinergic receptors is definitely cell-type specific, though heterologous. PV cells express more nAchR&#x003b1;3 than do somatostatin-expressing interneurons (<xref ref-type="fig" rid="F5">Figure 5B</xref>). Somatostatin expression is best correlated with M2 expression and nicotinic &#x003b2; subunit expression and negatively correlated with M1 expression (<xref ref-type="fig" rid="F5">Figure 5C</xref>). VIP and Htr3a expression is correlated with nAchR&#x003b1;3, nAchR&#x003b1;4, and nAchR&#x003b1;5. Furthermore, ChAT expression is correlated with M1 expression. In layer 5a, the effects of the predominantly-expressed nAChR and mAChRs seemed to be synergistic.</p><fig id="F5" position="float"><label>Figure 5</label><caption><p>Differential expression of cholinergic receptors in transcriptome-derived cell types. <bold>(A)</bold> Excitatory cell types. <bold>(B)</bold> Interneurons in somatosensory cortex. Gene expression is normalized to a maximum of 1 on a gene-by-gene basis. <bold>(C)</bold> Correlation matrix (positive values of correlation matrix Pearson correlation coefficient matrix). <bold>(D)</bold> Anti-correlation matrix (negative values of correlation matrix). The data is from Zeisel et al. (<xref rid="B147" ref-type="bibr">2018</xref>) and was collected with high-throughput single-cell RNA sequencing, a method which counts individual RNA molecules. Abbreviations: PV, parvalbumin; SST, somatostatin; VIP, vasointestinal peptide; ChAT, choline acetyltransferase. <bold>(E)</bold> Expression of ACh receptor genes across the Frontal cortex cell-clusters identified in Saunders et al. (<xref rid="B119" ref-type="bibr">2018</xref>). The data was collected using Drop-seq (a method which allows the use of older animals and elimination of certain technical artifacts) to profile the RNA expression of individual cells. Semi-supervised independent component analysis was used to group cells into the sub-clusters using network-based clustering (ibid). Expression levels were normalized to the highest expression across all the selected genes. In this data set, receptor expression was particularly high in L23 and L5a PCs.</p></caption><graphic xlink:href="fncir-13-00024-g0005"/></fig><p>We also examined an additional dataset for frontal cortex (<xref ref-type="fig" rid="F5">Figure 5E</xref>; Saunders et al., <xref rid="B119" ref-type="bibr">2018</xref>). M5 is expressed in a subset of interneurons, including some cholinergic and MCs. The nicotinic receptor Chrna5 is expressed in a subset of deep PCs. Chrna6 is most expressed in a particular type of layer 5 PC. This dataset illustrates that the degree of sub-classification of PCs is likely to be important. For example, there are many subtypes of L5PCs, which have different cholinergic receptor expression. Both datasets showed consistency in M3 expression in L2/3 and L5a PCs but not L4 and L5 PCs.</p><p>In addition to cell-type specific correlation, nAChR genes that encode heteromeric &#x003b1;/&#x003b2; subunits are well correlated among themselves (Zoli et al., <xref rid="B150" ref-type="bibr">2015</xref>; Saunders et al., <xref rid="B119" ref-type="bibr">2018</xref>). The genes encoding the &#x003b1; subunits correlate well with the corresponding &#x003b2; subunit.</p><p>Cholinergic neurons can be identified by cluster analysis (Zeisel et al., <xref rid="B147" ref-type="bibr">2018</xref>). In particular, separate types have been identified in the red nucleus and habenular nucleus of the thalamus (ibid). ACh often is released in neurons releasing other neurotransmitters (Zeisel et al., <xref rid="B147" ref-type="bibr">2018</xref>). In the habenular nucleus, the glutamate transporter Slc17a6, in cholinergic cells, suggesting co-release of glutamate and ACh (Mancarci et al., <xref rid="B87" ref-type="bibr">2017</xref>). In the ventral midbrain, a neuron type that was both dopaminergic and cholinergic was identified (Zeisel et al., <xref rid="B147" ref-type="bibr">2018</xref>). Many forebrain cholinergic neurons also are GABAergic (Mancarci et al., <xref rid="B87" ref-type="bibr">2017</xref>), consistent with the co-release of these two substances (Saunders et al., <xref rid="B118" ref-type="bibr">2015</xref>).</p></sec><sec id="s15"><title>Global Network Effect and Modulation of Brain States</title><p>The transition between different brain states that occurs whenever an organism switches from one behavioral state to another is associated with changes in the overall pattern of neural activity, which can be captured with EEG or LFP recordings. The pattern of EEG activity can change dramatically with the behavioral state of the animal (Lee and Dan, <xref rid="B79" ref-type="bibr">2012</xref>), as can be seen in the transition from slow-wave sleep to wakefulness (or from deep sleep to REM sleep), when the EEG pattern shifts from large and synchronous waves of neural activity to a more desynchronized and short-amplitude wave pattern (Berger, <xref rid="B15" ref-type="bibr">1929</xref>). Ensemble neuronal activity undergoes impressive changes during behavioral state transitions, and different brain states have been associated with different brain functions; definitive evidence for these functions although, is still lacking, and the mechanism by which these transitions are achieved in the cortical network is not yet understood. Many authors have proposed that the switch between cortical states may be driven by the action of neuromodulators like ACh (Lee and Dan, <xref rid="B79" ref-type="bibr">2012</xref>). However, precisely how these neuromodulators influence global cortical processing by locally targeting specific cells is largely an unsolved mystery.</p></sec><sec id="s16"><title>Basal Forebrain Modulation of Brain States</title><p>A large body of evidence suggests that the BF, a complex and heterogeneous structure classically defined by the presence of clusters of cholinergic neurons, is crucial for the maintenance of the sleep/wake cycle and for processes that underlie arousal and attentional modulation, but it is unclear which BF neurons promote each brain state and how they interact with each other to regulate transitions between states (Anaclet et al., <xref rid="B6" ref-type="bibr">2015</xref>). Already since 1930, it was known that BF lesions could cause severe insomnia (Saper et al., <xref rid="B115" ref-type="bibr">2001</xref>); however, this evidence has been an object of constant challenge over the years, and the attempts to replicate this experiment would yield different results. Finally, Szymusiak and McGinty (<xref rid="B129" ref-type="bibr">1986</xref>) observed that sleep-active cells were confined to the ventral BF in the cat (the horizontal limb of the diagonal bands of Broca, substantia innominata, entopeduncular nucleus and ventral globus pallidus) and that these areas partially overlap with those where chemical and electrical stimulations evoke sleep, and where lesions suppress sleep. The sleep-active cells were thus considered optimal candidates for mediating some of the sleep-promoting functions attributed to the BF (Szymusiak and McGinty, <xref rid="B129" ref-type="bibr">1986</xref>).</p><p>Many BF neurons are active during wake and during REM sleep (Lee and Dan, <xref rid="B79" ref-type="bibr">2012</xref>), and specific lesions reduce wakefulness, in agreement with the finding that BF lesions cause significant increases in delta waves occurrence during wakefulness, and that BF stimulation induces cortical desynchronization of EEG or LFP signals, accompanied by a decrease in correlated spiking. Furthermore, the BF receives inputs from the LDT and PPT pontine nuclei; cholinergic neurons that can be found at the level of the LDT nucleus exhibit an increase in firing rate during cortical activation, just before the transition from slow-wave sleep frequencies to faster frequencies (Saper et al., <xref rid="B116" ref-type="bibr">2010</xref>).</p><p>Therefore, it seems reasonable to hypothesize the existence of functionally diverse neurons in the BF: according to Duque et al. (<xref rid="B38" ref-type="bibr">2000</xref>), BF cells that exhibit different wake/sleep activity pattern, also express different molecular markers (Zaborszky and Duque, <xref rid="B145" ref-type="bibr">2000</xref>). There are three major neuronal types in the BF: cholinergic, glutamatergic and GABAergic cells (Anaclet et al., <xref rid="B6" ref-type="bibr">2015</xref>; Xu et al., <xref rid="B143" ref-type="bibr">2015</xref>). There might be extensive local synaptic interactions among BF neurons mediating local reciprocal inhibition between GABAergic neurons and sleep-active and wake-active cholinergic neurons. The well-known flip-flop circuit for sleep/wake cycle control (Saper et al., <xref rid="B116" ref-type="bibr">2010</xref>) could, therefore, comprise multiple loops and switches. However, some findings suggest that BF GABAergic neurons provide major contributions to wakefulness, while cholinergic and glutamatergic neurons appear to play a lesser role; chemogenetic activation of GABAergic neurons promotes wake and high-frequency EEG activity, whereas cholinergic or glutamatergic activation have a destabilizing effect on slow-wave-sleep (SWS), but has no effect on total wake (Anaclet et al., <xref rid="B6" ref-type="bibr">2015</xref>).</p><p>Cholinergic neurons residing in the BF can be divided into two subpopulations, that might be involved in different functions: an early-spiking population may reflect phasic changes in cortical ACh release associated with attention, while the late-spiking group could be more suited for the maintenance of the cholinergic tone during general cortical arousal (Unal et al., <xref rid="B135" ref-type="bibr">2012</xref>).</p></sec><sec id="s17"><title>Multi-Transmitter Neurons: ACh and GABA Co-transmission</title><p>Nevertheless, functional co-transmission of ACh and GABA seems to be a common feature of nearly all forebrain ACh-producing neurons (Henny and Jones, <xref rid="B57" ref-type="bibr">2008</xref>; Granger et al., <xref rid="B48" ref-type="bibr">2016</xref>). BF inputs to the neocortex are therefore not only constituted of different fibers, but also use a mixture of functionally diverse neurotransmitters (Kalmbach et al., <xref rid="B65" ref-type="bibr">2012</xref>). This opens the question of whether there is a substantial difference between the cholinergic modulation and the BF modulation of neocortical activity. The contribution of GABA needs to be considered when studying the functional impact of ACh-producing neurons: electrical stimulation of BF fibers might evoke markedly different responses than optogenetically-evoked selective cholinergic release.</p><p>Does the co-release happen in a target-specific modality, at different terminals branching from the same axon, or is the release site the same for both transmitters? And if so, how does GABA affect the ongoing cholinergic modulation? Release of an excitatory (ACh) and inhibitory (GABA) neurotransmitter by the same axons seems to be functionally antagonistic. However, both transmitters could act in parallel, depending on the mode of co-transmission (Granger et al., <xref rid="B48" ref-type="bibr">2016</xref>). If both ACh and GABA are released simultaneously onto the same post-synaptic cells, then GABA may act to shunt the (supposed) excitation generated by ACh. Otherwise, they could target different postsynaptic cells, such that GABA inhibits one cell population while ACh excites another. Given previous experimental results showing that GABA release from VIP interneurons shunts activity of Sst<sup>+</sup> interneurons, but not other VIP interneurons, it is thought that VIP/ChAT cortical interneurons may release ACh and GABA onto different post-synaptic targets, perhaps from separate synaptic vesicle populations (Granger et al., <xref rid="B48" ref-type="bibr">2016</xref>). Indeed, a recent analysis of the molecular composition of the pre-synaptic terminals of cortical VIP/ChAT interneurons revealed that ACh and GABA vesicles are confined to separate boutons. At the post-synaptic level, the subset of GABAergic boutons seems to contact prevalently other inhibitory interneurons, while ACh boutons target mostly L1 interneurons and other VIP/ChAT cortical interneurons. Here, ACh evokes EPSCs that are mediated by nicotinic receptors (Granger et al., <xref rid="B49" ref-type="bibr">2018</xref>). Another recent study conducted in the mPFC confirms that only 10%&#x02013;20% of post-synaptic targets of VIP/ChAT cortical interneurons are contacted by both cholinergic and GABAergic inputs (Obermayer et al., <xref rid="B103" ref-type="bibr">2018</xref>); here they report that VIP/ChAT neurons directly excite interneurons in layers 1&#x02013;3 as well as PCs in L2/3 and L6 by fast nicotinic transmission.</p><p>Immunolabeling studies (Beaulieu and Somogyi, <xref rid="B14" ref-type="bibr">1991</xref>) have shown substantial co-labeling of presynaptic cholinergic terminals for both GABA and ChAT in the neocortex, but more studies should address the functional consequences of the synaptic co-release of these neurotransmitters and try to dissect the differential impact of each transmitter on postsynaptic cells excitability. Analysing the co-localization of post-synaptic receptors or scaffolding proteins could also allow the identification of individual synapses that are sensitive to both ACh and GABA. These possibilities should be addressed systematically in order to precisely understand the contribution of each neurotransmitter to cortical processing.</p></sec><sec id="s18"><title>ACh Involvement in Neuroplasticity</title><p>Apart from the fine-tuning of sleep/wake transitions, cholinergic neuromodulation is tightly implicated in regulating selective attention to a given sensory stimulus by altering the activity of the sensory cortex that perceives that modality (Kim et al., <xref rid="B72" ref-type="bibr">2016</xref>). ACh is known to be especially involved in cortical arousal (Saper et al., <xref rid="B116" ref-type="bibr">2010</xref>) and in the state-dependent modulation of cortical activity; cholinergic neurons are active during locomotion (Buzsaki et al., <xref rid="B19" ref-type="bibr">1988</xref>) and during transition to the attentive state (Kim et al., <xref rid="B72" ref-type="bibr">2016</xref>). Studies have shown that the occurrence of relevant sensory events evokes a transient increase in ACh concentration in the rat PFC (Hasselmo and Sarter, <xref rid="B54" ref-type="bibr">2011</xref>). Conversely, activating cholinergic transmission in the PFC determines an improvement in subject&#x02019;s performance during sustained attention tasks (Saper et al., <xref rid="B116" ref-type="bibr">2010</xref>). It is, therefore, reasonable to hypothesize that ACh can induce long-lasting changes in neuronal excitability, and indeed this was demonstrated. Pioneering experiments showing that ablation of noradrenergic and cholinergic innervation in the striate cortex substantially impairs ocular dominance plasticity in kittens (Bear and Singer, <xref rid="B13" ref-type="bibr">1986</xref>) opened the way for subsequent studies on the involvement of ACh in cortical plasticity. Some showed that when a tone is paired with NBM stimulation or ACh application, auditory cortex receptive fields change and prolonged enhanced responses to the paired frequency can be observed (Metherate and Weinberger, <xref rid="B93" ref-type="bibr">1990</xref>; Rasmusson, <xref rid="B111" ref-type="bibr">2000</xref>). Others discovered that co-application of muscarinic agonists with glutamate induces a prolonged increase in response to glutamate in somatosensory cortical neurons (Sugihara et al., <xref rid="B128" ref-type="bibr">2016</xref>), and that these effects concern as well the somatosensory cortex and the primary visual area V1. According to Metherate and Weinberger (<xref rid="B93" ref-type="bibr">1990</xref>), the potentiation can be blocked by cortical application of atropine, but others (Sugihara et al., <xref rid="B128" ref-type="bibr">2016</xref>) report that cholinergic antagonists cannot reverse the prolonged changes, thereby confirming that ACh is necessary for the induction, but not the maintenance of these modifications. ACh seems to act more as an instructive, rather than a permissive signal (Lin et al., <xref rid="B83" ref-type="bibr">2015</xref>).</p><p>ACh is as well involved in the generation of LTD at synapses between cortical pyramidal neurons and striatal medium spiny neurons through disinhibition of Ca<sub>v</sub> channels. Here, the activation of D<sub>2</sub> receptors reduces basal ACh release from cholinergic striatal interneurons and lowers M<sub>1</sub> receptor tone in medium spiny neurons, which leads to enhanced opening of intraspine Ca<sub>v</sub>1.3 Ca<sup>2+</sup> channels in response to synaptic depolarization. The calcium transient results in enhanced production of endocannabinoids (ECs) such as 2-arachidonoylglycerol, and activation of presynaptic CB<sub>1</sub> receptors that reduce glutamate release (Wang et al., <xref rid="B141" ref-type="bibr">2006</xref>).</p><p>Furthermore, the role of several neuromodulatory systems in STDP induction (Pawlak et al., <xref rid="B105" ref-type="bibr">2010</xref>) has been studied across multiple brain areas. While dopamine (DA) and NA modulation of STDP has been mostly investigated in subcortical areas, ACh&#x02019;s role in STDP induction has been extensively researched in neocortical sensory areas and in the PFC. In mouse mPFC, nicotine application increases the threshold for STDP in L5PCs by reducing their dendritic calcium signals. This effect, however, is due to an enhancement in GABAergic transmission in various types of interneurons in the PFC network, that express multiple types of nAChRs (Couey et al., <xref rid="B28" ref-type="bibr">2007</xref>), and not to a direct nicotinic action on PCs.</p><p>Taken together, evidence suggests that cholinergic inputs to the cortex incoming from the BF should be viewed more as teaching, rather than motivational signals. Overall, activation of the cholinergic system controls the shift from a correlated or synchronized state, to a decorrelated or desynchronized state and results in an enhancement of cortical information processing (Lee and Dan, <xref rid="B79" ref-type="bibr">2012</xref>). However, exactly how the detection of relevant stimuli is enhanced and which are the mechanisms at the basis of this ACh-induced desynchronization are still a matter of open debate.</p></sec><sec id="s19"><title>ACh Enhancement of Sensory Processing</title><p>NBM stimulation has a differential effect on spontaneous and sensory-evoked activity. In a recent study, Meir et al. (<xref rid="B91" ref-type="bibr">2018</xref>) showed that NBM stimulation desynchronizes cortical LFP and increases the SNR of sensory-evoked responses while suppressing ongoing spontaneous synaptic activity. The authors recorded spontaneous PSPs occurring in L4 and showed that following NBM stimulation the frequency and amplitude of sPSPs were decreased. Moreover, the mean membrane voltage of the response became more hyperpolarized, and trial-to-trial variability was decreased, both during spontaneous and evoked activity. However, sensory stimulation did not change the amplitude of the response, whereas it caused a prominent reduction in the noise amplitude, therefore changing the SNR of the sensory response. By analyzing the coupling of Vm and LFP signals, they also showed that cholinergic activation largely reduced fluctuations in the membrane potential and caused a decorrelation in network activity.</p><p>Chen et al. (<xref rid="B25" ref-type="bibr">2015</xref>) were able to identify a defined microcircuit in the superficial layers of mouse V1 that supports ACh driven desynchronization. The authors measured the activity of different inhibitory interneurons while optogenetically stimulating superficial cholinergic axons, and found that cholinergic inputs facilitate Sst<sup>+</sup> interneurons, which in turn inhibit PV<sup>+</sup> interneurons and PCs. Optogenetic inhibition of Sst<sup>+</sup> neurons blocks desynchronization, whereas direct activation of Sst<sup>+</sup> neurons is sufficient to induce desynchronization (Chen et al., <xref rid="B25" ref-type="bibr">2015</xref>). The observed desynchronization in cortical activity may explain the role of ACh in mediating transitions between phases of the sleep-wake cycle, but it fails to explain how ACh enhances sensory processing. A large body of evidence suggests that ACh enhances sensory inputs while simultaneously suppressing intrinsic cortical activation (Kimura et al., <xref rid="B74" ref-type="bibr">1999</xref>; Disney et al., <xref rid="B36" ref-type="bibr">2007</xref>; Newman et al., <xref rid="B101" ref-type="bibr">2012</xref>), but a detailed understanding of this process is currently lacking. ACh&#x02019;s role may substantially differ across sensory areas and affect different tuning properties.</p><p>Nucleus basalis activation affects sensory responses to natural stimuli of a population of cortical neurons. Before BF stimulation, multi-unit activity (MUA) in the rat&#x02019;s V1 is highly correlated but poorly time-locked to the stimulus; after BF stimulation it becomes less correlated but more time-locked to the sensory event. NBM stimulation also decreases single-unit activity (SU) correlation (between cells correlation) and increases response reliability (between trials correlation coefficient) but does not induce any significant change in receptive field size, orientation tuning nor direction selectivity. Atropine application decreases NBM induced decorrelation, indicating that mAChRs support this effect (Goard and Dan, <xref rid="B47" ref-type="bibr">2009</xref>). After NBM stimulation a shift in the firing modality of the LGN resembling that found at the level of the thalamus can be observed, namely a transition from burst to tonic mode (Bazhenov et al., <xref rid="B12" ref-type="bibr">2002</xref>; Castro-Alamancos and Gulati, <xref rid="B22" ref-type="bibr">2014</xref>). A similar study (Thiele et al., <xref rid="B131" ref-type="bibr">2012</xref>) was conducted in the extrastriate cortex of the macaque and yielded opposing results: at the level of the middle temporal (MT) area it revealed how other tuning properties, like orientation and direction discriminability, are also affected by cholinergic modulation; in this case, ACh had little effect on response reliability, though it is still not clear whether these differences are attributable to differences existing between rodents and primates or to functional differences between sensory areas. In an effort to clarify the precise role of neocortical cholinergic modulation, Disney et al. (<xref rid="B36" ref-type="bibr">2007</xref>) concentrated on the role of nAChRs in a well-studied cortical model system, the V1 of the macaque monkey. Here they showed <italic>in vivo</italic> that nicotine reliably enhances the gain of responses to visual stimuli in layer 4c, but not in other layers. Having found &#x003b2;2-nAChR in a pre-synaptic position at the level of thalamo-cortical synapses on PV<sup>+</sup> interneurons, they prove that nicotine enhances detection of visual stimuli through enhanced TC transmission. These findings confirm that cholinergic activation causes an increase in cortical sensory responses through enhancement of thalamic synaptic transmission and suppression of intracortical inputs. A systematic effort to extend these results to other sensory areas is therefore needed in order to decipher whether the mechanism supporting cholinergic modulation is common throughout all cortical areas or if different tuning properties are affected each time.</p></sec><sec id="s20"><title>ACh Modulation of Thalamo-Cortical Transmission</title><p>Castro-Alamanco and Gulati recorded, multi-electrode activity (MUA) and field potential from adult rat barrel cortex following multi-whisker stimulation at 0.2 Hz, while increasing concentrations of carbachol or other drugs were applied by means of micro-dialysis. The authors found that the application of 50 &#x003bc;M carbachol, but not norepinephrine, can stop the emergence of the 10&#x02013;15 Hz oscillations that are observed during baseline recordings and that in the presence of atropine these oscillations are even enhanced (Castro-Alamancos and Gulati, <xref rid="B22" ref-type="bibr">2014</xref>). The effect of carbachol on barrel cortex LFP is thus congruent with the traditionally termed desynchronization for doses higher than 50 &#x003bc;M (Moruzzi and Magoun, <xref rid="B95" ref-type="bibr">1949</xref>; Steriade et al., <xref rid="B126" ref-type="bibr">1993</xref>). A low tone of cholinergic activation (0.5&#x02013;1 &#x003bc;M) however, reinforces the deactivated cortical state by enhancing synchronous slow oscillations. A very high tone of cholinergic activation (250&#x02013;2,500 &#x003bc;M) leads to a significant increase in tonic firing, without altering the overall firing rate. An interesting follow-up to this experiment would be to check whether the same effect can be observed in the whole somatosensory region, and across other sensory cortices. The group then tried to decipher whether cholinergic activation would also modulate thalamocortical activity: by recording from the VPM, they found that cholinergic cortical activation suppresses burst-firing in the thalamus and changes neuronal firing to a tonic mode. This result is fairly consistent with the outcome predicted by the model of thalamo-cortical slow-wave sleep oscillations and transition to activated states generated by Bazhenov et al. (<xref rid="B12" ref-type="bibr">2002</xref>). Here, the increase in ACh activity was modeled by the reduction of a K<sup>+</sup> leak current in pyramidal and thalamo-cortical cells and resulted in the abolishment of the hyperpolarizing phase of network activity and a consequent increase in the input/resistance relationship, accompanied by a switch to the tonic firing (15&#x02013;20 Hz) modality. The transition from bursting to tonic firing thus seems to be a characteristic feature of relay diencephalic structures like the thalamus and the meta-thalamus.</p><p>Enhanced thalamo-cortical transmission seems to be a constant finding across a vast number of articles and reviews (Bazhenov et al., <xref rid="B12" ref-type="bibr">2002</xref>; Disney et al., <xref rid="B36" ref-type="bibr">2007</xref>; Hasselmo and Sarter, <xref rid="B54" ref-type="bibr">2011</xref>) with the aim of revealing the mechanisms by which cholinergic neuromodulation operates. Next studies in this field should, therefore, consider the possibility that cholinergic inputs reach the cortex not only through direct BF projections but also exploiting the thalamo-cortical loop.</p><p>Voltage-sensitive dye imaging revealed that ACh application to the neocortex, upon stimulation of layer 2/3, suppresses the spread of excitation to nearby areas. Thus, ACh seems to play an important role in coding sensory stimuli by enhancing thalamocortical inputs, but at the same time, by suppressing intracortical interactions (Kimura et al., <xref rid="B74" ref-type="bibr">1999</xref>).</p><p>One of the proposed models for the cholinergic mediated shift from default mode to detection mode suggests that ACh acts to enhance the glutamatergic representation of thalamic input through stimulation of nAChRs, while suppressing the cortical spread of associational input through activation of mAChRs (Hasselmo and Sarter, <xref rid="B54" ref-type="bibr">2011</xref>). Minces et al. (<xref rid="B94" ref-type="bibr">2017</xref>) recently evaluated the effect of increases in cortical ACh following optogenetic BF stimulation on the correlation structure of the visual network and found that transient cholinergic release in the cortex decreases the slope between signal and noise correlations. The authors propose that this mechanism acts to increase the encoding capacity of the network.</p><p>Another article evaluated the impact of ACh on local circuit activation and found that cholinergic inputs exclude unreliable neurons from contributing to circuit activity while conserving neurons that were active in response to thalamic activity and showed strong correlations. Moreover, weak functional connections were pruned, thus yielding a more modular and hierarchical circuit structure. Once again, these results highlight how ACh is able to reorganize the circuit function in a way that promotes the discriminability of thalamic inputs at the expense of weak pairwise relationships (Runfeldt et al., <xref rid="B113" ref-type="bibr">2014</xref>).</p></sec><sec id="s21"><title>Sensory Modality-Specific Information Processing and ACh</title><p>Many studies (Disney et al., <xref rid="B36" ref-type="bibr">2007</xref>; Minces et al., <xref rid="B94" ref-type="bibr">2017</xref>) have focused on trying to understand the role played by ACh in improving stimuli detection or modifying receptor fields size in the visual cortex. While many of them have been done in primates, others have privileged the somatosensory areas and highlight the involvement of the cholinergic system in the regulation of sensory cortical processing in rodents as well, supporting the idea that cholinergic modulation of cortical microcircuits is functionally equivalent across brain areas and model organisms, even though a canonical and anatomically equivalent system is not strictly identifiable (Coppola and Disney, <xref rid="B27" ref-type="bibr">2018</xref>).</p><p>The finding that distinct neuronal clusters in the BF project selectively to specific sensory areas (Kim et al., <xref rid="B72" ref-type="bibr">2016</xref>) and that cholinergic inputs to sensory cortices are spatially segregated supports the idea that cholinergic release improves sensory discrimination in a modality-selective manner and with a high degree of specificity. The authors mapped BF projections to different sensory areas and found retrobead-labeled neurons from three different sensory cortices within the BF, with a clear distinction between the clusters of cells: neurons in the HDB project preferentially to V1, the posterior part of NBM projects to A1, while the aNBM preferentially projects to S1. These results were further confirmed by another experiment in which the authors optogenetically activated cholinergic neurons in the BF subnuclei and successfully induced modality-selective desynchronization in specific sensory cortices.</p><p>A similar experiment was performed by Chaves-Coira et al. (<xref rid="B24" ref-type="bibr">2016</xref>), who also used retrograde anatomical procedures to demonstrate the existence of specific neuronal groups in the BF implicated in the modulation of specific sensory cortices. However, here the authors found that most of the neurons located in the HDB projected to the S1 cortex, suggesting that this area is specialized in the sensory processing of tactile stimuli, and the NBM was found to have a similar number of cells projecting to S1 as to A1. Furthermore, optogenetic HDB stimulation induced a larger facilitation of tactile evoked potentials in S1 than auditory evoked potentials in A1, while optogenetic stimulation of the NBM facilitated either tactile or auditory evoked potentials equally. These results suggest that cholinergic projections to the cortex are organized into spatially segregated pools of neurons that modulate specific cortical areas; although, additional research will be needed in order to provide a clear and definitive picture of the topographical organization of the projections arising from the BF region and innervating the cortex. Despite the many attempts to clarify this issue, it remains unclear whether there exist distinct neuronal populations in the HDB, or whether the differences observed in the outcomes of the experiments mentioned above are due to discrepancies existing in the transgenic mouse lines used or to the slightly different techniques that were employed.</p><p>ACh is thus involved both in the bottom-up attentional process that leads to a general and whole-state arousal of the cortex and in the top-down modifications of circuit activity that occur during detection of behaviorally relevant sensory stimuli. Cognitive functions of cholinergic projection systems vary according to the brain area that is being modulated. Cholinergic modulation may act as a common mechanism to improve sensory encoding in several brain areas.</p></sec><sec id="s22"><title>Summary and Outlook</title><p>ACh release in the neocortex controls transitions between brain states, such as attention, memory and wakefulness, and can occur through volume or synaptic transmission. However, it is not clear yet whether one modality prevails upon the other or if they are complementary mechanisms. Further studies are needed to establish correlations between the distribution profile of the receptor subtypes, the relative proximity and density of cholinergic varicosities to assess differences between the two modalities. Moreover, as results could vastly vary across species, a systematic effort is crucial to be able to compare quantitative measurements.</p><p>The expression of muscarinic and nicotinic cholinergic receptors&#x02014;the two main types&#x02014;varies according to the cell-type and the pattern of receptor localization varies across cortical layers. A detailed knowledge of the subcellular localization of cholinergic receptors is, however, currently lacking. The detection of cholinoceptive structures such as the receptor protein has become easier with the advent of polyclonal antibodies targeting different subtypes. Future investigations should, therefore, converge on systematically measuring the amount of each receptor subtype across cellular compartments.</p><p>In this review, we have endeavored to determine, in a quantitative manner, the cellular and synaptic effects of ACh release in the neocortex. While the cholinergic modulation of excitatory PCs has been extensively researched, its effect on inhibitory interneurons is still largely unknown. For example, the effect of ACh on BCs (fast-spiking, PV<sup>+</sup> interneurons) remains unclear. This could be due to the lack of a thorough classification of diverse morphological types of BCs where a differential distribution of cholinergic receptors could modulate divergent cellular and synaptic effects. Furthermore, it is not clear whether bath-application of cholinergic agonists is comparable to a physiological activation of the cholinergic system. Applied concentrations of cholinergic agonists vary substantially (up to three orders of magnitude) across electrophysiological studies, which seldom use more than one concentration. To obtain carefully designed dose-response curves of the effects of cholinergic agonists is paramount to dissect the consequences of physiological ACh release in the neocortex. The advent of optogenetics holds promise in designing physiological protocols of ACh release. Future experiments should not only merely employ traditional bath-application of cholinergic agonists but also exploit optogenetics to reconcile how doses of agonists directly map to effects of endogenous, physiological release of ACh.</p><p>The effects of ACh on synaptic connections can vary drastically according to the identity of the presynaptic terminal and its postsynaptic partner. Additionally, the magnitude of the postsynaptic response also depends on the receptor subtype being activated. Therefore, there is a clear requirement for systematic investigations of the effects of ACh on different synapse-types, combined with knowledge of implicated cell-types and receptor subtypes to unravel the effects of ACh release on necortical synaptic transmission.</p><p>ACh is involved in the induction of synaptic plasticity mechanisms, which could support its role in cortical learning and memory. In addition, ACh enhances sensory processing by affecting receptor fields size and tuning properties. It is not clear, however, if the effects of ACh are modality-specific or can be generalized to all sensory processing, nor exactly which tuning properties are affected. Many studies point to a role of ACh in increasing the SNR of a sensory response, and others describe how ACh suppresses cortico-cortical interactions in favor of thalamic transmission. Therefore, further clarification is required on the matter. Moreover, special attention must be paid in integrating data from primates and rodents: neuromodulatory systems are commonly the object of evolutionary modifications, even though they might maintain some functional similarity throughout species.</p><p>The mechanisms of ACh-induced changes in the physiology of neocortical neurons and their synapses, and how these changes shape the emergence of global network states still remains elusive. The impact of ACh on global cortical computations sustains cognitive functions such as attention, learning and memory, which are characterized by desynchronized network activity. Cholinergic inputs mainly originate in the BF, a structure comprising distinct multi-transmitter neuronal populations. The functional relevance of neuronal subpopulations in the BF and the co-release of two potentially antagonistic transmitters to the desynchronization of cortical activity is unknown. Furthermore, recent work identifies that a sub-population of VIP<sup>+</sup> cortical interneurons co-release ACh and GABA with potentially differing functions across species. Future research should, therefore, focus on dissecting the impact of each transmitter on cellular excitability. In addition, analyzing the co-localization of post-synaptic receptors could also allow the identification of individual synapses that are sensitive to multiple neurotransmitters. All these possibilities should be addressed systematically in order to precisely understand the contribution of each neurotransmitter to ACh-induced effects on the emergence of cortical network states in health and disease.</p></sec><sec id="s23"><title>Author Contributions</title><p>CC, DK, PS and SR wrote the manuscript and drafted the figures and tables. SR, DK and HM reviewed and edited the manuscript and the figures. SR conceived the idea and supervised the study.</p></sec><sec id="s24"><title>Conflict of Interest Statement</title><p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p></sec></body><back><ack><p>We thank Dr Natali Barros-Zulaica and Taylor H. Newton for useful discussions.</p></ack><fn-group><fn fn-type="financial-disclosure"><p><bold>Funding.</bold> This work was supported by funding from the ETH Domain for the Blue Brain Project (BBP).</p></fn></fn-group><ref-list><title>References</title><ref id="B1"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Albuquerque</surname><given-names>E. X.</given-names></name><name><surname>Pereira</surname><given-names>E. F.</given-names></name><name><surname>Mike</surname><given-names>A.</given-names></name><name><surname>Eisenberg</surname><given-names>H. M.</given-names></name><name><surname>Maelicke</surname><given-names>A.</given-names></name><name><surname>Alkondon</surname><given-names>M.</given-names></name></person-group> (<year>2000</year>). <article-title>Neuronal nicotinic receptors in synaptic functions in humans and rats: physiological and clinical relevance</article-title>. <source>Behav. Brain Res.</source>
<volume>113</volume>, <fpage>131</fpage>&#x02013;<lpage>141</lpage>. <pub-id pub-id-type="doi">10.1016/s0166-4328(00)00208-4</pub-id><?supplied-pmid 10942040?><pub-id pub-id-type="pmid">10942040</pub-id></mixed-citation></ref><ref id="B2"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alger</surname><given-names>B. E.</given-names></name><name><surname>Nagode</surname><given-names>D. A.</given-names></name><name><surname>Tang</surname><given-names>A.-H.</given-names></name></person-group> (<year>2014</year>). <article-title>Muscarinic cholinergic receptors modulate inhibitory synaptic rhythms in hippocampus and neocortex</article-title>. <source>Front. Synaptic Neurosci.</source>
<volume>6</volume>:<fpage>18</fpage>. <pub-id pub-id-type="doi">10.3389/fnsyn.2014.00018</pub-id><?supplied-pmid 25249974?><pub-id pub-id-type="pmid">25249974</pub-id></mixed-citation></ref><ref id="B3"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alitto</surname><given-names>H. J.</given-names></name><name><surname>Dan</surname><given-names>Y.</given-names></name></person-group> (<year>2013</year>). <article-title>Cell-type-specific modulation of neocortical activity by basal forebrain input</article-title>. <source>Front. Syst. Neurosci.</source>
<volume>6</volume>:<fpage>79</fpage>. <pub-id pub-id-type="doi">10.3389/fnsys.2012.00079</pub-id><?supplied-pmid 23316142?><pub-id pub-id-type="pmid">23316142</pub-id></mixed-citation></ref><ref id="B4"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alkondon</surname><given-names>M.</given-names></name><name><surname>Albuquerque</surname><given-names>E. X.</given-names></name></person-group> (<year>2004</year>). <article-title>The nicotinic acetylcholine receptor subtypes and their function in the hippocampus and cerebral cortex</article-title>. <source>Prog. Brain Res.</source>
<volume>145</volume>, <fpage>109</fpage>&#x02013;<lpage>120</lpage>. <pub-id pub-id-type="doi">10.1016/s0079-6123(03)45007-3</pub-id><?supplied-pmid 14650910?><pub-id pub-id-type="pmid">14650910</pub-id></mixed-citation></ref><ref id="B5"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alkondon</surname><given-names>M.</given-names></name><name><surname>Pereira</surname><given-names>E. F.</given-names></name><name><surname>Eisenberg</surname><given-names>H. M.</given-names></name><name><surname>Albuquerque</surname><given-names>E. X.</given-names></name></person-group> (<year>1999</year>). <article-title>Choline and selective antagonists identify two subtypes of nicotinic acetylcholine receptors that modulate GABA release from CA1 interneurons in rat hippocampal slices</article-title>. <source>J. Neurosci.</source>
<volume>19</volume>, <fpage>2693</fpage>&#x02013;<lpage>2705</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.19-07-02693.1999</pub-id><?supplied-pmid 10087082?><pub-id pub-id-type="pmid">10087082</pub-id></mixed-citation></ref><ref id="B6"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anaclet</surname><given-names>C.</given-names></name><name><surname>Pedersen</surname><given-names>N. P.</given-names></name><name><surname>Ferrari</surname><given-names>L. L.</given-names></name><name><surname>Venner</surname><given-names>A.</given-names></name><name><surname>Bass</surname><given-names>C. E.</given-names></name><name><surname>Arrigoni</surname><given-names>E.</given-names></name><etal/></person-group>. (<year>2015</year>). <article-title>Basal forebrain control of wakefulness and cortical rhythms</article-title>. <source>Nat. Commun.</source>
<volume>6</volume>:<fpage>8744</fpage>. <pub-id pub-id-type="doi">10.1038/ncomms9744</pub-id><?supplied-pmid 26524973?><pub-id pub-id-type="pmid">26524973</pub-id></mixed-citation></ref><ref id="B7"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aoki</surname><given-names>C.</given-names></name><name><surname>Kabak</surname><given-names>S.</given-names></name></person-group> (<year>1992</year>). <article-title>Cholinergic terminals in the cat visual cortex: ultrastructural basis for interaction with glutamate-immunoreactive neurons and other cells</article-title>. <source>Vis. Neurosci.</source>
<volume>8</volume>, <fpage>177</fpage>&#x02013;<lpage>191</lpage>. <pub-id pub-id-type="doi">10.1017/s0952523800002832</pub-id><?supplied-pmid 1347700?><pub-id pub-id-type="pmid">1347700</pub-id></mixed-citation></ref><ref id="B8"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arroyo</surname><given-names>S.</given-names></name><name><surname>Bennett</surname><given-names>C.</given-names></name><name><surname>Aziz</surname><given-names>D.</given-names></name><name><surname>Brown</surname><given-names>S. P.</given-names></name><name><surname>Hestrin</surname><given-names>S.</given-names></name></person-group> (<year>2012</year>). <article-title>Prolonged disynaptic inhibition in the cortex mediated by slow, non-&#x003b1;7 nicotinic excitation of a specific subset of cortical interneurons</article-title>. <source>J. Neurosci.</source>
<volume>32</volume>, <fpage>3859</fpage>&#x02013;<lpage>3864</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.0115-12.2012</pub-id><?supplied-pmid 22423106?><pub-id pub-id-type="pmid">22423106</pub-id></mixed-citation></ref><ref id="B9"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Artinian</surname><given-names>L. R.</given-names></name><name><surname>Ding</surname><given-names>J. M.</given-names></name><name><surname>Gillette</surname><given-names>M. U.</given-names></name></person-group> (<year>2001</year>). <article-title>Carbon monoxide and nitric oxide: interacting messengers in muscarinic signaling to the brain&#x02019;s circadian clock</article-title>. <source>Exp. Neurol.</source>
<volume>171</volume>, <fpage>293</fpage>&#x02013;<lpage>300</lpage>. <pub-id pub-id-type="doi">10.1006/exnr.2001.7781</pub-id><?supplied-pmid 11573981?><pub-id pub-id-type="pmid">11573981</pub-id></mixed-citation></ref><ref id="B201"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Atzori</surname><given-names>M.</given-names></name><name><surname>Kanold</surname><given-names>P. O.</given-names></name><name><surname>Pineda</surname><given-names>J. C.</given-names></name><name><surname>Flores-Hernandez</surname><given-names>J.</given-names></name><name><surname>Paz</surname><given-names>R. D.</given-names></name></person-group> (<year>2005</year>). <article-title>Dopamine prevents muscarinic-induced decrease of glutamate release in the auditory cortex</article-title>. <source>Neuroscience</source>
<volume>134</volume>, <fpage>1153</fpage>&#x02013;<lpage>1165</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuroscience.2005.05.005</pub-id><?supplied-pmid 16019151?><pub-id pub-id-type="pmid">16019151</pub-id></mixed-citation></ref><ref id="B10"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bailey</surname><given-names>C. D. C.</given-names></name><name><surname>De Biasi</surname><given-names>M.</given-names></name><name><surname>Fletcher</surname><given-names>P. J.</given-names></name><name><surname>Lambe</surname><given-names>E. K.</given-names></name></person-group> (<year>2010</year>). <article-title>The nicotinic acetylcholine receptor &#x003b1;5 subunit plays a key role in attention circuitry and accuracy</article-title>. <source>J. Neurosci.</source>
<volume>30</volume>, <fpage>9241</fpage>&#x02013;<lpage>9252</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.2258-10.2010</pub-id><?supplied-pmid 20610759?><pub-id pub-id-type="pmid">20610759</pub-id></mixed-citation></ref><ref id="B11"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baker</surname><given-names>A. L.</given-names></name><name><surname>O&#x02019;Toole</surname><given-names>R. J.</given-names></name><name><surname>Gulledge</surname><given-names>A. T.</given-names></name></person-group> (<year>2018</year>). <article-title>Preferential cholinergic excitation of corticopontine neurons</article-title>. <source>J. Physiol.</source>
<volume>596</volume>, <fpage>1659</fpage>&#x02013;<lpage>1679</lpage>. <pub-id pub-id-type="doi">10.1113/jp275194</pub-id><?supplied-pmid 29330867?><pub-id pub-id-type="pmid">29330867</pub-id></mixed-citation></ref><ref id="B12"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bazhenov</surname><given-names>M.</given-names></name><name><surname>Timofeev</surname><given-names>I.</given-names></name><name><surname>Steriade</surname><given-names>M.</given-names></name><name><surname>Sejnowski</surname><given-names>T. J.</given-names></name></person-group> (<year>2002</year>). <article-title>Model of thalamocortical slow-wave sleep oscillations and transitions to activated states</article-title>. <source>J. Neurosci.</source>
<volume>22</volume>, <fpage>8691</fpage>&#x02013;<lpage>8704</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.22-19-08691.2002</pub-id><?supplied-pmid 12351744?><pub-id pub-id-type="pmid">12351744</pub-id></mixed-citation></ref><ref id="B13"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bear</surname><given-names>M. F.</given-names></name><name><surname>Singer</surname><given-names>W.</given-names></name></person-group> (<year>1986</year>). <article-title>Modulation of visual cortical plasticity by acetylcholine and noradrenaline</article-title>. <source>Nature</source>
<volume>320</volume>, <fpage>172</fpage>&#x02013;<lpage>176</lpage>. <pub-id pub-id-type="doi">10.1038/320172a0</pub-id><?supplied-pmid 3005879?><pub-id pub-id-type="pmid">3005879</pub-id></mixed-citation></ref><ref id="B14"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beaulieu</surname><given-names>C.</given-names></name><name><surname>Somogyi</surname><given-names>P.</given-names></name></person-group> (<year>1991</year>). <article-title>Enrichment of cholinergic synaptic terminals on GABAergic neurons and coexistence of immunoreactive GABA and choline acetyltransferase in the same synaptic terminals in the striate cortex of the cat</article-title>. <source>J. Comp. Neurol.</source>
<volume>304</volume>, <fpage>666</fpage>&#x02013;<lpage>680</lpage>. <pub-id pub-id-type="doi">10.1002/cne.903040412</pub-id><?supplied-pmid 2013651?><pub-id pub-id-type="pmid">2013651</pub-id></mixed-citation></ref><ref id="B15"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berger</surname><given-names>H.</given-names></name></person-group> (<year>1929</year>). <article-title>&#x000dc;ber das elektrenkephalogramm des menschen</article-title>. <source>Arch. F&#x000fc;r Psychiatr. Nervenkrankh.</source>
<volume>87</volume>, <fpage>527</fpage>&#x02013;<lpage>570</lpage>. <pub-id pub-id-type="doi">10.1007/BF01797193</pub-id></mixed-citation></ref><ref id="B16"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bertrand</surname><given-names>D.</given-names></name></person-group> (<year>2010</year>). <article-title>Neurocircuitry of the nicotinic cholinergic system</article-title>. <source>Dialogues Clin. Neurosci.</source>
<volume>12</volume>, <fpage>463</fpage>&#x02013;<lpage>470</lpage>. <?supplied-pmid 21319492?><pub-id pub-id-type="pmid">21319492</pub-id></mixed-citation></ref><ref id="B17"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Borda</surname><given-names>T.</given-names></name><name><surname>Genaro</surname><given-names>A.</given-names></name><name><surname>Sterin-Borda</surname><given-names>L.</given-names></name><name><surname>Cremaschi</surname><given-names>G.</given-names></name></person-group> (<year>1998</year>). <article-title>Involvement of endogenous nitric oxide signalling system in brain muscarinic acetylcholine receptor activation</article-title>. <source>J. Neural Transm.</source>
<volume>105</volume>, <fpage>193</fpage>&#x02013;<lpage>204</lpage>. <pub-id pub-id-type="doi">10.1007/s007020050048</pub-id><?supplied-pmid 9660097?><pub-id pub-id-type="pmid">9660097</pub-id></mixed-citation></ref><ref id="B18"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brombas</surname><given-names>A.</given-names></name><name><surname>Fletcher</surname><given-names>L. N.</given-names></name><name><surname>Williams</surname><given-names>S. R.</given-names></name></person-group> (<year>2014</year>). <article-title>Activity-dependent modulation of layer 1 inhibitory neocortical circuits by acetylcholine</article-title>. <source>J. Neurosci.</source>
<volume>34</volume>, <fpage>1932</fpage>&#x02013;<lpage>1941</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.4470-13.2014</pub-id><?supplied-pmid 24478372?><pub-id pub-id-type="pmid">24478372</pub-id></mixed-citation></ref><ref id="B202"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Buisson</surname><given-names>B.</given-names></name><name><surname>Bertrand</surname><given-names>D.</given-names></name></person-group> (<year>2001</year>). <article-title>Chronic exposure to nicotine upregulates the human &#x003b1;4&#x003b2;2 nicotinic acetylcholine receptor function</article-title>. <source>J. Neurosci.</source>
<volume>21</volume>, <fpage>1819</fpage>&#x02013;<lpage>1829</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.21-06-01819.2001</pub-id><?supplied-pmid 11245666?><pub-id pub-id-type="pmid">11245666</pub-id></mixed-citation></ref><ref id="B19"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Buzsaki</surname><given-names>G.</given-names></name><name><surname>Bickford</surname><given-names>R. G.</given-names></name><name><surname>Ponomareff</surname><given-names>G.</given-names></name><name><surname>Thal</surname><given-names>L. J.</given-names></name><name><surname>Mandel</surname><given-names>R.</given-names></name><name><surname>Gage</surname><given-names>F. H.</given-names></name></person-group> (<year>1988</year>). <article-title>Nucleus basalis and thalamic control of neocortical activity in the freely moving rat</article-title>. <source>J. Neurosci.</source>
<volume>8</volume>, <fpage>4007</fpage>&#x02013;<lpage>4026</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.08-11-04007.1988</pub-id><?supplied-pmid 3183710?><pub-id pub-id-type="pmid">3183710</pub-id></mixed-citation></ref><ref id="B20"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Callender</surname><given-names>J. A.</given-names></name><name><surname>Newton</surname><given-names>A. C.</given-names></name></person-group> (<year>2017</year>). <article-title>Conventional protein kinase C in the brain: 40 years later</article-title>. <source>Neuronal Signal.</source>
<volume>1</volume>:<fpage>NS20160005</fpage>
<pub-id pub-id-type="doi">10.1042/ns20160005</pub-id></mixed-citation></ref><ref id="B21"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carr</surname><given-names>D. B.</given-names></name><name><surname>Surmeier</surname><given-names>D. J.</given-names></name></person-group> (<year>2007</year>). <article-title>M1 muscarinic receptor modulation of Kir2 channels enhances temporal summation of excitatory synaptic potentials in prefrontal cortex pyramidal neurons</article-title>. <source>J. Neurophysiol.</source>
<volume>97</volume>, <fpage>3432</fpage>&#x02013;<lpage>3438</lpage>. <pub-id pub-id-type="doi">10.1152/jn.00828.2006</pub-id><?supplied-pmid 17376848?><pub-id pub-id-type="pmid">17376848</pub-id></mixed-citation></ref><ref id="B22"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Castro-Alamancos</surname><given-names>M. A.</given-names></name><name><surname>Gulati</surname><given-names>T.</given-names></name></person-group> (<year>2014</year>). <article-title>Neuromodulators produce distinct activated states in neocortex</article-title>. <source>J. Neurosci.</source>
<volume>34</volume>, <fpage>12353</fpage>&#x02013;<lpage>12367</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.1858-14.2014</pub-id><?supplied-pmid 25209276?><pub-id pub-id-type="pmid">25209276</pub-id></mixed-citation></ref><ref id="B23"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cauli</surname><given-names>B.</given-names></name><name><surname>Tong</surname><given-names>X.-K.</given-names></name><name><surname>Rancillac</surname><given-names>A.</given-names></name><name><surname>Serluca</surname><given-names>N.</given-names></name><name><surname>Lambolez</surname><given-names>B.</given-names></name><name><surname>Rossier</surname><given-names>J.</given-names></name><etal/></person-group>. (<year>2004</year>). <article-title>Cortical GABA interneurons in neurovascular coupling: relays for subcortical vasoactive pathways</article-title>. <source>J. Neurosci.</source>
<volume>24</volume>, <fpage>8940</fpage>&#x02013;<lpage>8949</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.3065-04.2004</pub-id><?supplied-pmid 15483113?><pub-id pub-id-type="pmid">15483113</pub-id></mixed-citation></ref><ref id="B24"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chaves-Coira</surname><given-names>I.</given-names></name><name><surname>Barros-Zulaica</surname><given-names>N.</given-names></name><name><surname>Rodrigo-Angulo</surname><given-names>M.</given-names></name><name><surname>N&#x000fa;&#x000f1;ez</surname><given-names>&#x000c1;.</given-names></name></person-group> (<year>2016</year>). <article-title>Modulation of specific sensory cortical areas by segregated basal forebrain cholinergic neurons demonstrated by neuronal tracing and optogenetic stimulation in mice</article-title>. <source>Front. Neural Circuits</source>
<volume>10</volume>:<fpage>28</fpage>. <pub-id pub-id-type="doi">10.3389/fncir.2016.00028</pub-id><?supplied-pmid 27147975?><pub-id pub-id-type="pmid">27147975</pub-id></mixed-citation></ref><ref id="B25"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>N.</given-names></name><name><surname>Sugihara</surname><given-names>H.</given-names></name><name><surname>Sur</surname><given-names>M.</given-names></name></person-group> (<year>2015</year>). <article-title>An acetylcholine-activated microcircuit drives temporal dynamics of cortical activity</article-title>. <source>Nat. Neurosci.</source>
<volume>18</volume>, <fpage>892</fpage>&#x02013;<lpage>902</lpage>. <pub-id pub-id-type="doi">10.1038/nn.4002</pub-id><?supplied-pmid 25915477?><pub-id pub-id-type="pmid">25915477</pub-id></mixed-citation></ref><ref id="B26"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Christophe</surname><given-names>E.</given-names></name><name><surname>Roebuck</surname><given-names>A.</given-names></name><name><surname>Staiger</surname><given-names>J. F.</given-names></name><name><surname>Lavery</surname><given-names>D. J.</given-names></name><name><surname>Charpak</surname><given-names>S.</given-names></name><name><surname>Audinat</surname><given-names>E.</given-names></name></person-group> (<year>2002</year>). <article-title>Two types of nicotinic receptors mediate an excitation of neocortical layer I interneurons</article-title>. <source>J. Neurophysiol.</source>
<volume>88</volume>, <fpage>1318</fpage>&#x02013;<lpage>1327</lpage>. <pub-id pub-id-type="doi">10.1152/jn.2002.88.3.1318</pub-id><?supplied-pmid 12205153?><pub-id pub-id-type="pmid">12205153</pub-id></mixed-citation></ref><ref id="B27"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Coppola</surname><given-names>J. J.</given-names></name><name><surname>Disney</surname><given-names>A. A.</given-names></name></person-group> (<year>2018</year>). <article-title>Is there a canonical cortical circuit for the cholinergic system? Anatomical differences across common model systems</article-title>. <source>Front. Neural Circuits</source>
<volume>12</volume>:<fpage>8</fpage>. <pub-id pub-id-type="doi">10.3389/fncir.2018.00008</pub-id><?supplied-pmid 29440996?><pub-id pub-id-type="pmid">29440996</pub-id></mixed-citation></ref><ref id="B28"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Couey</surname><given-names>J. J.</given-names></name><name><surname>Meredith</surname><given-names>R. M.</given-names></name><name><surname>Spijker</surname><given-names>S.</given-names></name><name><surname>Poorthuis</surname><given-names>R. B.</given-names></name><name><surname>Smit</surname><given-names>A. B.</given-names></name><name><surname>Brussaard</surname><given-names>A. B.</given-names></name><etal/></person-group>. (<year>2007</year>). <article-title>Distributed network actions by nicotine increase the threshold for spike-timing-dependent plasticity in prefrontal cortex</article-title>. <source>Neuron</source>
<volume>54</volume>, <fpage>73</fpage>&#x02013;<lpage>87</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2007.03.006</pub-id><?supplied-pmid 17408579?><pub-id pub-id-type="pmid">17408579</pub-id></mixed-citation></ref><ref id="B29"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dajas-Bailador</surname><given-names>F.</given-names></name><name><surname>Wonnacott</surname><given-names>S.</given-names></name></person-group> (<year>2004</year>). <article-title>Nicotinic acetylcholine receptors and the regulation of neuronal signalling</article-title>. <source>Trends Pharmacol. Sci.</source>
<volume>25</volume>, <fpage>317</fpage>&#x02013;<lpage>324</lpage>. <pub-id pub-id-type="doi">10.1016/s0165-6147(04)00118-x</pub-id><?supplied-pmid 15165747?><pub-id pub-id-type="pmid">15165747</pub-id></mixed-citation></ref><ref id="B30"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dale</surname><given-names>H. H.</given-names></name></person-group> (<year>1914</year>). <article-title>The action of certain esters and ethers of choline and their relation to muscarine</article-title>. <source>J. Pharmacol. Exp. Ther.</source>
<volume>6</volume>, <fpage>147</fpage>&#x02013;<lpage>190</lpage>.</mixed-citation></ref><ref id="B31"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dani</surname><given-names>J. A.</given-names></name><name><surname>Bertrand</surname><given-names>D.</given-names></name></person-group> (<year>2007</year>). <article-title>Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system</article-title>. <source>Annu. Rev. Pharmacol. Toxicol.</source>
<volume>47</volume>, <fpage>699</fpage>&#x02013;<lpage>729</lpage>. <pub-id pub-id-type="doi">10.1146/annurev.pharmtox.47.120505.105214</pub-id><?supplied-pmid 17009926?><pub-id pub-id-type="pmid">17009926</pub-id></mixed-citation></ref><ref id="B32"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dasari</surname><given-names>S.</given-names></name><name><surname>Hill</surname><given-names>C.</given-names></name><name><surname>Gulledge</surname><given-names>A. T.</given-names></name></person-group> (<year>2017</year>). <article-title>A unifying hypothesis for M1 muscarinic receptor signalling in pyramidal neurons</article-title>. <source>J. Physiol.</source>
<volume>595</volume>, <fpage>1711</fpage>&#x02013;<lpage>1723</lpage>. <pub-id pub-id-type="doi">10.1113/jp273627</pub-id><?supplied-pmid 27861914?><pub-id pub-id-type="pmid">27861914</pub-id></mixed-citation></ref><ref id="B33"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dasgupta</surname><given-names>R.</given-names></name><name><surname>Seibt</surname><given-names>F.</given-names></name><name><surname>Beierlein</surname><given-names>M.</given-names></name></person-group> (<year>2018</year>). <article-title>Synaptic release of acetylcholine rapidly suppresses cortical activity by recruiting muscarinic receptors in layer 4</article-title>. <source>J. Neurosci.</source>
<volume>38</volume>, <fpage>5338</fpage>&#x02013;<lpage>5350</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.0566-18.2018</pub-id><?supplied-pmid 29739869?><pub-id pub-id-type="pmid">29739869</pub-id></mixed-citation></ref><ref id="B34"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Delmas</surname><given-names>P.</given-names></name><name><surname>Brown</surname><given-names>D. A.</given-names></name></person-group> (<year>2005</year>). <article-title>Pathways modulating neural KCNQ/M (Kv7) potassium channels</article-title>. <source>Nat. Rev. Neurosci.</source>
<volume>6</volume>, <fpage>850</fpage>&#x02013;<lpage>862</lpage>. <pub-id pub-id-type="doi">10.1038/nrn1785</pub-id><?supplied-pmid 16261179?><pub-id pub-id-type="pmid">16261179</pub-id></mixed-citation></ref><ref id="B35"><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Descarries</surname><given-names>L.</given-names></name><name><surname>Mechawar</surname><given-names>N.</given-names></name></person-group> (<year>2000</year>). &#x0201c;<article-title>Ultrastructural evidence for diffuse transmission by monoamine and acetylcholine neurons of the central nervous system</article-title>,&#x0201d; in <source>Progress in Brain Research</source>, eds <person-group person-group-type="editor"><name><surname>Agnati</surname><given-names>L. F.</given-names></name><name><surname>Fuxe</surname><given-names>K.</given-names></name><name><surname>Nicholson</surname><given-names>C.</given-names></name><name><surname>Sykov&#x000e1;</surname><given-names>E.</given-names></name></person-group> (<publisher-loc>Amsterdam</publisher-loc>: <publisher-name>Elsevier</publisher-name>), <fpage>27</fpage>&#x02013;<lpage>47</lpage>.</mixed-citation></ref><ref id="B36"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Disney</surname><given-names>A. A.</given-names></name><name><surname>Aoki</surname><given-names>C.</given-names></name><name><surname>Hawken</surname><given-names>M. J.</given-names></name></person-group> (<year>2007</year>). <article-title>Gain modulation by nicotine in macaque V1</article-title>. <source>Neuron</source>
<volume>56</volume>, <fpage>701</fpage>&#x02013;<lpage>713</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2007.09.034</pub-id><?supplied-pmid 18031686?><pub-id pub-id-type="pmid">18031686</pub-id></mixed-citation></ref><ref id="B37"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Disney</surname><given-names>A. A.</given-names></name><name><surname>Domakonda</surname><given-names>K. V.</given-names></name><name><surname>Aoki</surname><given-names>C.</given-names></name></person-group> (<year>2006</year>). <article-title>Differential expression of muscarinic acetylcholine receptors across excitatory and inhibitory cells in visual cortical areas V1 and V2 of the macaque monkey</article-title>. <source>J. Comp. Neurol.</source>
<volume>499</volume>, <fpage>49</fpage>&#x02013;<lpage>63</lpage>. <pub-id pub-id-type="doi">10.1002/cne.21096</pub-id><?supplied-pmid 16958109?><pub-id pub-id-type="pmid">16958109</pub-id></mixed-citation></ref><ref id="B38"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Duque</surname><given-names>A.</given-names></name><name><surname>Balatoni</surname><given-names>B.</given-names></name><name><surname>Detari</surname><given-names>L.</given-names></name><name><surname>Zaborszky</surname><given-names>L.</given-names></name></person-group> (<year>2000</year>). <article-title>EEG correlation of the discharge properties of identified neurons in the basal forebrain</article-title>. <source>J. Neurophysiol.</source>
<volume>84</volume>, <fpage>1627</fpage>&#x02013;<lpage>1635</lpage>. <pub-id pub-id-type="doi">10.1152/jn.2000.84.3.1627</pub-id><?supplied-pmid 10980032?><pub-id pub-id-type="pmid">10980032</pub-id></mixed-citation></ref><ref id="B39"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eccles</surname><given-names>J. C.</given-names></name><name><surname>Fatt</surname><given-names>P.</given-names></name><name><surname>Koketsu</surname><given-names>K.</given-names></name></person-group> (<year>1953</year>). <article-title>Cholinergic and inhibitory synapses in a central nervous pathway</article-title>. <source>Aust. J. Sci.</source>
<volume>16</volume>, <fpage>50</fpage>&#x02013;<lpage>54</lpage>.</mixed-citation></ref><ref id="B40"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eckenstein</surname><given-names>F. P.</given-names></name><name><surname>Baughman</surname><given-names>R. W.</given-names></name><name><surname>Quinn</surname><given-names>J.</given-names></name></person-group> (<year>1988</year>). <article-title>An anatomical study of cholinergic innervation in rat cerebral cortex</article-title>. <source>Neuroscience</source>
<volume>25</volume>, <fpage>457</fpage>&#x02013;<lpage>474</lpage>. <pub-id pub-id-type="doi">10.1016/0306-4522(88)90251-5</pub-id><?supplied-pmid 2456488?><pub-id pub-id-type="pmid">2456488</pub-id></mixed-citation></ref><ref id="B41"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eggermann</surname><given-names>E.</given-names></name><name><surname>Feldmeyer</surname><given-names>D.</given-names></name></person-group> (<year>2009</year>). <article-title>Cholinergic filtering in the recurrent excitatory microcircuit of cortical layer 4</article-title>. <source>Proc. Natl. Acad. Sci. U S A</source>
<volume>106</volume>, <fpage>11753</fpage>&#x02013;<lpage>11758</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0810062106</pub-id><?supplied-pmid 19564614?><pub-id pub-id-type="pmid">19564614</pub-id></mixed-citation></ref><ref id="B42"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Elhusseiny</surname><given-names>A.</given-names></name><name><surname>Hamel</surname><given-names>E.</given-names></name></person-group> (<year>2000</year>). <article-title>Muscarinic&#x02014;but not nicotinic&#x02014;acetylcholine receptors mediate a nitric oxide-dependent dilation in brain cortical arterioles: a possible role for the M5 receptor subtype</article-title>. <source>J. Cereb. Blood Flow Metab.</source>
<volume>20</volume>, <fpage>298</fpage>&#x02013;<lpage>305</lpage>. <pub-id pub-id-type="doi">10.1097/00004647-200002000-00011</pub-id><?supplied-pmid 10698067?><pub-id pub-id-type="pmid">10698067</pub-id></mixed-citation></ref><ref id="B43"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fanselow</surname><given-names>E. E.</given-names></name><name><surname>Richardson</surname><given-names>K. A.</given-names></name><name><surname>Connors</surname><given-names>B. W.</given-names></name></person-group> (<year>2008</year>). <article-title>Selective, state-dependent activation of somatostatin-expressing inhibitory interneurons in mouse neocortex</article-title>. <source>J. Neurophysiol.</source>
<volume>100</volume>, <fpage>2640</fpage>&#x02013;<lpage>2652</lpage>. <pub-id pub-id-type="doi">10.1152/jn.90691.2008</pub-id><?supplied-pmid 18799598?><pub-id pub-id-type="pmid">18799598</pub-id></mixed-citation></ref><ref id="B203"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Figl</surname><given-names>A.</given-names></name><name><surname>Cohen</surname><given-names>B. N.</given-names></name></person-group> (<year>2000</year>). <article-title>The subunit dominates the relaxation kinetics of heteromeric neuronal nicotinic receptors</article-title>. <source>J. Physiol.</source>
<volume>524</volume>, <fpage>685</fpage>&#x02013;<lpage>699</lpage>. <pub-id pub-id-type="doi">10.1111/j.1469-7793.2000.00685.x</pub-id><?supplied-pmid 10790151?><pub-id pub-id-type="pmid">10790151</pub-id></mixed-citation></ref><ref id="B44"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gericke</surname><given-names>A.</given-names></name><name><surname>Sniatecki</surname><given-names>J. J.</given-names></name><name><surname>Mayer</surname><given-names>V. G. A.</given-names></name><name><surname>Goloborodko</surname><given-names>E.</given-names></name><name><surname>Patzak</surname><given-names>A.</given-names></name><name><surname>Wess</surname><given-names>J.</given-names></name><etal/></person-group>. (<year>2011</year>). <article-title>Role of M1, M3, and M5 muscarinic acetylcholine receptors in cholinergic dilation of small arteries studied with gene-targeted mice</article-title>. <source>Am. J. Physiol. Heart Circ. Physiol.</source>
<volume>300</volume>, <fpage>H1602</fpage>&#x02013;<lpage>H1608</lpage>. <pub-id pub-id-type="doi">10.1152/ajpheart.00982.2010</pub-id><?supplied-pmid 21335473?><pub-id pub-id-type="pmid">21335473</pub-id></mixed-citation></ref><ref id="B45"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Giacobini</surname><given-names>E.</given-names></name></person-group> (<year>2003</year>). <article-title>Cholinergic function and Alzheimer&#x02019;s disease</article-title>. <source>Int. J. Geriatr. Psychiatry</source>
<volume>18</volume>, <fpage>S1</fpage>&#x02013;<lpage>S5</lpage>. <pub-id pub-id-type="doi">10.1002/gps.935</pub-id><?supplied-pmid 12973744?><pub-id pub-id-type="pmid">12973744</pub-id></mixed-citation></ref><ref id="B46"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gil</surname><given-names>Z.</given-names></name><name><surname>Connors</surname><given-names>B. W.</given-names></name><name><surname>Amitai</surname><given-names>Y.</given-names></name></person-group> (<year>1997</year>). <article-title>Differential regulation of neocortical synapses by neuromodulators and activity</article-title>. <source>Neuron</source>
<volume>19</volume>, <fpage>679</fpage>&#x02013;<lpage>686</lpage>. <pub-id pub-id-type="doi">10.1016/s0896-6273(00)80380-3</pub-id><?supplied-pmid 9331357?><pub-id pub-id-type="pmid">9331357</pub-id></mixed-citation></ref><ref id="B47"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goard</surname><given-names>M.</given-names></name><name><surname>Dan</surname><given-names>Y.</given-names></name></person-group> (<year>2009</year>). <article-title>Basal forebrain activation enhances cortical coding of natural scenes</article-title>. <source>Nat. Neurosci.</source>
<volume>12</volume>, <fpage>1444</fpage>&#x02013;<lpage>1449</lpage>. <pub-id pub-id-type="doi">10.1038/nn.2402</pub-id><?supplied-pmid 19801988?><pub-id pub-id-type="pmid">19801988</pub-id></mixed-citation></ref><ref id="B48"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Granger</surname><given-names>A. J.</given-names></name><name><surname>Mulder</surname><given-names>N.</given-names></name><name><surname>Saunders</surname><given-names>A.</given-names></name><name><surname>Sabatini</surname><given-names>B. L.</given-names></name></person-group> (<year>2016</year>). <article-title>Cotransmission of acetylcholine and GABA</article-title>. <source>Neuropharmacology</source>
<volume>100</volume>, <fpage>40</fpage>&#x02013;<lpage>46</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuropharm.2015.07.031</pub-id><?supplied-pmid 26220313?><pub-id pub-id-type="pmid">26220313</pub-id></mixed-citation></ref><ref id="B49"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Granger</surname><given-names>A. J.</given-names></name><name><surname>Wang</surname><given-names>W.</given-names></name><name><surname>Robertson</surname><given-names>K.</given-names></name><name><surname>El-Rifai</surname><given-names>M.</given-names></name><name><surname>Zanello</surname><given-names>A.</given-names></name><name><surname>Bistrong</surname><given-names>K.</given-names></name><etal/></person-group> (<year>2018</year>). <article-title>Target-specific co-transmission of acetylcholine and GABA from a subset of cortical VIP<sup>+</sup> interneurons</article-title>. <source>BioRxiv</source>:69064 [<italic>preprint</italic>]. <pub-id pub-id-type="doi">10.1101/469064</pub-id></mixed-citation></ref><ref id="B50"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Groleau</surname><given-names>M.</given-names></name><name><surname>Kang</surname><given-names>J. I.</given-names></name><name><surname>Hupp&#x000e9;-Gourgues</surname><given-names>F.</given-names></name><name><surname>Vaucher</surname><given-names>E.</given-names></name></person-group> (<year>2015</year>). <article-title>Distribution and effects of the muscarinic receptor subtypes in the primary visual cortex</article-title>. <source>Front. Synaptic Neurosci.</source>
<volume>7</volume>:<fpage>10</fpage>. <pub-id pub-id-type="doi">10.3389/fnsyn.2015.00010</pub-id><?supplied-pmid 26150786?><pub-id pub-id-type="pmid">26150786</pub-id></mixed-citation></ref><ref id="B52"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gulledge</surname><given-names>A. T.</given-names></name><name><surname>Park</surname><given-names>S. B.</given-names></name><name><surname>Kawaguchi</surname><given-names>Y.</given-names></name><name><surname>Stuart</surname><given-names>G. J.</given-names></name></person-group> (<year>2007</year>). <article-title>Heterogeneity of phasic cholinergic signaling in neocortical neurons</article-title>. <source>J. Neurophysiol.</source>
<volume>97</volume>, <fpage>2215</fpage>&#x02013;<lpage>2229</lpage>. <pub-id pub-id-type="doi">10.1152/jn.00493.2006</pub-id><?supplied-pmid 17122323?><pub-id pub-id-type="pmid">17122323</pub-id></mixed-citation></ref><ref id="B51"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gulledge</surname><given-names>A. T.</given-names></name><name><surname>Stuart</surname><given-names>G. J.</given-names></name></person-group> (<year>2005</year>). <article-title>Cholinergic inhibition of neocortical pyramidal neurons</article-title>. <source>J. Neurosci.</source>
<volume>25</volume>, <fpage>10308</fpage>&#x02013;<lpage>10320</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.2697-05.2005</pub-id><?supplied-pmid 16267239?><pub-id pub-id-type="pmid">16267239</pub-id></mixed-citation></ref><ref id="B204"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haj-Dahmane</surname><given-names>S.</given-names></name><name><surname>Andrade</surname><given-names>R.</given-names></name></person-group> (<year>1996</year>). <article-title>Muscarinic activation of a voltage-dependent cation nonselective current in rat association cortex</article-title>. <source>J. Neurosci.</source>
<volume>16</volume>, <fpage>3848</fpage>&#x02013;<lpage>3861</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.16-12-03848.1996</pub-id><?supplied-pmid 8656279?><pub-id pub-id-type="pmid">8656279</pub-id></mixed-citation></ref><ref id="B205"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hales</surname><given-names>T. G.</given-names></name><name><surname>Dunlop</surname><given-names>J. I.</given-names></name><name><surname>Deeb</surname><given-names>T. Z.</given-names></name><name><surname>Carland</surname><given-names>J. E.</given-names></name><name><surname>Kelley</surname><given-names>S. P.</given-names></name><name><surname>Lambert</surname><given-names>J. J.</given-names></name><etal/></person-group>. (<year>2006</year>). <article-title>Common determinants of single channel conductance within the large cytoplasmic loop of 5-hydroxytryptamine type 3 and alpha4beta2 nicotinic acetylcholine receptors</article-title>. <source>J. Biol. Chem.</source>
<volume>281</volume>, <fpage>8062</fpage>&#x02013;<lpage>8071</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M513222200</pub-id><?supplied-pmid 16407231?><pub-id pub-id-type="pmid">16407231</pub-id></mixed-citation></ref><ref id="B54"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hasselmo</surname><given-names>M. E.</given-names></name><name><surname>Sarter</surname><given-names>M.</given-names></name></person-group> (<year>2011</year>). <article-title>Modes and models of forebrain cholinergic neuromodulation of cognition</article-title>. <source>Neuropsychopharmacology</source>
<volume>36</volume>, <fpage>52</fpage>&#x02013;<lpage>73</lpage>. <pub-id pub-id-type="doi">10.1038/npp.2010.104</pub-id><?supplied-pmid 20668433?><pub-id pub-id-type="pmid">20668433</pub-id></mixed-citation></ref><ref id="B55"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hay</surname><given-names>Y. A.</given-names></name><name><surname>Lambolez</surname><given-names>B.</given-names></name><name><surname>Tricoire</surname><given-names>L.</given-names></name></person-group> (<year>2016</year>). <article-title>Nicotinic transmission onto layer 6 cortical neurons relies on synaptic activation of non-&#x003b1;7 receptors</article-title>. <source>Cereb. Cortex</source>
<volume>26</volume>, <fpage>2549</fpage>&#x02013;<lpage>2562</lpage>. <pub-id pub-id-type="doi">10.1093/cercor/bhv085</pub-id><?supplied-pmid 25934969?><pub-id pub-id-type="pmid">25934969</pub-id></mixed-citation></ref><ref id="B56"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hedrick</surname><given-names>T.</given-names></name><name><surname>Waters</surname><given-names>J.</given-names></name></person-group> (<year>2015</year>). <article-title>Acetylcholine excites neocortical pyramidal neurons via nicotinic receptors</article-title>. <source>J. Neurophysiol.</source>
<volume>113</volume>, <fpage>2195</fpage>&#x02013;<lpage>2209</lpage>. <pub-id pub-id-type="doi">10.1152/jn.00716.2014</pub-id><?supplied-pmid 25589590?><pub-id pub-id-type="pmid">25589590</pub-id></mixed-citation></ref><ref id="B57"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Henny</surname><given-names>P.</given-names></name><name><surname>Jones</surname><given-names>B. E.</given-names></name></person-group> (<year>2008</year>). <article-title>Projections from basal forebrain to prefrontal cortex comprise cholinergic, GABAergic and glutamatergic inputs to pyramidal cells or interneurons</article-title>. <source>Eur. J. Neurosci.</source>
<volume>27</volume>, <fpage>654</fpage>&#x02013;<lpage>670</lpage>. <pub-id pub-id-type="doi">10.1111/j.1460-9568.2008.06029.x</pub-id><?supplied-pmid 18279318?><pub-id pub-id-type="pmid">18279318</pub-id></mixed-citation></ref><ref id="B58"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heys</surname><given-names>J. G.</given-names></name><name><surname>Hasselmo</surname><given-names>M. E.</given-names></name></person-group> (<year>2012</year>). <article-title>Neuromodulation of <italic>I</italic><sub>h</sub> in layer II medial entorhinal cortex stellate cells: a voltage-clamp study</article-title>. <source>J. Neurosci.</source>
<volume>32</volume>, <fpage>9066</fpage>&#x02013;<lpage>9072</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.0868-12.2012</pub-id><?supplied-pmid 22745506?><pub-id pub-id-type="pmid">22745506</pub-id></mixed-citation></ref><ref id="B59"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heys</surname><given-names>J. G.</given-names></name><name><surname>Schultheiss</surname><given-names>N. W.</given-names></name><name><surname>Shay</surname><given-names>C. F.</given-names></name><name><surname>Tsuno</surname><given-names>Y.</given-names></name><name><surname>Hasselmo</surname><given-names>M. E.</given-names></name></person-group> (<year>2012</year>). <article-title>Effects of acetylcholine on neuronal properties in entorhinal cortex</article-title>. <source>Front. Behav. Neurosci.</source>
<volume>6</volume>:<fpage>32</fpage>. <pub-id pub-id-type="doi">10.3389/fnbeh.2012.00032</pub-id><?supplied-pmid 22837741?><pub-id pub-id-type="pmid">22837741</pub-id></mixed-citation></ref><ref id="B60"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hilscher</surname><given-names>M. M.</given-names></name><name><surname>Le&#x000e3;o</surname><given-names>R. N.</given-names></name><name><surname>Edwards</surname><given-names>S. J.</given-names></name><name><surname>Le&#x000e3;o</surname><given-names>K. E.</given-names></name><name><surname>Kullander</surname><given-names>K.</given-names></name></person-group> (<year>2017</year>). <article-title>Chrna2-martinotti cells synchronize layer 5 type a pyramidal cells via rebound excitation</article-title>. <source>PLoS Biol.</source>
<volume>15</volume>:<fpage>e2001392</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pbio.2001392</pub-id><?supplied-pmid 28182735?><pub-id pub-id-type="pmid">28182735</pub-id></mixed-citation></ref><ref id="B206"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hsiao</surname><given-names>B.</given-names></name><name><surname>Mihalak</surname><given-names>K. B.</given-names></name><name><surname>Magleby</surname><given-names>K. L.</given-names></name><name><surname>Luetje</surname><given-names>C. W.</given-names></name></person-group> (<year>2008</year>). <article-title>Zinc potentiates neuronal nicotinic receptors by increasing burst duration</article-title>. <source>J. Neurophysiol.</source>
<volume>99</volume>, <fpage>999</fpage>&#x02013;<lpage>1007</lpage>. <pub-id pub-id-type="doi">10.1152/jn.01040.2007</pub-id><?supplied-pmid 18094103?><pub-id pub-id-type="pmid">18094103</pub-id></mixed-citation></ref><ref id="B61"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hwang</surname><given-names>J.-I.</given-names></name><name><surname>Kim</surname><given-names>H. S.</given-names></name><name><surname>Lee</surname><given-names>J. R.</given-names></name><name><surname>Kim</surname><given-names>E.</given-names></name><name><surname>Ryu</surname><given-names>S. H.</given-names></name><name><surname>Suh</surname><given-names>P.-G.</given-names></name></person-group> (<year>2005</year>). <article-title>The interaction of phospholipase C-&#x003b2;3 with Shank2 regulates mGluR-mediated calcium signal</article-title>. <source>J. Biol. Chem.</source>
<volume>280</volume>, <fpage>12467</fpage>&#x02013;<lpage>12473</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M410740200</pub-id><?supplied-pmid 15632121?><pub-id pub-id-type="pmid">15632121</pub-id></mixed-citation></ref><ref id="B62"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jiang</surname><given-names>M.</given-names></name><name><surname>Bajpayee</surname><given-names>N. S.</given-names></name></person-group> (<year>2009</year>). <article-title>Molecular mechanisms of go signaling</article-title>. <source>Neurosignals</source>
<volume>17</volume>, <fpage>23</fpage>&#x02013;<lpage>41</lpage>. <pub-id pub-id-type="doi">10.1159/000186688</pub-id><?supplied-pmid 19212138?><pub-id pub-id-type="pmid">19212138</pub-id></mixed-citation></ref><ref id="B63"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jiang</surname><given-names>X.</given-names></name><name><surname>Wang</surname><given-names>G.</given-names></name><name><surname>Lee</surname><given-names>A. J.</given-names></name><name><surname>Stornetta</surname><given-names>R. L.</given-names></name><name><surname>Zhu</surname><given-names>J. J.</given-names></name></person-group> (<year>2013</year>). <article-title>The organization of two new cortical interneuronal circuits</article-title>. <source>Nat. Neurosci.</source>
<volume>16</volume>, <fpage>210</fpage>&#x02013;<lpage>218</lpage>. <pub-id pub-id-type="doi">10.1038/nn.3305</pub-id><?supplied-pmid 23313910?><pub-id pub-id-type="pmid">23313910</pub-id></mixed-citation></ref><ref id="B65"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kalmbach</surname><given-names>A.</given-names></name><name><surname>Hedrick</surname><given-names>T.</given-names></name><name><surname>Waters</surname><given-names>J.</given-names></name></person-group> (<year>2012</year>). <article-title>Selective optogenetic stimulation of cholinergic axons in neocortex</article-title>. <source>J. Neurophysiol.</source>
<volume>107</volume>, <fpage>2008</fpage>&#x02013;<lpage>2019</lpage>. <pub-id pub-id-type="doi">10.1152/jn.00870.2011</pub-id><?supplied-pmid 22236708?><pub-id pub-id-type="pmid">22236708</pub-id></mixed-citation></ref><ref id="B66"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kan</surname><given-names>W.</given-names></name><name><surname>Adjobo-Hermans</surname><given-names>M.</given-names></name><name><surname>Burroughs</surname><given-names>M.</given-names></name><name><surname>Faibis</surname><given-names>G.</given-names></name><name><surname>Malik</surname><given-names>S.</given-names></name><name><surname>Tall</surname><given-names>G. G.</given-names></name><etal/></person-group>. (<year>2014</year>). <article-title>M3 muscarinic receptor interaction with phospholipase C &#x003b2;3 determines its signaling efficiency</article-title>. <source>J. Biol. Chem.</source>
<volume>289</volume>, <fpage>11206</fpage>&#x02013;<lpage>11218</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M113.538546</pub-id><?supplied-pmid 24596086?><pub-id pub-id-type="pmid">24596086</pub-id></mixed-citation></ref><ref id="B67"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kassam</surname><given-names>S. M.</given-names></name><name><surname>Herman</surname><given-names>P. M.</given-names></name><name><surname>Goodfellow</surname><given-names>N. M.</given-names></name><name><surname>Alves</surname><given-names>N. C.</given-names></name><name><surname>Lambe</surname><given-names>E. K.</given-names></name></person-group> (<year>2008</year>). <article-title>Developmental excitation of corticothalamic neurons by nicotinic acetylcholine receptors</article-title>. <source>J. Neurosci.</source>
<volume>28</volume>, <fpage>8756</fpage>&#x02013;<lpage>8764</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.2645-08.2008</pub-id><?supplied-pmid 18753377?><pub-id pub-id-type="pmid">18753377</pub-id></mixed-citation></ref><ref id="B68"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Katz</surname><given-names>B.</given-names></name><name><surname>Miledi</surname><given-names>R.</given-names></name></person-group> (<year>1973</year>). <article-title>The binding of acetylcholine to receptors and its removal from the synaptic cleft</article-title>. <source>J. Physiol.</source>
<volume>231</volume>, <fpage>549</fpage>&#x02013;<lpage>574</lpage>. <pub-id pub-id-type="doi">10.1113/jphysiol.1973.sp010248</pub-id><?supplied-pmid 4361216?><pub-id pub-id-type="pmid">4361216</pub-id></mixed-citation></ref><ref id="B69"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kawaguchi</surname><given-names>Y.</given-names></name></person-group> (<year>1997</year>). <article-title>Selective cholinergic modulation of cortical GABAergic cell subtypes</article-title>. <source>J. Neurophysiol.</source>
<volume>78</volume>, <fpage>1743</fpage>&#x02013;<lpage>1747</lpage>. <pub-id pub-id-type="doi">10.1152/jn.1997.78.3.1743</pub-id><?supplied-pmid 9310461?><pub-id pub-id-type="pmid">9310461</pub-id></mixed-citation></ref><ref id="B70"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kawaguchi</surname><given-names>Y.</given-names></name><name><surname>Kubota</surname><given-names>Y.</given-names></name></person-group> (<year>1997</year>). <article-title>GABAergic cell subtypes and their synaptic connections in rat frontal cortex</article-title>. <source>Cereb. Cortex</source>
<volume>7</volume>, <fpage>476</fpage>&#x02013;<lpage>486</lpage>. <pub-id pub-id-type="doi">10.1093/cercor/7.6.476</pub-id><?supplied-pmid 9276173?><pub-id pub-id-type="pmid">9276173</pub-id></mixed-citation></ref><ref id="B71"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kennedy</surname><given-names>H.</given-names></name><name><surname>Bullier</surname><given-names>J.</given-names></name></person-group> (<year>1985</year>). <article-title>A double-labeling investigation of the afferent connectivity to cortical areas V1 and V2 of the macaque monkey</article-title>. <source>J. Neurosci.</source>
<volume>5</volume>, <fpage>2815</fpage>&#x02013;<lpage>2830</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.05-10-02815.1985</pub-id><?supplied-pmid 3840201?><pub-id pub-id-type="pmid">3840201</pub-id></mixed-citation></ref><ref id="B72"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>J.-H.</given-names></name><name><surname>Jung</surname><given-names>A.-H.</given-names></name><name><surname>Jeong</surname><given-names>D.</given-names></name><name><surname>Choi</surname><given-names>I.</given-names></name><name><surname>Kim</surname><given-names>K.</given-names></name><name><surname>Shin</surname><given-names>S.</given-names></name><etal/></person-group>. (<year>2016</year>). <article-title>Selectivity of neuromodulatory projections from the basal forebrain and locus ceruleus to primary sensory cortices</article-title>. <source>J. Neurosci.</source>
<volume>36</volume>, <fpage>5314</fpage>&#x02013;<lpage>5327</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.4333-15.2016</pub-id><?supplied-pmid 27170128?><pub-id pub-id-type="pmid">27170128</pub-id></mixed-citation></ref><ref id="B74"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kimura</surname><given-names>F.</given-names></name><name><surname>Fukuda</surname><given-names>M.</given-names></name><name><surname>Tsumoto</surname><given-names>T.</given-names></name></person-group> (<year>1999</year>). <article-title>Acetylcholine suppresses the spread of excitation in the visual cortex revealed by optical recording: possible differential effect depending on the source of input</article-title>. <source>Eur. J. Neurosci.</source>
<volume>11</volume>, <fpage>3597</fpage>&#x02013;<lpage>3609</lpage>. <pub-id pub-id-type="doi">10.1046/j.1460-9568.1999.00779.x</pub-id><?supplied-pmid 10564367?><pub-id pub-id-type="pmid">10564367</pub-id></mixed-citation></ref><ref id="B75"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kocharyan</surname><given-names>A.</given-names></name><name><surname>Fernandes</surname><given-names>P.</given-names></name><name><surname>Tong</surname><given-names>X.-K.</given-names></name><name><surname>Vaucher</surname><given-names>E.</given-names></name><name><surname>Hamel</surname><given-names>E.</given-names></name></person-group> (<year>2008</year>). <article-title>Specific subtypes of cortical GABA interneurons contribute to the neurovascular coupling response to basal forebrain stimulation</article-title>. <source>J. Cereb. Blood Flow Metab.</source>
<volume>28</volume>, <fpage>221</fpage>&#x02013;<lpage>231</lpage>. <pub-id pub-id-type="doi">10.1038/sj.jcbfm.9600558</pub-id><?supplied-pmid 17895909?><pub-id pub-id-type="pmid">17895909</pub-id></mixed-citation></ref><ref id="B76"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koukouli</surname><given-names>F.</given-names></name><name><surname>Rooy</surname><given-names>M.</given-names></name><name><surname>Tziotis</surname><given-names>D.</given-names></name><name><surname>Sailor</surname><given-names>K. A.</given-names></name><name><surname>O&#x02019;Neill</surname><given-names>H. C.</given-names></name><name><surname>Levenga</surname><given-names>J.</given-names></name><etal/></person-group>. (<year>2017</year>). <article-title>Nicotine reverses hypofrontality in animal models of addiction and schizophrenia</article-title>. <source>Nat. Med.</source>
<volume>23</volume>, <fpage>347</fpage>&#x02013;<lpage>354</lpage>. <pub-id pub-id-type="doi">10.1038/nm.4274</pub-id><?supplied-pmid 28112735?><pub-id pub-id-type="pmid">28112735</pub-id></mixed-citation></ref><ref id="B77"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krnjevi&#x00107;</surname><given-names>K.</given-names></name></person-group> (<year>2004</year>). <article-title>Synaptic mechanisms modulated by acetylcholine in cerebral cortex</article-title>. <source>Prog. Brain Res.</source>
<volume>145</volume>, <fpage>81</fpage>&#x02013;<lpage>93</lpage>. <pub-id pub-id-type="doi">10.1016/s0079-6123(03)45005-x</pub-id><?supplied-pmid 14650908?><pub-id pub-id-type="pmid">14650908</pub-id></mixed-citation></ref><ref id="B78"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kruglikov</surname><given-names>I.</given-names></name><name><surname>Rudy</surname><given-names>B.</given-names></name></person-group> (<year>2008</year>). <article-title>Perisomatic GABA release and thalamocortical integration onto neocortical excitatory cells are regulated by neuromodulators</article-title>. <source>Neuron</source>
<volume>58</volume>, <fpage>911</fpage>&#x02013;<lpage>924</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2008.04.024</pub-id><?supplied-pmid 18579081?><pub-id pub-id-type="pmid">18579081</pub-id></mixed-citation></ref><ref id="B207"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kuryatov</surname><given-names>A.</given-names></name><name><surname>Berrettini</surname><given-names>W.</given-names></name><name><surname>Lindstrom</surname><given-names>J.</given-names></name></person-group> (<year>2011</year>). <article-title>Acetylcholine receptor (AChR) a5 subunit variant associated with risk for nicotine dependence and lung cancer reduces (a4&#x003b2;2)2a5 AChR function</article-title>. <source>Mol. Pharmacol.</source>
<volume>79</volume>, <fpage>119</fpage>&#x02013;<lpage>125</lpage>. <pub-id pub-id-type="doi">10.1124/mol.110.066357</pub-id><?supplied-pmid 20881005?><pub-id pub-id-type="pmid">20881005</pub-id></mixed-citation></ref><ref id="B79"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>S.-H.</given-names></name><name><surname>Dan</surname><given-names>Y.</given-names></name></person-group> (<year>2012</year>). <article-title>Neuromodulation of brain states</article-title>. <source>Neuron</source>
<volume>76</volume>, <fpage>209</fpage>&#x02013;<lpage>222</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2012.09.012</pub-id><?supplied-pmid 23040816?><pub-id pub-id-type="pmid">23040816</pub-id></mixed-citation></ref><ref id="B80"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Letzkus</surname><given-names>J. J.</given-names></name><name><surname>Wolff</surname><given-names>S. B. E.</given-names></name><name><surname>Meyer</surname><given-names>E. M. M.</given-names></name><name><surname>Tovote</surname><given-names>P.</given-names></name><name><surname>Courtin</surname><given-names>J.</given-names></name><name><surname>Herry</surname><given-names>C.</given-names></name><etal/></person-group>. (<year>2011</year>). <article-title>A disinhibitory microcircuit for associative fear learning in the auditory cortex</article-title>. <source>Nature</source>
<volume>480</volume>, <fpage>331</fpage>&#x02013;<lpage>335</lpage>. <pub-id pub-id-type="doi">10.1038/nature10674</pub-id><?supplied-pmid 22158104?><pub-id pub-id-type="pmid">22158104</pub-id></mixed-citation></ref><ref id="B81"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Levey</surname><given-names>A. I.</given-names></name><name><surname>Kitt</surname><given-names>C. A.</given-names></name><name><surname>Simonds</surname><given-names>W. F.</given-names></name><name><surname>Price</surname><given-names>D. L.</given-names></name><name><surname>Brann</surname><given-names>M. R.</given-names></name></person-group> (<year>1991</year>). <article-title>Identification and localization of muscarinic acetylcholine receptor proteins in brain with subtype-specific antibodies</article-title>. <source>J. Neurosci.</source>
<volume>11</volume>, <fpage>3218</fpage>&#x02013;<lpage>3226</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.11-10-03218.1991</pub-id><?supplied-pmid 1941081?><pub-id pub-id-type="pmid">1941081</pub-id></mixed-citation></ref><ref id="B82"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Levy</surname><given-names>R. B.</given-names></name><name><surname>Reyes</surname><given-names>A. D.</given-names></name><name><surname>Aoki</surname><given-names>C.</given-names></name></person-group> (<year>2006</year>). <article-title>Nicotinic and muscarinic reduction of unitary excitatory postsynaptic potentials in sensory cortex; dual intracellular recording <italic>in vitro</italic></article-title>. <source>J. Neurophysiol.</source>
<volume>95</volume>, <fpage>2155</fpage>&#x02013;<lpage>2166</lpage>. <pub-id pub-id-type="doi">10.1152/jn.00603.2005</pub-id><?supplied-pmid 16421199?><pub-id pub-id-type="pmid">16421199</pub-id></mixed-citation></ref><ref id="B208"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>P.</given-names></name><name><surname>Steinbach</surname><given-names>J. H.</given-names></name></person-group> (<year>2010</year>). <article-title>The neuronal nicotinic alpha4beta2 receptor has a high maximal probability of being open</article-title>. <source>Br. J. Pharmacol.</source>
<volume>160</volume>, <fpage>1906</fpage>&#x02013;<lpage>1915</lpage>. <pub-id pub-id-type="doi">10.1111/j.1476-5381.2010.00761.x</pub-id><?supplied-pmid 20649589?><pub-id pub-id-type="pmid">20649589</pub-id></mixed-citation></ref><ref id="B83"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>S.-C.</given-names></name><name><surname>Brown</surname><given-names>R. E.</given-names></name><name><surname>Shuler</surname><given-names>M. G. H.</given-names></name><name><surname>Petersen</surname><given-names>C. C. H.</given-names></name><name><surname>Kepecs</surname><given-names>A.</given-names></name></person-group> (<year>2015</year>). <article-title>Optogenetic dissection of the basal forebrain neuromodulatory control of cortical activation, plasticity, and cognition</article-title>. <source>J. Neurosci.</source>
<volume>35</volume>, <fpage>13896</fpage>&#x02013;<lpage>13903</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.2590-15.2015</pub-id><?supplied-pmid 26468190?><pub-id pub-id-type="pmid">26468190</pub-id></mixed-citation></ref><ref id="B84"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Little</surname><given-names>J. T.</given-names></name><name><surname>Johnson</surname><given-names>D. N.</given-names></name><name><surname>Minichiello</surname><given-names>M.</given-names></name><name><surname>Weingartner</surname><given-names>H.</given-names></name><name><surname>Sunderland</surname><given-names>T.</given-names></name></person-group> (<year>1998</year>). <article-title>Combined nicotinic and muscarinic blockade in elderly normal volunteers: cognitive, behavioral, and physiologic responses</article-title>. <source>Neuropsychopharmacology</source>
<volume>19</volume>, <fpage>60</fpage>&#x02013;<lpage>69</lpage>. <pub-id pub-id-type="doi">10.1016/s0893-133x(98)00002-5</pub-id><?supplied-pmid 9608577?><pub-id pub-id-type="pmid">9608577</pub-id></mixed-citation></ref><ref id="B85"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Loewi</surname><given-names>O.</given-names></name></person-group> (<year>1924</year>). <article-title>&#x000dc;ber humorale &#x000dc;bertragbarkeit der Herznervenwirkung: V. Mitteilung. Die &#x000dc;bertragbarkeit der negativ chrono- und dromotropen Vaguswirkung</article-title>. <source>Pfl&#x000fc;g. Arch. F&#x000fc;r Gesamte Physiol. Menschen Tiere</source>
<volume>204</volume>, <fpage>629</fpage>&#x02013;<lpage>640</lpage>. <pub-id pub-id-type="doi">10.1007/BF01731235</pub-id></mixed-citation></ref><ref id="B86"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lysakowski</surname><given-names>A.</given-names></name><name><surname>Wainer</surname><given-names>B. H.</given-names></name><name><surname>Bruce</surname><given-names>G.</given-names></name><name><surname>Hersh</surname><given-names>L. B.</given-names></name></person-group> (<year>1989</year>). <article-title>An atlas of the regional and laminar distribution of choline acetyltransferase immunoreactivity in rat cerebral cortex</article-title>. <source>Neuroscience</source>
<volume>28</volume>, <fpage>291</fpage>&#x02013;<lpage>336</lpage>. <pub-id pub-id-type="doi">10.1016/0306-4522(89)90180-2</pub-id><?supplied-pmid 2646551?><pub-id pub-id-type="pmid">2646551</pub-id></mixed-citation></ref><ref id="B87"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mancarci</surname><given-names>B. O.</given-names></name><name><surname>Toker</surname><given-names>L.</given-names></name><name><surname>Tripathy</surname><given-names>S. J.</given-names></name><name><surname>Li</surname><given-names>B.</given-names></name><name><surname>Rocco</surname><given-names>B.</given-names></name><name><surname>Sibille</surname><given-names>E.</given-names></name><etal/></person-group>. (<year>2017</year>). <article-title>Cross-laboratory analysis of brain cell type transcriptomes with applications to interpretation of bulk tissue data</article-title>. <source>eNeuro</source>
<volume>4</volume>:<fpage>ENEURO.0212&#x02013;17.2017</fpage>. <pub-id pub-id-type="doi">10.1523/eneuro.0212-17.2017</pub-id><?supplied-pmid 29204516?><pub-id pub-id-type="pmid">29204516</pub-id></mixed-citation></ref><ref id="B88"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marchi</surname><given-names>M.</given-names></name><name><surname>Grilli</surname><given-names>M.</given-names></name></person-group> (<year>2010</year>). <article-title>Presynaptic nicotinic receptors modulating neurotransmitter release in the central nervous system: functional interactions with other coexisting receptors</article-title>. <source>Prog. Neurobiol.</source>
<volume>92</volume>, <fpage>105</fpage>&#x02013;<lpage>111</lpage>. <pub-id pub-id-type="doi">10.1016/j.pneurobio.2010.06.004</pub-id><?supplied-pmid 20558239?><pub-id pub-id-type="pmid">20558239</pub-id></mixed-citation></ref><ref id="B209"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Markram</surname><given-names>H.</given-names></name><name><surname>L&#x000fc;bke</surname><given-names>J.</given-names></name><name><surname>Frotscher</surname><given-names>M.</given-names></name><name><surname>Roth</surname><given-names>A.</given-names></name><name><surname>Sakmann</surname><given-names>B.</given-names></name></person-group> (<year>1997</year>). <article-title>Physiology and anatomy of synaptic connections between thick tufted pyramidal neurones in the developing rat neocortex</article-title>. <source>J. Physiol.</source>
<volume>500</volume>, <fpage>409</fpage>&#x02013;<lpage>440</lpage>. <pub-id pub-id-type="doi">10.1113/jphysiol.1997.sp022031</pub-id><?supplied-pmid 9147328?><pub-id pub-id-type="pmid">9147328</pub-id></mixed-citation></ref><ref id="B89"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mathes</surname><given-names>C.</given-names></name><name><surname>Thompson</surname><given-names>S. H.</given-names></name></person-group> (<year>1996</year>). <article-title>The nitric oxide/cGMP pathway couples muscarinic receptors to the activation of Ca<sup>2+</sup> influx</article-title>. <source>J. Neurosci.</source>
<volume>16</volume>, <fpage>1702</fpage>&#x02013;<lpage>1709</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.16-05-01702.1996</pub-id><?supplied-pmid 8774438?><pub-id pub-id-type="pmid">8774438</pub-id></mixed-citation></ref><ref id="B210"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McCormick</surname><given-names>D. A.</given-names></name></person-group> (<year>1992</year>). <article-title>Cellular mechanisms underlying cholinergic and noradrenergic modulation of neuronal firing mode in the cat and guinea pig dorsal lateral geniculate nucleus</article-title>. <source>J. Neurosci.</source>
<volume>12</volume>, <fpage>278</fpage>&#x02013;<lpage>289</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.12-01-00278.1992</pub-id><?supplied-pmid 1309574?><pub-id pub-id-type="pmid">1309574</pub-id></mixed-citation></ref><ref id="B90"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McCormick</surname><given-names>D. A.</given-names></name><name><surname>Prince</surname><given-names>D. A.</given-names></name></person-group> (<year>1985</year>). <article-title>Two types of muscarinic response to acetylcholine in mammalian cortical neurons</article-title>. <source>Proc. Natl. Acad. Sci. U S A</source>
<volume>82</volume>, <fpage>6344</fpage>&#x02013;<lpage>6348</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.82.18.6344</pub-id><?supplied-pmid 3862134?><pub-id pub-id-type="pmid">3862134</pub-id></mixed-citation></ref><ref id="B91"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meir</surname><given-names>I.</given-names></name><name><surname>Katz</surname><given-names>Y.</given-names></name><name><surname>Lampl</surname><given-names>I.</given-names></name></person-group> (<year>2018</year>). <article-title>Membrane potential correlates of network decorrelation and improved SNR by cholinergic activation in the somatosensory cortex</article-title>. <source>J. Neurosci.</source>
<volume>38</volume>, <fpage>10692</fpage>&#x02013;<lpage>10708</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.1159-18.2018</pub-id><?supplied-pmid 30373769?><pub-id pub-id-type="pmid">30373769</pub-id></mixed-citation></ref><ref id="B92"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Metherate</surname><given-names>R.</given-names></name><name><surname>Hsieh</surname><given-names>C. Y.</given-names></name></person-group> (<year>2004</year>). <article-title>Synaptic mechanisms and cholinergic regulation in auditory cortex</article-title>. <source>Prog. Brain Res.</source>
<volume>145</volume>, <fpage>143</fpage>&#x02013;<lpage>156</lpage>. <pub-id pub-id-type="doi">10.1016/s0079-6123(03)45010-3</pub-id><?supplied-pmid 14650913?><pub-id pub-id-type="pmid">14650913</pub-id></mixed-citation></ref><ref id="B93"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Metherate</surname><given-names>R.</given-names></name><name><surname>Weinberger</surname><given-names>N. M.</given-names></name></person-group> (<year>1990</year>). <article-title>Cholinergic modulation of responses to single tones produces tone-specific receptive field alterations in cat auditory cortex</article-title>. <source>Synapse</source>
<volume>6</volume>, <fpage>133</fpage>&#x02013;<lpage>145</lpage>. <pub-id pub-id-type="doi">10.1002/syn.890060204</pub-id><?supplied-pmid 2237776?><pub-id pub-id-type="pmid">2237776</pub-id></mixed-citation></ref><ref id="B94"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Minces</surname><given-names>V.</given-names></name><name><surname>Pinto</surname><given-names>L.</given-names></name><name><surname>Dan</surname><given-names>Y.</given-names></name><name><surname>Chiba</surname><given-names>A. A.</given-names></name></person-group> (<year>2017</year>). <article-title>Cholinergic shaping of neural correlations</article-title>. <source>Proc. Natl. Acad. Sci. U S A</source>
<volume>114</volume>, <fpage>5725</fpage>&#x02013;<lpage>5730</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1621493114</pub-id><?supplied-pmid 28507133?><pub-id pub-id-type="pmid">28507133</pub-id></mixed-citation></ref><ref id="B95"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moruzzi</surname><given-names>G.</given-names></name><name><surname>Magoun</surname><given-names>H. W.</given-names></name></person-group> (<year>1949</year>). <article-title>Brain stem reticular formation and activation of the EEG</article-title>. <source>Electroencephalogr. Clin. Neurophysiol.</source>
<volume>1</volume>, <fpage>455</fpage>&#x02013;<lpage>473</lpage>. <pub-id pub-id-type="doi">10.1016/0013-4694(49)90066-8</pub-id><?supplied-pmid 18421835?><pub-id pub-id-type="pmid">18421835</pub-id></mixed-citation></ref><ref id="B96"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mrzijak</surname><given-names>L.</given-names></name><name><surname>Pappy</surname><given-names>M.</given-names></name><name><surname>Leranth</surname><given-names>C.</given-names></name><name><surname>Goldman-Rakic</surname><given-names>P. S.</given-names></name></person-group> (<year>1995</year>). <article-title>Cholinergic synaptic circuitry in the macaque prefrontal cortex</article-title>. <source>J. Comp. Neurol.</source>
<volume>357</volume>, <fpage>603</fpage>&#x02013;<lpage>617</lpage>. <pub-id pub-id-type="doi">10.1002/cne.903570409</pub-id><?supplied-pmid 7673486?><pub-id pub-id-type="pmid">7673486</pub-id></mixed-citation></ref><ref id="B97"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mrzljak</surname><given-names>L.</given-names></name><name><surname>Levey</surname><given-names>A. I.</given-names></name><name><surname>Goldman-Rakic</surname><given-names>P. S.</given-names></name></person-group> (<year>1993</year>). <article-title>Association of m1 and m2 muscarinic receptor proteins with asymmetric synapses in the primate cerebral cortex: morphological evidence for cholinergic modulation of excitatory neurotransmission</article-title>. <source>Proc. Natl. Acad. Sci. U S A</source>
<volume>90</volume>, <fpage>5194</fpage>&#x02013;<lpage>5198</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.90.11.5194</pub-id><?supplied-pmid 8389473?><pub-id pub-id-type="pmid">8389473</pub-id></mixed-citation></ref><ref id="B98"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mu&#x000f1;oz</surname><given-names>W.</given-names></name><name><surname>Rudy</surname><given-names>B.</given-names></name></person-group> (<year>2014</year>). <article-title>Spatiotemporal specificity in cholinergic control of neocortical function</article-title>. <source>Curr. Opin. Neurobiol.</source>
<volume>26</volume>, <fpage>149</fpage>&#x02013;<lpage>160</lpage>. <pub-id pub-id-type="doi">10.1016/j.conb.2014.02.015</pub-id><?supplied-pmid 24637201?><pub-id pub-id-type="pmid">24637201</pub-id></mixed-citation></ref><ref id="B99"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mu&#x000f1;oz</surname><given-names>W.</given-names></name><name><surname>Tremblay</surname><given-names>R.</given-names></name><name><surname>Levenstein</surname><given-names>D.</given-names></name><name><surname>Rudy</surname><given-names>B.</given-names></name></person-group> (<year>2017</year>). <article-title>Layer-specific modulation of neocortical dendritic inhibition during active wakefulness</article-title>. <source>Science</source>
<volume>355</volume>, <fpage>954</fpage>&#x02013;<lpage>959</lpage>. <pub-id pub-id-type="doi">10.1126/science.aag2599</pub-id><?supplied-pmid 28254942?><pub-id pub-id-type="pmid">28254942</pub-id></mixed-citation></ref><ref id="B100"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nashmi</surname><given-names>R.</given-names></name><name><surname>Lester</surname><given-names>H. A.</given-names></name></person-group> (<year>2006</year>). <article-title>CNS localization of neuronal nicotinic receptors</article-title>. <source>J. Mol. Neurosci.</source>
<volume>30</volume>, <fpage>181</fpage>&#x02013;<lpage>184</lpage>. <pub-id pub-id-type="doi">10.1385/jmn:30:1:181</pub-id><?supplied-pmid 17192671?><pub-id pub-id-type="pmid">17192671</pub-id></mixed-citation></ref><ref id="B101"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Newman</surname><given-names>E. L.</given-names></name><name><surname>Gupta</surname><given-names>K.</given-names></name><name><surname>Climer</surname><given-names>J. R.</given-names></name><name><surname>Monaghan</surname><given-names>C. K.</given-names></name><name><surname>Hasselmo</surname><given-names>M. E.</given-names></name></person-group> (<year>2012</year>). <article-title>Cholinergic modulation of cognitive processing: insights drawn from computational models</article-title>. <source>Front. Behav. Neurosci.</source>
<volume>6</volume>:<fpage>24</fpage>. <pub-id pub-id-type="doi">10.3389/fnbeh.2012.00024</pub-id><?supplied-pmid 22707936?><pub-id pub-id-type="pmid">22707936</pub-id></mixed-citation></ref><ref id="B102"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nguyen</surname><given-names>Q.</given-names></name><name><surname>Sapp</surname><given-names>D. W.</given-names></name><name><surname>Van Ness</surname><given-names>P. C.</given-names></name><name><surname>Olsen</surname><given-names>R. W.</given-names></name></person-group> (<year>1995</year>). <article-title>Modulation of GABAA receptor binding in human brain by neuroactive steroids: species and brain regional differences</article-title>. <source>Synapse</source>
<volume>19</volume>, <fpage>77</fpage>&#x02013;<lpage>87</lpage>. <pub-id pub-id-type="doi">10.1002/syn.890190203</pub-id><?supplied-pmid 7725245?><pub-id pub-id-type="pmid">7725245</pub-id></mixed-citation></ref><ref id="B211"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nu&#x000f1;ez</surname><given-names>A.</given-names></name><name><surname>Dom&#x000ed;nguez</surname><given-names>S.</given-names></name><name><surname>Bu&#x000f1;o</surname><given-names>W.</given-names></name><name><surname>Fern&#x000e1;ndez de Sevilla</surname><given-names>D.</given-names></name></person-group> (<year>2012</year>). <article-title>Cholinergic-mediated response enhancement in barrel cortex layer V pyramidal neurons</article-title>. <source>J. Neurophysiol.</source>
<volume>108</volume>, <fpage>1656</fpage>&#x02013;<lpage>1668</lpage>. <pub-id pub-id-type="doi">10.1152/jn.00156.2012</pub-id><?supplied-pmid 22723675?><pub-id pub-id-type="pmid">22723675</pub-id></mixed-citation></ref><ref id="B103"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Obermayer</surname><given-names>J.</given-names></name><name><surname>Heistek</surname><given-names>T. S.</given-names></name><name><surname>Kerkhofs</surname><given-names>A.</given-names></name><name><surname>Goriounova</surname><given-names>N. A.</given-names></name><name><surname>Kroon</surname><given-names>T.</given-names></name><name><surname>Baayen</surname><given-names>J. C.</given-names></name><etal/></person-group>. (<year>2018</year>). <article-title>Lateral inhibition by Martinotti interneurons is facilitated by cholinergic inputs in human and mouse neocortex</article-title>. <source>Nat. Commun.</source>
<volume>9</volume>:<fpage>4101</fpage>. <pub-id pub-id-type="doi">10.1038/s41467-018-06628-w</pub-id><?supplied-pmid 30291244?><pub-id pub-id-type="pmid">30291244</pub-id></mixed-citation></ref><ref id="B104"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Obermayer</surname><given-names>J.</given-names></name><name><surname>Verhoog</surname><given-names>M. B.</given-names></name><name><surname>Luchicchi</surname><given-names>A.</given-names></name><name><surname>Mansvelder</surname><given-names>H. D.</given-names></name></person-group> (<year>2017</year>). <article-title>Cholinergic modulation of cortical microcircuits is layer-specific: evidence from rodent, monkey and human brain</article-title>. <source>Front. Neural Circuits</source>
<volume>11</volume>:<fpage>100</fpage>. <pub-id pub-id-type="doi">10.3389/fncir.2017.00100</pub-id><?supplied-pmid 29276477?><pub-id pub-id-type="pmid">29276477</pub-id></mixed-citation></ref><ref id="B105"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pawlak</surname><given-names>V.</given-names></name><name><surname>Wickens</surname><given-names>J. R.</given-names></name><name><surname>Kirkwood</surname><given-names>A.</given-names></name><name><surname>Kerr</surname><given-names>J. N.</given-names></name></person-group> (<year>2010</year>). <article-title>Timing is not everything: neuromodulation opens the STDP gate</article-title>. <source>Front. Synaptic Neurosci.</source>
<volume>2</volume>:<fpage>146</fpage>. <pub-id pub-id-type="doi">10.3389/fnsyn.2010.00146</pub-id><?supplied-pmid 21423532?><pub-id pub-id-type="pmid">21423532</pub-id></mixed-citation></ref><ref id="B106"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Poorthuis</surname><given-names>R. B.</given-names></name><name><surname>Bloem</surname><given-names>B.</given-names></name><name><surname>Schak</surname><given-names>B.</given-names></name><name><surname>Wester</surname><given-names>J.</given-names></name><name><surname>de Kock</surname><given-names>C. P. J.</given-names></name><name><surname>Mansvelder</surname><given-names>H. D.</given-names></name></person-group> (<year>2013</year>). <article-title>Layer-specific modulation of the prefrontal cortex by nicotinic acetylcholine receptors</article-title>. <source>Cereb. Cortex</source>
<volume>23</volume>, <fpage>148</fpage>&#x02013;<lpage>161</lpage>. <pub-id pub-id-type="doi">10.1093/cercor/bhr390</pub-id><?supplied-pmid 22291029?><pub-id pub-id-type="pmid">22291029</pub-id></mixed-citation></ref><ref id="B107"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Poorthuis</surname><given-names>R. B.</given-names></name><name><surname>Enke</surname><given-names>L.</given-names></name><name><surname>Letzkus</surname><given-names>J. J.</given-names></name></person-group> (<year>2014</year>). <article-title>Cholinergic circuit modulation through differential recruitment of neocortical interneuron types during behaviour</article-title>. <source>J. Physiol.</source>
<volume>592</volume>, <fpage>4155</fpage>&#x02013;<lpage>4164</lpage>. <pub-id pub-id-type="doi">10.1113/jphysiol.2014.273862</pub-id><?supplied-pmid 24879871?><pub-id pub-id-type="pmid">24879871</pub-id></mixed-citation></ref><ref id="B108"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Poorthuis</surname><given-names>R. B.</given-names></name><name><surname>Muhammad</surname><given-names>K.</given-names></name><name><surname>Wang</surname><given-names>M.</given-names></name><name><surname>Verhoog</surname><given-names>M. B.</given-names></name><name><surname>Junek</surname><given-names>S.</given-names></name><name><surname>Wrana</surname><given-names>A.</given-names></name><etal/></person-group>. (<year>2018</year>). <article-title>Rapid neuromodulation of layer 1 interneurons in human neocortex</article-title>. <source>Cell Rep.</source>
<volume>23</volume>, <fpage>951</fpage>&#x02013;<lpage>958</lpage>. <pub-id pub-id-type="doi">10.1016/j.celrep.2018.03.111</pub-id><?supplied-pmid 29694902?><pub-id pub-id-type="pmid">29694902</pub-id></mixed-citation></ref><ref id="B109"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Radnikow</surname><given-names>G.</given-names></name><name><surname>Feldmeyer</surname><given-names>D.</given-names></name></person-group> (<year>2018</year>). <article-title>Layer- and cell type-specific modulation of excitatory neuronal activity in the neocortex</article-title>. <source>Front. Neuroanat.</source>
<volume>12</volume>:<fpage>1</fpage>. <pub-id pub-id-type="doi">10.3389/fnana.2018.00001</pub-id><?supplied-pmid 29440997?><pub-id pub-id-type="pmid">29440997</pub-id></mixed-citation></ref><ref id="B110"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ramaswamy</surname><given-names>S.</given-names></name><name><surname>Colangelo</surname><given-names>C.</given-names></name><name><surname>Markram</surname><given-names>H.</given-names></name></person-group> (<year>2018</year>). <article-title>Data-driven modeling of cholinergic modulation of neural microcircuits: bridging neurons, synapses and network activity</article-title>. <source>Front. Neural Circuits</source>
<volume>12</volume>:<fpage>77</fpage>. <pub-id pub-id-type="doi">10.3389/fncir.2018.00077</pub-id><?supplied-pmid 30356701?><pub-id pub-id-type="pmid">30356701</pub-id></mixed-citation></ref><ref id="B111"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rasmusson</surname><given-names>D.</given-names></name></person-group> (<year>2000</year>). <article-title>The role of acetylcholine in cortical synaptic plasticity</article-title>. <source>Behav. Brain Res.</source>
<volume>115</volume>, <fpage>205</fpage>&#x02013;<lpage>218</lpage>. <pub-id pub-id-type="doi">10.1016/s0166-4328(00)00259-x</pub-id><?supplied-pmid 11000421?><pub-id pub-id-type="pmid">11000421</pub-id></mixed-citation></ref><ref id="B212"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rovira</surname><given-names>J. C.</given-names></name><name><surname>Ballesta</surname><given-names>J. J.</given-names></name><name><surname>Vicente-Agull&#x000f3;</surname><given-names>F.</given-names></name><name><surname>Campos-Caro</surname><given-names>A.</given-names></name><name><surname>Criado</surname><given-names>M.</given-names></name><name><surname>Sala</surname><given-names>F.</given-names></name><etal/></person-group>. (<year>1998</year>). <article-title>A residue in the middle of the M2&#x02013;M3 loop of the beta4 subunit specifically affects gating of neuronal nicotinic receptors</article-title>. <source>FEBS Lett.</source>
<volume>433</volume>, <fpage>89</fpage>&#x02013;<lpage>92</lpage>. <pub-id pub-id-type="doi">10.1016/s0014-5793(98)00889-8</pub-id><?supplied-pmid 9738939?><pub-id pub-id-type="pmid">9738939</pub-id></mixed-citation></ref><ref id="B112"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rudy</surname><given-names>B.</given-names></name><name><surname>Fishell</surname><given-names>G.</given-names></name><name><surname>Lee</surname><given-names>S.</given-names></name><name><surname>Hjerling-Leffler</surname><given-names>J.</given-names></name></person-group> (<year>2011</year>). <article-title>Three groups of interneurons account for nearly 100% of neocortical GABAergic neurons</article-title>. <source>Dev. Neurobiol.</source>
<volume>71</volume>, <fpage>45</fpage>&#x02013;<lpage>61</lpage>. <pub-id pub-id-type="doi">10.1002/dneu.20853</pub-id><?supplied-pmid 21154909?><pub-id pub-id-type="pmid">21154909</pub-id></mixed-citation></ref><ref id="B113"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Runfeldt</surname><given-names>M. J.</given-names></name><name><surname>Sadovsky</surname><given-names>A. J.</given-names></name><name><surname>MacLean</surname><given-names>J. N.</given-names></name></person-group> (<year>2014</year>). <article-title>Acetylcholine functionally reorganizes neocortical microcircuits</article-title>. <source>J. Neurophysiol.</source>
<volume>112</volume>, <fpage>1205</fpage>&#x02013;<lpage>1216</lpage>. <pub-id pub-id-type="doi">10.1152/jn.00071.2014</pub-id><?supplied-pmid 24872527?><pub-id pub-id-type="pmid">24872527</pub-id></mixed-citation></ref><ref id="B114"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sabri</surname><given-names>O.</given-names></name><name><surname>Kendziorra</surname><given-names>K.</given-names></name><name><surname>Wolf</surname><given-names>H.</given-names></name><name><surname>Gertz</surname><given-names>H.-J.</given-names></name><name><surname>Brust</surname><given-names>P.</given-names></name></person-group> (<year>2008</year>). <article-title>Acetylcholine receptors in dementia and mild cognitive impairment</article-title>. <source>Eur. J. Nucl. Med. Mol. Imaging</source>
<volume>35</volume>, <fpage>S30</fpage>&#x02013;<lpage>S45</lpage>. <pub-id pub-id-type="doi">10.1007/s00259-007-0701-1</pub-id><?supplied-pmid 18228017?><pub-id pub-id-type="pmid">18228017</pub-id></mixed-citation></ref><ref id="B213"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Salgado</surname><given-names>H.</given-names></name><name><surname>Bellay</surname><given-names>T.</given-names></name><name><surname>Nichols</surname><given-names>J. A.</given-names></name><name><surname>Bose</surname><given-names>M.</given-names></name><name><surname>Martinolich</surname><given-names>L.</given-names></name><name><surname>Perrotti</surname><given-names>L.</given-names></name><etal/></person-group>. (<year>2007</year>). <article-title>Muscarinic M<sub>2</sub> and M<sub>1</sub> receptors reduce GABA release by Ca<sup>2+</sup> channel modulation through activation of PI<sub>3</sub>K/Ca<sup>2+</sup> -independent and PLC/Ca<sup>2+</sup> -dependent PKC</article-title>. <source>J. Neurophysiol.</source>
<volume>98</volume>, <fpage>952</fpage>&#x02013;<lpage>965</lpage>. <pub-id pub-id-type="doi">10.1152/jn.00060.2007</pub-id><?supplied-pmid 17581851?><pub-id pub-id-type="pmid">17581851</pub-id></mixed-citation></ref><ref id="B115"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saper</surname><given-names>C. B.</given-names></name><name><surname>Chou</surname><given-names>T. C.</given-names></name><name><surname>Scammell</surname><given-names>T. E.</given-names></name></person-group> (<year>2001</year>). <article-title>The sleep switch: hypothalamic control of sleep and wakefulness</article-title>. <source>Trends Neurosci.</source>
<volume>24</volume>, <fpage>726</fpage>&#x02013;<lpage>731</lpage>. <pub-id pub-id-type="doi">10.1016/s0166-2236(00)02002-6</pub-id><?supplied-pmid 11718878?><pub-id pub-id-type="pmid">11718878</pub-id></mixed-citation></ref><ref id="B116"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saper</surname><given-names>C. B.</given-names></name><name><surname>Fuller</surname><given-names>P. M.</given-names></name><name><surname>Pedersen</surname><given-names>N. P.</given-names></name><name><surname>Lu</surname><given-names>J.</given-names></name><name><surname>Scammell</surname><given-names>T. E.</given-names></name></person-group> (<year>2010</year>). <article-title>Sleep state switching</article-title>. <source>Neuron</source>
<volume>68</volume>, <fpage>1023</fpage>&#x02013;<lpage>1042</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2010.11.032</pub-id><?supplied-pmid 21172606?><pub-id pub-id-type="pmid">21172606</pub-id></mixed-citation></ref><ref id="B117"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sarter</surname><given-names>M.</given-names></name><name><surname>Parikh</surname><given-names>V.</given-names></name><name><surname>Howe</surname><given-names>W. M.</given-names></name></person-group> (<year>2009</year>). <article-title>Phasic acetylcholine release and the volume transmission hypothesis: time to move on</article-title>. <source>Nat. Rev. Neurosci.</source>
<volume>10</volume>, <fpage>383</fpage>&#x02013;<lpage>390</lpage>. <pub-id pub-id-type="doi">10.1038/nrn2635</pub-id><?supplied-pmid 19377503?><pub-id pub-id-type="pmid">19377503</pub-id></mixed-citation></ref><ref id="B118"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saunders</surname><given-names>A.</given-names></name><name><surname>Granger</surname><given-names>A. J.</given-names></name><name><surname>Sabatini</surname><given-names>B. L.</given-names></name></person-group> (<year>2015</year>). <article-title>Corelease of acetylcholine and GABA from cholinergic forebrain neurons</article-title>. <source>Elife</source>
<volume>4</volume>:<fpage>e06412</fpage>. <pub-id pub-id-type="doi">10.7554/elife.06412</pub-id><?supplied-pmid 25723967?><pub-id pub-id-type="pmid">25723967</pub-id></mixed-citation></ref><ref id="B119"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saunders</surname><given-names>A.</given-names></name><name><surname>Macosko</surname><given-names>E. Z.</given-names></name><name><surname>Wysoker</surname><given-names>A.</given-names></name><name><surname>Goldman</surname><given-names>M.</given-names></name><name><surname>Krienen</surname><given-names>F. M.</given-names></name><name><surname>de Rivera</surname><given-names>H.</given-names></name><etal/></person-group>. (<year>2018</year>). <article-title>Molecular diversity and specializations among the cells of the adult mouse brain</article-title>. <source>Cell</source>
<volume>174</volume>, <fpage>1015.e16</fpage>&#x02013;<lpage>1030.e16</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2018.07.028</pub-id><?supplied-pmid 30096299?><pub-id pub-id-type="pmid">30096299</pub-id></mixed-citation></ref><ref id="B214"><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Schmiedeberg</surname><given-names>O.</given-names></name><name><surname>Koppe</surname><given-names>R.</given-names></name></person-group> (<year>1869</year>). <source>Das Muscarin. Das Giftige Alkaloid des Fliegenpilzes.</source>
<publisher-loc>Leipzig</publisher-loc>: <publisher-name>Vogel</publisher-name>.</mixed-citation></ref><ref id="B120"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schr&#x000f6;der</surname><given-names>H.</given-names></name></person-group> (<year>1992</year>). <article-title>Immunohistochemistry of cholinergic receptors</article-title>. <source>Anat. Embryol.</source>
<volume>186</volume>, <fpage>407</fpage>&#x02013;<lpage>429</lpage>. <pub-id pub-id-type="doi">10.1007/bf00185457</pub-id><?supplied-pmid 1443653?><pub-id pub-id-type="pmid">1443653</pub-id></mixed-citation></ref><ref id="B121"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schr&#x000f6;der</surname><given-names>H.</given-names></name><name><surname>Zilles</surname><given-names>K.</given-names></name><name><surname>Luiten</surname><given-names>P. G. M.</given-names></name><name><surname>Strosberg</surname><given-names>A.</given-names></name></person-group> (<year>1990</year>). <article-title>Immunocytochemical visualization of muscarinic cholinoceptors in the human cerebral cortex</article-title>. <source>Brain Res.</source>
<volume>514</volume>, <fpage>249</fpage>&#x02013;<lpage>258</lpage>. <pub-id pub-id-type="doi">10.1016/0006-8993(90)91420-l</pub-id><?supplied-pmid 2357541?><pub-id pub-id-type="pmid">2357541</pub-id></mixed-citation></ref><ref id="B122"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schr&#x000f6;der</surname><given-names>H.</given-names></name><name><surname>Zilles</surname><given-names>K.</given-names></name><name><surname>Maelicke</surname><given-names>A.</given-names></name><name><surname>Haj&#x000f3;s</surname><given-names>F.</given-names></name></person-group> (<year>1989</year>). <article-title>Immunohisto- and cytochemical localization of cortical nicotinic cholinoceptors in rat and man</article-title>. <source>Brain Res.</source>
<volume>502</volume>, <fpage>287</fpage>&#x02013;<lpage>295</lpage>. <pub-id pub-id-type="doi">10.1016/0006-8993(89)90624-0</pub-id><?supplied-pmid 2819467?><pub-id pub-id-type="pmid">2819467</pub-id></mixed-citation></ref><ref id="B215"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shalinsky</surname><given-names>M. H.</given-names></name><name><surname>Magistretti</surname><given-names>J.</given-names></name><name><surname>Ma</surname><given-names>L.</given-names></name><name><surname>Alonso</surname><given-names>A. A.</given-names></name></person-group> (<year>2002</year>). <article-title>Muscarinic activation of a cation current and associated current noise in entorhinal-cortex layer-II neurons</article-title>. <source>J. Neurophysiol.</source>
<volume>88</volume>, <fpage>1197</fpage>&#x02013;<lpage>1211</lpage>. <pub-id pub-id-type="doi">10.1152/jn.2002.88.3.1197</pub-id><?supplied-pmid 12205141?><pub-id pub-id-type="pmid">12205141</pub-id></mixed-citation></ref><ref id="B123"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shen</surname><given-names>J.</given-names></name><name><surname>Yakel</surname><given-names>J. L.</given-names></name></person-group> (<year>2009</year>). <article-title>Nicotinic acetylcholine receptor-mediated calcium signaling in the nervous system</article-title>. <source>Acta Pharmacol. Sin.</source>
<volume>30</volume>, <fpage>673</fpage>&#x02013;<lpage>680</lpage>. <pub-id pub-id-type="doi">10.1038/aps.2009.64</pub-id><?supplied-pmid 19448647?><pub-id pub-id-type="pmid">19448647</pub-id></mixed-citation></ref><ref id="B124"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smiley</surname><given-names>J. F.</given-names></name><name><surname>Morrell</surname><given-names>F.</given-names></name><name><surname>Mesulam</surname><given-names>M. M.</given-names></name></person-group> (<year>1997</year>). <article-title>Cholinergic synapses in human cerebral cortex: an ultrastructural study in serial sections</article-title>. <source>Exp. Neurol.</source>
<volume>144</volume>, <fpage>361</fpage>&#x02013;<lpage>368</lpage>. <pub-id pub-id-type="doi">10.1006/exnr.1997.6413</pub-id><?supplied-pmid 9168836?><pub-id pub-id-type="pmid">9168836</pub-id></mixed-citation></ref><ref id="B125"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sparks</surname><given-names>D. W.</given-names></name><name><surname>Tian</surname><given-names>M. K.</given-names></name><name><surname>Sargin</surname><given-names>D.</given-names></name><name><surname>Venkatesan</surname><given-names>S.</given-names></name><name><surname>Intson</surname><given-names>K.</given-names></name><name><surname>Lambe</surname><given-names>E. K.</given-names></name></person-group> (<year>2018</year>). <article-title>Opposing cholinergic and serotonergic modulation of layer 6 in prefrontal cortex</article-title>. <source>Front. Neural Circuits</source>
<volume>11</volume>:<fpage>107</fpage>. <pub-id pub-id-type="doi">10.3389/fncir.2017.00107</pub-id><?supplied-pmid 29354034?><pub-id pub-id-type="pmid">29354034</pub-id></mixed-citation></ref><ref id="B126"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Steriade</surname><given-names>M.</given-names></name><name><surname>Amzica</surname><given-names>F.</given-names></name><name><surname>Nunez</surname><given-names>A.</given-names></name></person-group> (<year>1993</year>). <article-title>Cholinergic and noradrenergic modulation of the slow (approximately 0.3 Hz) oscillation in neocortical cells</article-title>. <source>J. Neurophysiol.</source>
<volume>70</volume>, <fpage>1385</fpage>&#x02013;<lpage>1400</lpage>. <pub-id pub-id-type="doi">10.1152/jn.1993.70.4.1385</pub-id><?supplied-pmid 8283204?><pub-id pub-id-type="pmid">8283204</pub-id></mixed-citation></ref><ref id="B216"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stetzer</surname><given-names>E.</given-names></name><name><surname>Ebbinghaus</surname><given-names>U.</given-names></name><name><surname>Storch</surname><given-names>A.</given-names></name><name><surname>Poteur</surname><given-names>L.</given-names></name><name><surname>Schrattenholz</surname><given-names>A.</given-names></name><name><surname>Kramer</surname><given-names>G.</given-names></name><etal/></person-group>. (<year>1996</year>). <article-title>Stable expression in HEK-293 cells of the rat alpha3/beta4 subtype of neuronal nicotinic acetylcholine receptor</article-title>. <source>FEBS Lett.</source>
<volume>397</volume>, <fpage>39</fpage>&#x02013;<lpage>44</lpage>. <pub-id pub-id-type="doi">10.1016/s0014-5793(96)01115-5</pub-id><?supplied-pmid 8941710?><pub-id pub-id-type="pmid">8941710</pub-id></mixed-citation></ref><ref id="B127"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stewart</surname><given-names>A. E.</given-names></name><name><surname>Yan</surname><given-names>Z.</given-names></name><name><surname>Surmeier</surname><given-names>D. J.</given-names></name><name><surname>Foehring</surname><given-names>R. C.</given-names></name></person-group> (<year>1999</year>). <article-title>Muscarine modulates Ca<sup>2+</sup> channel currents in rat sensorimotor pyramidal cells via two distinct pathways</article-title>. <source>J. Neurophysiol.</source>
<volume>81</volume>, <fpage>72</fpage>&#x02013;<lpage>84</lpage>. <pub-id pub-id-type="doi">10.1152/jn.1999.81.1.72</pub-id><?supplied-pmid 9914268?><pub-id pub-id-type="pmid">9914268</pub-id></mixed-citation></ref><ref id="B128"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sugihara</surname><given-names>H.</given-names></name><name><surname>Chen</surname><given-names>N.</given-names></name><name><surname>Sur</surname><given-names>M.</given-names></name></person-group> (<year>2016</year>). <article-title>Cell-specific modulation of plasticity and cortical state by cholinergic inputs to the visual cortex</article-title>. <source>J. Physiol. Paris</source>
<volume>110</volume>, <fpage>37</fpage>&#x02013;<lpage>43</lpage>. <pub-id pub-id-type="doi">10.1016/j.jphysparis.2016.11.004</pub-id><?supplied-pmid 27840211?><pub-id pub-id-type="pmid">27840211</pub-id></mixed-citation></ref><ref id="B129"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Szymusiak</surname><given-names>R.</given-names></name><name><surname>McGinty</surname><given-names>D.</given-names></name></person-group> (<year>1986</year>). <article-title>Sleep suppression following kainic acid-induced lesions of the basal forebrain</article-title>. <source>Exp. Neurol.</source>
<volume>94</volume>, <fpage>598</fpage>&#x02013;<lpage>614</lpage>. <pub-id pub-id-type="doi">10.1016/0014-4886(86)90240-2</pub-id><?supplied-pmid 3780909?><pub-id pub-id-type="pmid">3780909</pub-id></mixed-citation></ref><ref id="B130"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Teles-Grilo Ruivo</surname><given-names>L. M.</given-names></name><name><surname>Mellor</surname><given-names>J. R.</given-names></name></person-group> (<year>2013</year>). <article-title>Cholinergic modulation of hippocampal network function</article-title>. <source>Front. Synaptic Neurosci.</source>
<volume>5</volume>:<fpage>2</fpage>. <pub-id pub-id-type="doi">10.3389/fnsyn.2013.00002</pub-id><?supplied-pmid 23908628?><pub-id pub-id-type="pmid">23908628</pub-id></mixed-citation></ref><ref id="B131"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thiele</surname><given-names>A.</given-names></name><name><surname>Herrero</surname><given-names>J. L.</given-names></name><name><surname>Distler</surname><given-names>C.</given-names></name><name><surname>Hoffmann</surname><given-names>K.-P.</given-names></name></person-group> (<year>2012</year>). <article-title>Contribution of cholinergic and GABAergic mechanisms to direction tuning, discriminability, response reliability and neuronal rate correlations in macaque middle temporal area</article-title>. <source>J. Neurosci.</source>
<volume>32</volume>, <fpage>16602</fpage>&#x02013;<lpage>16615</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.0554-12.2012</pub-id><?supplied-pmid 23175816?><pub-id pub-id-type="pmid">23175816</pub-id></mixed-citation></ref><ref id="B132"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tribollet</surname><given-names>E.</given-names></name><name><surname>Bertrand</surname><given-names>D.</given-names></name><name><surname>Marguerat</surname><given-names>A.</given-names></name><name><surname>Raggenbass</surname><given-names>M.</given-names></name></person-group> (<year>2004</year>). <article-title>Comparative distribution of nicotinic receptor subtypes during development, adulthood and aging: an autoradiographic study in the rat brain</article-title>. <source>Neuroscience</source>
<volume>124</volume>, <fpage>405</fpage>&#x02013;<lpage>420</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuroscience.2003.09.028</pub-id><?supplied-pmid 14980390?><pub-id pub-id-type="pmid">14980390</pub-id></mixed-citation></ref><ref id="B217"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsodyks</surname><given-names>M. V.</given-names></name><name><surname>Markram</surname><given-names>H.</given-names></name></person-group> (<year>1997</year>). <article-title>The neural code between neocortical pyramidal neurons depends on neurotransmitter release probability</article-title>. <source>Proc. Natl. Acad. Sci. U S A</source>
<volume>94</volume>, <fpage>719</fpage>&#x02013;<lpage>723</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.94.2.719</pub-id><?supplied-pmid 9012851?><pub-id pub-id-type="pmid">9012851</pub-id></mixed-citation></ref><ref id="B133"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Turrini</surname><given-names>P.</given-names></name><name><surname>Casu</surname><given-names>M. A.</given-names></name><name><surname>Wong</surname><given-names>T. P.</given-names></name><name><surname>De Koninck</surname><given-names>Y.</given-names></name><name><surname>Ribeiro-da-Silva</surname><given-names>A.</given-names></name><name><surname>Cuello</surname><given-names>A. C.</given-names></name></person-group> (<year>2001</year>). <article-title>Cholinergic nerve terminals establish classical synapses in the rat cerebral cortex: synaptic pattern and age-related atrophy</article-title>. <source>Neuroscience</source>
<volume>105</volume>, <fpage>277</fpage>&#x02013;<lpage>285</lpage>. <pub-id pub-id-type="doi">10.1016/s0306-4522(01)00172-5</pub-id><?supplied-pmid 11672595?><pub-id pub-id-type="pmid">11672595</pub-id></mixed-citation></ref><ref id="B134"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Umbriaco</surname><given-names>D.</given-names></name><name><surname>Watkins</surname><given-names>K. C.</given-names></name><name><surname>Descarries</surname><given-names>L.</given-names></name><name><surname>Cozzari</surname><given-names>C.</given-names></name><name><surname>Hartman</surname><given-names>B. K.</given-names></name></person-group> (<year>1994</year>). <article-title>Ultrastructural and morphometric features of the acetylcholine innervation in adult rat parietal cortex: an electron microscopic study in serial sections</article-title>. <source>J. Comp. Neurol.</source>
<volume>348</volume>, <fpage>351</fpage>&#x02013;<lpage>373</lpage>. <pub-id pub-id-type="doi">10.1002/cne.903480304</pub-id><?supplied-pmid 7844253?><pub-id pub-id-type="pmid">7844253</pub-id></mixed-citation></ref><ref id="B135"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Unal</surname><given-names>C. T.</given-names></name><name><surname>Golowasch</surname><given-names>J. P.</given-names></name><name><surname>Zaborszky</surname><given-names>L.</given-names></name></person-group> (<year>2012</year>). <article-title>Adult mouse basal forebrain harbors two distinct cholinergic populations defined by their electrophysiology</article-title>. <source>Front. Behav. Neurosci.</source>
<volume>6</volume>:<fpage>21</fpage>. <pub-id pub-id-type="doi">10.3389/fnbeh.2012.00021</pub-id><?supplied-pmid 22586380?><pub-id pub-id-type="pmid">22586380</pub-id></mixed-citation></ref><ref id="B136"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Urban-Ciecko</surname><given-names>J.</given-names></name><name><surname>Jouhanneau</surname><given-names>J.-S.</given-names></name><name><surname>Myal</surname><given-names>S. E.</given-names></name><name><surname>Poulet</surname><given-names>J. F. A.</given-names></name><name><surname>Barth</surname><given-names>A. L.</given-names></name></person-group> (<year>2018</year>). <article-title>Precisely timed nicotinic activation drives SST inhibition in neocortical circuits</article-title>. <source>Neuron</source>
<volume>97</volume>, <fpage>611</fpage>&#x02013;<lpage>625.e5</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2018.01.037</pub-id><?supplied-pmid 29420933?><pub-id pub-id-type="pmid">29420933</pub-id></mixed-citation></ref><ref id="B137"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Van der Zee</surname><given-names>E. A.</given-names></name><name><surname>Luiten</surname><given-names>P. G.</given-names></name></person-group> (<year>1999</year>). <article-title>Muscarinic acetylcholine receptors in the hippocampus, neocortex and amygdala: a review of immunocytochemical localization in relation to learning and memory</article-title>. <source>Prog. Neurobiol.</source>
<volume>58</volume>, <fpage>409</fpage>&#x02013;<lpage>471</lpage>. <pub-id pub-id-type="doi">10.1016/s0301-0082(98)00092-6</pub-id><?supplied-pmid 10380240?><pub-id pub-id-type="pmid">10380240</pub-id></mixed-citation></ref><ref id="B138"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van der Zee</surname><given-names>E. A.</given-names></name><name><surname>Streefland</surname><given-names>C.</given-names></name><name><surname>Strosberg</surname><given-names>A. D.</given-names></name><name><surname>Schr&#x000f6;der</surname><given-names>H.</given-names></name><name><surname>Luiten</surname><given-names>P. G.</given-names></name></person-group> (<year>1992</year>). <article-title>Visualization of cholinoceptive neurons in the rat neocortex: colocalization of muscarinic and nicotinic acetylcholine receptors</article-title>. <source>Mol. Brain Res.</source>
<volume>14</volume>, <fpage>326</fpage>&#x02013;<lpage>336</lpage>. <pub-id pub-id-type="doi">10.1016/0169-328x(92)90100-p</pub-id><?supplied-pmid 1326695?><pub-id pub-id-type="pmid">1326695</pub-id></mixed-citation></ref><ref id="B139"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Venter</surname><given-names>J. C.</given-names></name><name><surname>di Porzio</surname><given-names>U.</given-names></name><name><surname>Robinson</surname><given-names>D. A.</given-names></name><name><surname>Shreeve</surname><given-names>S. M.</given-names></name><name><surname>Lai</surname><given-names>J.</given-names></name><name><surname>Kerlavage</surname><given-names>A. R.</given-names></name><etal/></person-group>. (<year>1988</year>). <article-title>Evolution of neurotransmitter receptor systems</article-title>. <source>Prog. Neurobiol.</source>
<volume>30</volume>, <fpage>105</fpage>&#x02013;<lpage>169</lpage>. <pub-id pub-id-type="doi">10.1016/0301-0082(88)90004-4</pub-id><?supplied-pmid 2830635?><pub-id pub-id-type="pmid">2830635</pub-id></mixed-citation></ref><ref id="B218"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vidal</surname><given-names>C.</given-names></name><name><surname>Changeux</surname><given-names>J.-P.</given-names></name></person-group> (<year>1993</year>). <article-title>Nicotinic and muscarinic modulations of excitatory synaptic transmission in the rat prefrontal cortexin vitro</article-title>. <source>Neuroscience</source>
<volume>56</volume>, <fpage>23</fpage>&#x02013;<lpage>32</lpage>. <pub-id pub-id-type="doi">10.1016/0306-4522(93)90558-w</pub-id><?supplied-pmid 7901807?><pub-id pub-id-type="pmid">7901807</pub-id></mixed-citation></ref><ref id="B140"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>von Engelhardt</surname><given-names>J.</given-names></name><name><surname>Eliava</surname><given-names>M.</given-names></name><name><surname>Meyer</surname><given-names>A. H.</given-names></name><name><surname>Rozov</surname><given-names>A.</given-names></name><name><surname>Monyer</surname><given-names>H.</given-names></name></person-group> (<year>2007</year>). <article-title>Functional characterization of intrinsic cholinergic interneurons in the cortex</article-title>. <source>J. Neurosci.</source>
<volume>27</volume>, <fpage>5633</fpage>&#x02013;<lpage>5642</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.4647-06.2007</pub-id><?supplied-pmid 17522308?><pub-id pub-id-type="pmid">17522308</pub-id></mixed-citation></ref><ref id="B141"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Z.</given-names></name><name><surname>Kai</surname><given-names>L.</given-names></name><name><surname>Day</surname><given-names>M.</given-names></name><name><surname>Ronesi</surname><given-names>J.</given-names></name><name><surname>Yin</surname><given-names>H. H.</given-names></name><name><surname>Ding</surname><given-names>J.</given-names></name><etal/></person-group>. (<year>2006</year>). <article-title>Dopaminergic control of corticostriatal long-term synaptic depression in medium spiny neurons is mediated by cholinergic interneurons</article-title>. <source>Neuron</source>
<volume>50</volume>, <fpage>443</fpage>&#x02013;<lpage>452</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2006.04.010</pub-id><?supplied-pmid 16675398?><pub-id pub-id-type="pmid">16675398</pub-id></mixed-citation></ref><ref id="B142"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wevers</surname><given-names>A.</given-names></name></person-group> (<year>2011</year>). <article-title>Localisation of pre- and postsynaptic cholinergic markers in the human brain</article-title>. <source>Behav. Brain Res.</source>
<volume>221</volume>, <fpage>341</fpage>&#x02013;<lpage>355</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbr.2010.02.025</pub-id><?supplied-pmid 20170687?><pub-id pub-id-type="pmid">20170687</pub-id></mixed-citation></ref><ref id="B143"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>M.</given-names></name><name><surname>Chung</surname><given-names>S.</given-names></name><name><surname>Zhang</surname><given-names>S.</given-names></name><name><surname>Zhong</surname><given-names>P.</given-names></name><name><surname>Ma</surname><given-names>C.</given-names></name><name><surname>Chang</surname><given-names>W.-C.</given-names></name><etal/></person-group>. (<year>2015</year>). <article-title>Basal forebrain circuit for sleep-wake control</article-title>. <source>Nat. Neurosci.</source>
<volume>18</volume>, <fpage>1641</fpage>&#x02013;<lpage>1647</lpage>. <pub-id pub-id-type="doi">10.1038/nn.4143</pub-id><?supplied-pmid 26457552?><pub-id pub-id-type="pmid">26457552</pub-id></mixed-citation></ref><ref id="B219"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yamamoto</surname><given-names>K.</given-names></name><name><surname>Koyanagi</surname><given-names>Y.</given-names></name><name><surname>Koshikawa</surname><given-names>N.</given-names></name><name><surname>Kobayashi</surname><given-names>M.</given-names></name></person-group> (<year>2010</year>). <article-title>Postsynaptic cell type-dependent cholinergic regulation of GABAergic synaptic transmission in rat insular cortex</article-title>. <source>J. Neurophysiol.</source>
<volume>104</volume>, <fpage>1933</fpage>&#x02013;<lpage>1945</lpage>. <pub-id pub-id-type="doi">10.1152/jn.00438.2010</pub-id><?supplied-pmid 20685921?><pub-id pub-id-type="pmid">20685921</pub-id></mixed-citation></ref><ref id="B144"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yamasaki</surname><given-names>M.</given-names></name><name><surname>Matsui</surname><given-names>M.</given-names></name><name><surname>Watanabe</surname><given-names>M.</given-names></name></person-group> (<year>2010</year>). <article-title>Preferential localization of muscarinic M1 receptor on dendritic shaft and spine of cortical pyramidal cells and its anatomical evidence for volume transmission</article-title>. <source>J. Neurosci.</source>
<volume>30</volume>, <fpage>4408</fpage>&#x02013;<lpage>4418</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.5719-09.2010</pub-id><?supplied-pmid 20335477?><pub-id pub-id-type="pmid">20335477</pub-id></mixed-citation></ref><ref id="B145"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zaborszky</surname><given-names>L.</given-names></name><name><surname>Duque</surname><given-names>A.</given-names></name></person-group> (<year>2000</year>). <article-title>Local synaptic connections of basal forebrain neurons</article-title>. <source>Behav. Brain Res.</source>
<volume>115</volume>, <fpage>143</fpage>&#x02013;<lpage>158</lpage>. <pub-id pub-id-type="doi">10.1016/s0166-4328(00)00255-2</pub-id><?supplied-pmid 11000417?><pub-id pub-id-type="pmid">11000417</pub-id></mixed-citation></ref><ref id="B146"><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Zaborszky</surname><given-names>L.</given-names></name><name><surname>Duque</surname><given-names>A.</given-names></name><name><surname>Gielow</surname><given-names>M.</given-names></name><name><surname>Gombkoto</surname><given-names>P.</given-names></name><name><surname>Nadasdy</surname><given-names>Z.</given-names></name><name><surname>Somogyi</surname><given-names>J.</given-names></name></person-group> (<year>2015</year>). &#x0201c;<article-title>Organization of the basal forebrain cholinergic projection system</article-title>,&#x0201d; in <source>The Rat Nervous System</source>, ed. <person-group person-group-type="editor"><name><surname>Paxinos</surname><given-names>G.</given-names></name></person-group> (<publisher-loc>Amsterdam</publisher-loc>: <publisher-name>Elsevier Inc.</publisher-name>), <fpage>491</fpage>&#x02013;<lpage>507</lpage>.</mixed-citation></ref><ref id="B147"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zeisel</surname><given-names>A.</given-names></name><name><surname>Hochgerner</surname><given-names>H.</given-names></name><name><surname>L&#x000f6;nnerberg</surname><given-names>P.</given-names></name><name><surname>Johnsson</surname><given-names>A.</given-names></name><name><surname>Memic</surname><given-names>F.</given-names></name><name><surname>van der Zwan</surname><given-names>J.</given-names></name><etal/></person-group>. (<year>2018</year>). <article-title>Molecular architecture of the mouse nervous system</article-title>. <source>Cell</source>
<volume>174</volume>, <fpage>999</fpage>&#x02013;<lpage>1014.e22</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2018.06.021</pub-id><?supplied-pmid 30096314?><pub-id pub-id-type="pmid">30096314</pub-id></mixed-citation></ref><ref id="B148"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Z.</given-names></name><name><surname>S&#x000e9;gu&#x000e9;la</surname><given-names>P.</given-names></name></person-group> (<year>2010</year>). <article-title>Metabotropic induction of persistent activity in layers II/III of anterior cingulate cortex</article-title>. <source>Cereb. Cortex</source>
<volume>20</volume>, <fpage>2948</fpage>&#x02013;<lpage>2957</lpage>. <pub-id pub-id-type="doi">10.1093/cercor/bhq043</pub-id><?supplied-pmid 20348157?><pub-id pub-id-type="pmid">20348157</pub-id></mixed-citation></ref><ref id="B149"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zoli</surname><given-names>M.</given-names></name><name><surname>Moretti</surname><given-names>M.</given-names></name><name><surname>Zanardi</surname><given-names>A.</given-names></name><name><surname>McIntosh</surname><given-names>J. M.</given-names></name><name><surname>Clementi</surname><given-names>F.</given-names></name><name><surname>Gotti</surname><given-names>C.</given-names></name></person-group> (<year>2002</year>). <article-title>Identification of the nicotinic receptor subtypes expressed on dopaminergic terminals in the rat striatum</article-title>. <source>J. Neurosci.</source>
<volume>22</volume>, <fpage>8785</fpage>&#x02013;<lpage>8789</lpage>. <pub-id pub-id-type="doi">10.1523/jneurosci.22-20-08785.2002</pub-id><?supplied-pmid 12388584?><pub-id pub-id-type="pmid">12388584</pub-id></mixed-citation></ref><ref id="B150"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zoli</surname><given-names>M.</given-names></name><name><surname>Pistillo</surname><given-names>F.</given-names></name><name><surname>Gotti</surname><given-names>C.</given-names></name></person-group> (<year>2015</year>). <article-title>Diversity of native nicotinic receptor subtypes in mammalian brain</article-title>. <source>Neuropharmacology</source>
<volume>96</volume>, <fpage>302</fpage>&#x02013;<lpage>311</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuropharm.2014.11.003</pub-id><?supplied-pmid 25460185?><pub-id pub-id-type="pmid">25460185</pub-id></mixed-citation></ref><ref id="B151"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zuccolo</surname><given-names>E.</given-names></name><name><surname>Lim</surname><given-names>D.</given-names></name><name><surname>Kheder</surname><given-names>D. A.</given-names></name><name><surname>Perna</surname><given-names>A.</given-names></name><name><surname>Catarsi</surname><given-names>P.</given-names></name><name><surname>Botta</surname><given-names>L.</given-names></name><etal/></person-group>. (<year>2017</year>). <article-title>Acetylcholine induces intracellular Ca<sup>2+</sup> oscillations and nitric oxide release in mouse brain endothelial cells</article-title>. <source>Cell Calcium</source>
<volume>66</volume>, <fpage>33</fpage>&#x02013;<lpage>47</lpage>. <pub-id pub-id-type="doi">10.1016/j.ceca.2017.06.003</pub-id><?supplied-pmid 28807148?><pub-id pub-id-type="pmid">28807148</pub-id></mixed-citation></ref></ref-list></back></article>